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Abstract 
The presence of small regulatory RNAs (sRNA) have now been identified in 
many bacteria. With the ability to regulate multiple targets at the post 
transcriptional level, sRNAs allow bacteria to adapt to changing environments 
through a regulatory step that is independent of any transcriptional signals of 
the target mRNAs. Previous reports show a role for sRNAs in the stress 
response [1]. Therefore Mycobacterium tuberculosis sRNAs could be critical for 
the adaptive response to the harsh environment encountered during infection. 
Multiple potential sRNAs have been identified in M. tuberculosis within the last 
few years using cDNA cloning and high throughput RNA sequencing techniques 
[2, 3]. Four verified sRNAs found using these two approaches, were selected for 
detailed investigation. The aims of the study were to identify function and 
interactions for the sRNAs ncRv10243, ncRv11690, ncRv12659 and 
ncRv13661 of Mycobacterium tuberculosis and assess their role in virulence. 
Transcriptomic and proteomic approaches were used to investigate sRNA 
expression strains for regulatory targets.  
Deletion and/or over expression were shown to result in changes of both mRNA 
and protein abundance, indicating that all candidates were functional in M. tb. 
Each sRNA had a varied pattern of expression, induced under a variety of 
stress conditions including infection. Deletion of 3 of the sRNAs however did not 
result in attenuation in the mouse model of infection. 
The challenge of characterising sRNAs demonstrates that one single technique 
is inadequate to identify function and a multi-pronged approach is more likely to 
identify direct targets. 
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 Introduction 
 Tuberculosis 
Tuberculosis (TB) is one of the world’s biggest and oldest killers among the 
infectious diseases. It is an ancient disease, and evidence of tubercular decay 
has been found in the skulls and spines of Egyptian mummies showing direct 
evidence of TB colonising humans more than 5,000 years ago [4]. Recently, 
analysis of whole genome sequences from the Mycobacterium tuberculosis 
Complex (MBTC) alongside human mitochondrial genomes has led to the 
estimation that TB is actually more than 70,000 years old [5].  
Tuberculosis can be caused by various species of mycobacteria but mainly by 
Mycobacterium tuberculosis (M. tb). The discovery of M. tb as the cause of TB 
infection was famously demonstrated by Robert Koch to the Berlin Physiological 
Society in 1882, which contributed greatly to him being awarded the Nobel Prize 
in 1905, [6, 7]. In 1993 the WHO declared TB to be a ‘global emergency’ due to 
the rapid spread of disease accelerated by HIV, drug resistance and the 
movement of people around the world. 
The latest estimations by the World Health Organisation (WHO) show that TB is 
responsible for killing approximately 1.3 million people a year, and it is 
estimated that one third of the world’s population is latently infected with TB [8]. 
The greatest incidence of disease by far is in Southern Africa where it has 
escalated due to its deadly synergy with HIV. TB is a leading cause of death 
among those infected with HIV; in 2012 it was estimated that 20% of deaths 
among people with HIV/AIDS are due to TB [8].  
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Although the burden of disease falls generally on the developing world, it is 
increasingly becoming a problem in lower incidence countries in the west mainly 
due to immigration, poverty and homelessness [9]. In the UK, almost three 
quarters of TB cases occurred amongst people born outside of the country, but 
only 15% of these were recent migrants. In 2013 70% of all TB cases in the UK, 
were found to be residents in deprived areas, with almost half of these people 
being unemployed. These are similar statistics to the 2003 study by Antoine et 
al indicating no change in trend [10].  
1.1.1 Mycobacteria and the Mycobacterium tuberculosis 
Complex 
M. tb is an actinomycete belonging to the family Mycobacteriaceae. This 
genus includes the M. tuberculosis Complex (MTBC), Mycobacterium 
leprae, and non-tuberculous mycobacteria [11]. The MTBC is made up of 
mycobacteria causing TB in human and animal hosts; comprising the 
well-known M. tb, Mycobacterium bovis and the vaccine strain M. bovis 
Bacille Calmette-Guérin (BCG) as well as Mycobacterium africanum, 
Mycobacterium canettii and Mycobacterium microti [12].The members of 
the complex differ in host specificity, pathogenicity and a small number of 
phenotypic and/or genotypic characteristics  
Pathogenic mycobacteria are capable of causing a variety of diseases. In 
addition to the well-known human pathogen M. tb, is M. leprae, which 
causes leprosy and M. ulcerans which results in Buruli ulcers. Other 
mycobacteria can act as opportunistic pathogens of humans as is the 
case for M. avium and M. marinum are also common pathogens of birds, 
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and fish, causing granulomatous lesions of the organs or skin 
respectively. 
Mycobacteria can be divided into two categories of slow and fast 
growers. The slow growers such as M. tb take a week or more to grow 
on solid agar while the fast growers such as M. smegmatis take 2-3 days 
[13]. This equates to a doubling time of approximately 17 hours for M. tb 
and 4 hours for M. smegmatis. Environmental mycobacteria are 
distinguished from the members of the MTBC and M. leprae by the fact 
that they are not obligate pathogens. In general it appears that slow 
growers such as M. tb and M. marinum are pathogens whereas fast 
growers such as M. smegmatis are environmental species [14]. 
Chemostat experiments have shown that the control of growth rate in 
mycobacteria is not due to acceleration or deceleration of cellular 
processes but through the control of particular gene sets [15]. These 
genes include transcriptional regulators e.g. hspR and some genes 
previously implicated in virulence and persistence (ppsA and ppsB) [15]. 
It is advantageous for the pathogenic species to be slow growers in order 
to establish an infection and transmit to another host. If the disease were 
to progress too quickly the host may die before transmission. 
It is of note that rapidly growing mycobacteria still grow significantly more 
slowly than most bacteria. This could be in part due to differences in 
rRNA. The number of ribosomal (rrn) operons varies between species 
and a correlation has been observed between the bacterial maximum 
growth rate and the number of rrn operons in the genome [16]. The slow 
21 
 
growing M. tb contains but one rrn operon, whereas the faster growing 
M. smegmatis contains two, rrnA and rrnB [17]. However, if you remove 
all but one ribosomal operon from the fast growing species Escherichia 
coli (E. coli) a fast doubling time is still maintained [18]. This suggests 
that it is not the number of rrn operons that dictates the maximum 
doubling time, but in fact the contrary, with the growth rate dictating the 
number of rrn required. 
M. tb is a gram positive bacterium that is distinct from other gram positive 
bacteria as it possesses an acid fast cell wall that contributes to its 
hydrophobic nature. This complex cell envelope is rich in lipids 
containing mycolic acids (Figure 1.1) and accounts for 60% of the dry 
weight of the bacteria [19]. It is this lipid rich layer that is believed to 
confer resistance to killing through acidic and alkaline compounds, 
antibiotics, and free radicals [20] and it has been shown that these lipids 
are critical for virulence [21].  
  
22 
 
 
 
 
Figure 1.1 The structure of the M. tuberculosis cell envelope 
CF = cord factor, GMM = glucose monomycolate, PAT =polyacyltrehalose,  
LOS = lipooligosaccharides, PDIM = phthiocerol dimycoserosates,  
PheGP = phenolic glycolipids, SGL = sulphoglycolipids, GroMM = glycerol 
monomycolate. 
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 The pathogenesis of tuberculosis 
M. tb predominantly presents as a pulmonary infection in humans, with the 
ability to lie dormant in the body for decades. It is transmitted through the 
inhalation of aerosolised droplets and once the bacteria are inside the lung, they 
are taken up by alveolar macrophages [22, 23]. Upon phagocytosis of the 
bacteria an induction of a localised proinflammatory response leads to the 
recruitment of mononuclear cells from neighbouring blood vessels. This is the 
initial step that leads to the granuloma formation that is a common feature of 
tuberculosis. The granuloma consists of centrally infected macrophages 
surrounded by foamy giant cells and macrophages with a mantle of 
lymphocytes [24]. The bacteria reside in the macrophages through an ability to 
block phagosome maturation and to resist damage by free radicals, thereby 
allowing them to replicate freely. This strategy is part of the success story of 
tuberculosis as it is these cells that are supposed to sustain an effective initial 
barrier to bacterial infection (Figure 1.2). 
In an immuno-competent individual this aggregation of immune cells prevents 
the spread of infection. The granuloma serves both to prevent dissemination of 
the bacteria and to provide an environment for cross talk between immune cells. 
During this stage there are usually no symptoms and the host is not infectious. 
If immunity is weakened such as in the case of HIV infection, the granulomatous 
lesion fails to contain the mycobacteria. These lesions can contain large 
numbers of bacteria (>109 bacilli), and their rupture can result in the 
dissemination of M. tb to other organs through the circulatory system. Active 
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disease then develops and the patient becomes infectious, spreading the 
disease by aerosol [25]. 
It had long been accepted that M. tb resides exclusively within membrane-
enclosed vacuoles within the macrophage. Some experiments in the 1980’s and 
1990’s discovered M. tb free of the phagosomal membrane after a few days of 
infection. There is now a growing debate on the localisation of the bacterium 
within the phagosome, reviewed in [26]. Translocation of the bacilli into the 
cytosol has been observed by several groups [27-29]. In the study by Van der 
Wel et al. involving infections of human monocyte-derived dendritic cells and 
macrophages, it was observed that M. tb containing phagosomes fused with 
lysosomes and then gradually the bacteria translocate to the cytosol after 2 
days infection [29]. The results were interpreted as evidence that the cytosol 
was more permissive to bacterial growth than the endosome. These findings 
are quite controversial as this phenomenon has not been observed by all 
groups. 
The infectious life cycle of TB is complex, it must adopt various growth states in 
order to transmit, infect and also remain latent for years undetected in many 
hosts. For this reason, M. tb has been found to exist in many states on a 
spectrum ranging from an active, to persistent or dormant (latent) TB infection 
[30], Figure 1.3. The term dormant refers to bacteria, which are in a non-
replicating drug-resistant state. These bacteria are viable but unable to form 
colonies directly or immediately on plating but which can be resuscitated to form 
colonies under appropriate conditions [31, 32]. Persistence refers to genetically 
drug-susceptible bacteria that can survive indefinitely within the host despite 
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continued exposure to the drug in question [33]. Separate granulomatous 
lesions within the lung of one individual can have different fates, with some 
lesions being active while others are sterile [34], and in fact the population 
within the granuloma itself could be phenotypically heterogeneous. A greater 
understanding of the mechanisms controlling the life cycle of M. tb will enhance 
future drug development and allow both dormant and actively replicating 
bacteria to be targeted in concert. 
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Figure 1.2 The pathology of the granuloma taken from (Russell 2007) 
Aerosolised droplets are delivered to the lung where the first infected cells are the 
alveolar macrophages. The infected macrophage then invades the adjoining 
epithelium where a proinflammatory response then leads to the recruitment of 
monocytes from neighbouring blood vessels. A granuloma develops with 
macrophages, giant cells and foamy macrophages. In many of these lesions, the 
cells are separated by a fibrous layer of extracellular matrix.   
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Figure 1.3 The Differing Physiological States of M. tuberculosis 
LTBI = Latent tuberculosis infection, rpfs = resuscitation promoting factors.  
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 Tuberculosis therapy 
Most of the first line drugs still used today were discovered decades ago and 
drug resistance is increasing. Multidrug-resistant tuberculosis (MDR-TB) is a 
form of TB caused by bacteria that do not respond to at least isoniazid and 
rifampicin, which are the two most powerful front line drugs. 450,000 cases of 
MDR-TB were reported in 2012 [8]. Extensively drug-resistant TB (XDR-TB) 
cases also exist, in these cases the patient presents with resistance not only to 
the front line drugs rifampicin, isoniazid, ethambutol and pyrazinamide, but also 
to some of the most effective second-line anti-TB drugs. Second line drugs 
include, fluoroquinolones, and the injectables; capreomycin, kanamycin or 
amikacin. Totally drug resistant tuberculosis (TDR-TB) cases have also been 
characterised with in vitro resistance to all first and second line drugs tested, 
(isoniazid, rifampicin, streptomycin, ethambutol, pyrazinamide, ethionamide, 
para-aminosalicylic acid, cycloserine, ofloxacin, amikacin, ciprofloxacin, 
capreomycin, and kanamycin). These TDR-TB bacilli have been found to be 
morphologically different from other M. tb with variations in shape, cell division 
and thickness of cell wall [35]. Resistant strains exhibit different fitness profiles 
when grown in competition with different susceptible strains. Drug-resistant 
strains often demonstrate decreased competitive ability against susceptible 
strains in the absence of the drug [36] [37]. The problem of drug resistance 
hampering treatment has led to an urgent need for new therapies. 
Part of the problem with drug resistance stems from the prolonged treatment 
period required to cure the patient. The long treatment period coupled with 
potential side effects of the drugs lead to non-compliance followed by the 
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emergence of drug resistance. The current regime for active pulmonary disease 
is a 6 month course of four antimicrobial drugs, consisting of isoniazid (an 
inhibitor of mycolic acid synthesis) and rifampicin (an inhibitor of RNA synthesis) 
[38] for 6 months. Pyrazinamide (an inhibitor of trans-translation [39]) and 
ethambutol (an inhibitor of cell wall synthesis) must be taken in addition to 
isoniazid and rifampicin for the first two months of treatment [38]. MDR-TB and 
XDR-TB patients require an even longer treatment period with a combination of 
first line and second line drugs.  
 Vaccination 
The only vaccine currently in use for M. tb is BCG, which was developed at the 
Pasteur Institute by Albert Calmette and Camille Guérin, who attenuated a 
mycobacterium related to M. tb (M. bovis), by passaging it for 13 years and 
monitoring its decrease in virulence [40]. In 1921, the vaccine was administered 
to infants in France, where it reduced mortality by approximately 90%. Since 
this time BCG has become widely used due to its low cost and safety. 
Unfortunately the BCG vaccine has had limited efficacy in the developing world, 
especially against the pulmonary form. It is thought that this is due to prior 
sensitisation to environmental mycobacteria. In order for more effective 
vaccines to be designed we need to gain a better understanding of M. tb and its 
host response during infection [41]. 
 Gene Regulation 
The M. tuberculosis genome consists of ~4,000 protein encoding genes whose 
expression is controlled by 13 sigma factors, responsible for global regulation of 
gene transcription. During exponential growth, bacteria constitutively express 
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so-called ‘housekeeping’ genes, which possess promoters that are recognised 
by primary group 1 sigma factors such as σ70 [42]. This house keeping sigma 
factor homologue is termed SigA in M. tb [43].  
When the bacteria sense stress, for example low oxygen (hypoxia) and low pH, 
which may be encountered in the different host environments, they must adapt 
to these stresses quickly.  One common strategy adopted is to replace the 
primary sigma factor that is associated with the core RNA polymerase (RNAP) 
with an alternative sigma factor. This changes the promoter specificity of the 
RNAP and thereby allows expression of a different set of genes [44]. This 
conventional form of transcriptional regulation is complemented by 
approximately 200 transcription factors in M. tb. One such example is that of 
CarD which interacts directly with the β subunit of RNAP [45]. These 
transcription factors dictate the expression of subsets of genes through direct 
interaction with either the DNA or RNAP. 
The central dogma of molecular biology is the concept that information flows 
from DNA to RNA to protein, and it is this, which determines the cellular 
phenotype. Gradually this simplified idea is becoming more and more out dated 
as the understanding of the role of RNA in the cell grows. It has long been 
understood that tRNA, mRNA, and rRNA are fundamental parts of all bacterial 
cells. They are necessary for translation, but in addition to these transcripts are 
also small RNAs (sRNAs). The complementary network of sRNAs, capable of 
acting at the transcriptional and post transcriptional level has challenged the 
central dogma. There is now a growing appreciation of the abundance of 
sRNAs and their importance in cell processes. 
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sRNAs are short RNA transcripts (typically consisting of ~50-250 nucleotides) 
which are not translated [46]. These sRNAs are capable of interacting with 
mRNA and proteins, either as RNA alone or in association with proteins as part 
of a ribonucleoprotein (RNP) complex. Many roles have been described for 
sRNAs including transcriptional regulation, RNA processing and modification, 
mRNA stability and translation as well as protein degradation and translocation 
[47].  
 Identification of sRNAs 
Non-coding RNAs were initially identified by the detection of highly abundant 
sRNAs through direct labelling and sequencing. This led to the discoveries of 
housekeeping RNAs such as RNaseP, tmRNA and 4.5S RNA, which are 
involved in tRNA maturation, ribosome rescue and protein translocation 
respectively.  
To date, E. coli and Salmonella typhimurium (Salmonella) have by far the most 
identified sRNAs, with over 80 having been described [48-50] for E. coli and 
approximately 280 identified for Salmonella [51, 52]. A mixture of techniques 
have been used to find sRNAs, from in silico prediction and bioinformatic based 
approaches [53] to cloning and sequence based methods.  
Even when the complete genome sequence of an organism is known, new 
sRNAs can be overlooked because there are no specific classes of sRNAs that 
can be found based solely on sequence. In 2001 a combination of techniques 
were employed to look for new sRNAs in E. coli [54]. The sequences of 
intergenic regions longer than 180bp were compared to Salmonella and 
32 
 
Klebsiella pneumonia by NCBI Unfinished Microbial Genomes database using 
the BLAST program [55]. Sequences with greater than 80 nucleotides 
conservation were then filtered based on their orientation and distance in 
relation to the flanking ORFs. Finally the remaining potential sRNAs were 
examined for promoters, terminators and inverted repeat regions. These 
predictions were compared with microarray data and resulted in a possible 59 
sRNAs of which 17 were confirmed by northern blot and considered to be new 
sRNAs [54]. 
An alternative approach using bioinformatics to identify sRNAs has been taken 
to conduct genome-wide annotations for putative sRNA genes in the intergenic 
regions of eleven pathogens using the sRNAPredict2 program [56]. In total, 
more than 2700 sRNAs were revealed as unannotated candidate sRNA loci in 
the diverse bacteria, although these remain to be experimentally confirmed.  
One unbiased method to investigate the sRNA component of an organism is to 
clone and directly sequence short bacterial transcripts by parallel RNA 
sequencing. This approach was adopted with the pathogen Vibrio cholerae, in 
which they discovered 500 new putative intergenic sRNAs and 127 putative 
antisense sRNAs from the growth conditions examined [57].  
Most recent work employs new technologies such as high-throughput RNA 
sequencing (RNA seq) and high-density tiling arrays to detect the expression of 
sRNAs in both pathogenic and non-pathogenic species [58, 59].  
Many sRNAs were identified in Salmonella by the co-immunoprecipitation (coIP) 
with the epitope-tagged RNA chaperone Hfq. High throughput sequencing 
analysis from RNA co-immunoprecipitated with either the epitope-tagged Hfq or 
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the control coIP, identified new sRNAs doubling the number of sRNAs 
previously known to be expressed in Salmonella [60].  
 Hfq 
Approximately half of all sequenced bacterial genomes encode an Hfq 
homologue. The Hfq protein is highly conserved in prokaryotes and belongs to 
the Sm protein family whose members are known to be involved in RNA 
interactions [61, 62]. Hfq is an RNA chaperone known to bind to both sRNA and 
mRNA, facilitating their pairing. 
The protein forms a hexameric ring structure which contains at least two RNA 
binding faces [63, 64]. One face binds to single stranded A/U-rich regions (i.e. 
sRNA and mRNA) [65], the other to polyA (i.e. mRNA) [66]. Hfq has been 
shown to play a central role in sRNA–mRNA interactions facilitating the short 
and imperfect base pairing between the sRNAs and their mRNA targets. Förster 
resonance energy transfer studies (FRET) showed that Hfq promotes both RNA 
annealing and strand exchange by binding rapidly to both the sRNA DsrA and 
rpoS mRNA [67]. Strand exchange occurs as the internal structure of rpoS is 
disrupted and pairing occurs with DsrA resulting in the Shine-Dalgarno 
sequence of the mRNA rpoS becoming exposed.  
In Gram-negative pathogens deletion of Hfq often leads to a loss of virulence, 
which is attributed in part to loss of proper sRNA function [58, 68]. However, Hfq 
is not always required for proper sRNA function. For instance, there is no 
homologue in the Actinomycetes-Deinococcus-Cyanobacteria [49, 69], of which 
M. tb is a member. There is conflicting evidence as to whether Hfq is required 
for virulence in Staphylococcus aureus. One study found that deletion of Hfq 
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had no effect on the expression of virulence genes, nor was the protein highly 
expressed [70]. A later study however found 116 genes to be differentially 
expressed in an Hfq mutant, and 49 of these were shown to bind Hfq by 
immunoprecipitation [71].  It was concluded from the latter study that the 
differences in Hfq phenotype observed, could be due to strain variation as the 
initial study strain lacked Hfq expression [71].  
The lack of a homologue for Hfq in M. tb could possibly be due to the existence 
of a functional analogue. Due to the lack of sequence homology this would be 
very difficult to identify. Alternatively, it could simply be that M. tb lacks the 
requirement for such a protein. It could be that there is more extended base 
pairing between the sRNA and the mRNA. Or a higher percentage of G or C 
bases present in the binding sequence would be expected to result in more 
stable conformations. The high GC content of M. tb (67%) could favour this 
theory as the low frequency of AU-rich stretches provide fewer potential binding 
sites that are known to mediate Hfq interactions [72]. 
It is possible that other proteins could contribute to base-pairing sRNA function 
thereby substituting for the lack of an Hfq homologue. In B. subtilis three 
proteins (FbpA-FbpC) have been identified as possible RNA chaperones 
needed for the FsrA sRNA to regulate sdhC expression [73]. However these are 
specific for one RNA and not global regulators as is the case for Hfq. 
The YbeY protein found in most bacteria was suggested as a possible 
candidate as an Hfq analog. This protein in M. tb is Rv2367c and shares 
structural similarities with eukaryotic Argonaute proteins which are known to 
bind small non-coding RNAs [74]. The E. coli YbeY has been shown to be a 
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strand-specific endoribonuclease, playing key roles in 70S ribosome quality 
control and 16S ribosomal RNA maturation [75]. In addition, deletion of YbeY 
results in similar phenotypes to those of a Hfq mutant [76] demonstrating that 
YbeY plays a role in sRNA regulation in bacteria that is of equal importance to 
that of Hfq.  
In addition to binding RNAs, Hfq is also thought to interact with components of 
the ribosome and degradosome [77].  
1.8 The Degradosome and RNases. 
The degradosome is an RNA degrading complex that consists of key RNA 
enzymes that are responsible for RNA degradation processes. In E. coli the 
complex is comprised of RNase E, RNA helicase B, enolase, and the 
exoribonuclease polynucleotide phosphorylase (PNPase) [78-82]. RNase E is 
present in many bacteria, including mycobacteria [83], however the components 
of the degradosome are not conserved between species. Very little is known 
about the degradosome and RNA metabolism in mycobacteria. M. tb possesses 
RNaseE but it was found to interact with only some of the degradosome 
components identified in enteric bacteria [83]. 
It is known from other bacteria that RNase E functions as a scaffold for the 
assembly of the RNA degrading complex and acts as an endoribonuclease 
being the primary instigator of transcript degradation. Once RNase E has 
initiated cleavage, degradation of the RNA quickly follows [84]. However, RNA 
maturation is also a function of RNase E, cleaving precursors of structured 
RNAs resulting in processed transcripts that are not marked for decay [85].  
 In Salmonella there exist two pathways for the degradation of sRNA MicA 
which controls the outer membrane porins (OMPs) OmpA and LamB. Turnover 
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of this sRNA is either through RNase E cleaving the unpaired MicA, or by the 
endoribonuclease RNase III, which cleaves MicA in complex with its target 
mRNA due to the enzyme specificity for double stranded RNA [86].  
The mechanism for RNase III has similarity to the eukaryotic RNAi system 
where the double stranded enzymes Dicer and Drosha play an important role 
[86-88]. M. tb possesses an RNaseIII enzyme which has been shown in S. 
aureus to be important in antisense regulation [89] the maturation of rRNAs and 
tRNAs, and regulating the turnover of mRNAs and sRNAs [90].  
In a co-IP study, RNase III was shown to have a positive effect on protein 
synthesis with RNase III–mediated cleavage in the 5′UTR enhancing the 
stability and translation of cspA mRNA, which encodes a major cold-shock 
protein. Moreover, RNase III cleaved overlapping 5′UTRs of divergently 
transcribed genes to generate leaderless mRNAs, resulting in a new 
mechanism for co-regulating neighbouring genes [90]. 
Another RNase of significant importance as a post-transcriptional regulator of 
sRNAs is the 3’-5’ exoribonuclease PNPase. PNPase has been found to 
stabilize several sRNAs in E. coli including RhyB, SgrS, CyaR [91], and its 
action is growth phase dependent [92]. When a sRNA is not associated with 
Hfq, it is degraded in a target independent pathway. As the 3’ ends to the sRNA 
are exposed when not bound by Hfq PNPase degradation can occur [92]. 
1.9 Regulation of Gene Expression by sRNAs in bacteria 
sRNAs can be divided into two types, trans-encoded/intergenic and cis-
encoded/antisense. Cis-encoded sRNAs are located on the opposite strand to a 
coding region and have extensive complementarity (>75 nucleotides) to their 
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targets [50]. Trans-encoded sRNAs are located in intergenic regions of the 
chromosome and can regulate multiple mRNAs across the genome (Figure 
1.4). Due to their interaction with multiple targets they have limited 
complementarity (10-30 nucleotides) to the mRNA and form imperfect base-
pairing interactions [50]. The sRNA pairing with the mRNA can result in the 
enhancement or repression of translation. In addition to effects on translation, 
several trans-encoded sRNAs have also been shown to bind proteins to 
modulate their activity [69, 93].  
The first sRNAs were observed in E. coli in the 1970’s with the discovery of 
4.5S and 10S, although no function was ascertained at the time [94, 95]. The 
next sRNA discovery was in the 1980’s when the plasmid-encoded antisense 
RNA, termed RNA I, was discovered and found to control plasmid copy number 
in E. coli [96, 97]. Studies by the Tomizawa and Stougard groups led to the 
understanding of the importance of secondary structure that allows RNA/RNA 
duplex formation [98-100]. At the same time the idea that an RNA transcript 
could interact with an mRNA from a distal gene was also proposed [101, 102].  
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Figure 1.4 Representation of genomic locations of sRNAs. 
Cis-encoded sRNAs are found antisense to the mRNA target and possess a high 
degree of complementarity. Trans-encoded sRNAs are found at different locations 
on the genome, regulate multiple targets and therefore have limited 
complementarity. Ribosome Binding Site (RBS) 
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1.9.1 Translational Repression 
MicF was the first example of a trans-encoded RNA, it was found to 
negatively regulate the translation of the outer membrane protein OmpF in 
E. coli [102]. Since this discovery, additional outer membrane proteins, 
OmpA and OmpC have also been shown to be regulated at the 
translational level by sRNAs MicA and MicC [103, 104]. The sRNAs MicA 
and MicC act to inhibit translation by binding to the mRNA (with imperfect 
base pairing complementarity), to mask the ribosome binding site (RBS) 
and prevent the mRNA being loaded into the ribosome [105] see Figure 
1.5. sRNAs in E. coli such as MicA, MicC, Spot42 and OxyS sRNAs were 
shown by in vitro toeprinting experiments to directly interfere with 30S 
ribosome binding of their target mRNAs OmpA, OmpC, galK and fhlA 
[104, 106-108]. Toeprinting is a method used to study the formation of 
ribosomal initiation complexes in bacteria, which allows visualisation of 
how mRNA conformational changes alter ribosome binding at the initiation 
site in vitro. This differs from the method of DNA foot printing where the 
sequence specificity of DNA-binding proteins in vitro is ascertained. 
E. coli is not the only organism in which this mode of action has been 
observed. 
sRNAs RNAIII and SR1 in the Gram-positive bacteria S. aureus and 
Bacillus subtilis, respectively, have also been shown to inhibit translation 
[87, 109].  
As more work on sRNA regulatory mechanisms is performed, variations 
on the basic theme of translational repression have been discovered. 
Binding of sRNAs to mRNAs outside the RBS can still inhibit translation 
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[110-113]. Two such mechanisms include the recruitment of Hfq to bind at 
a site overlapping the ribosome binding site blocking access to the 
ribosome [114] or by binding to mRNA sequences that apparently act as 
translational enhancer elements [115, 116] 
Regardless of the precise regulatory mechanism, sRNA-mediated 
translational repression often results in mRNA degradation by an RNase E 
degradosome-dependent pathway. The ribosomes protect the mRNA from 
RNase E degradation by masking the RNase E recognition sites [117], 
thus sRNA inhibition of translation unmasks these sites and leaves target 
mRNAs susceptible to ribonuclease attack [118]. 
However, translational inhibition is not always coupled to mRNA 
degradation. It has been observed that mutations abolishing RNase E-
dependent turnover of sRNA targets can have no impact on translational 
repression [119-121]. There are also some cases where sRNA-mediated 
translational repression has no significant effect on mRNA levels [107].  
This mode of regulation allows for differential regulation of genes within 
the same operon. Such is the case in E. coli, the spot42 sRNA targets the 
RBS of galK within the galETKM polycistronic mRNA (which is involved in 
galactose metabolism) to prevent translation initiation of galK without 
affecting the other genes of the operon [107]. 
The reverse is also true, with cases where sRNAs do not directly affect 
translation but target mRNAs for degradation [122, 123].  
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Figure 1.5 Translational inhibition mediated by sRNAs. 
Translational Inhibition by sRNAs typically involves base pairing to the mRNA to 
occlude the ribosome binding site of the mRNA. This prevents ribosome 
association and thus represses translation. Such as is the case for the sRNA 
Spot42 which binds to its mRNA targets with imperfect complementarity under 
glucose stress [107]. 
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1.9.2 Translational Activation 
sRNAs are capable of not only repressing translation but also activating 
translation. The E. coli sRNAs DsrA and RprA are induced under low 
temperature and surface stress, respectively. DsrA and RprA bind to the 
mRNA of rpoS, (the stress sigma factor) and increase translation through 
a change in secondary structure of rpoS to reveal an otherwise masked 
ribosome binding site [93, 124, 125]. The rpoS mRNA has a long highly 
structured 5’ untranslated region (UTR), which can fold to mask the 
ribosome binding site. Upon pairing of the sRNA with the mRNA the 
secondary structure is opened to allow access to the RBS (see Figure 
1.6). This form of regulation, as with translational repression, is not limited 
to monocistronic mRNAs. Examples of discordant operon regulation by 
activation also exist. GlmZ sRNA increases translation of glmS in the 
glmUS operon by influencing the action of another sRNA GlmY, in a 
hierarchical fashion [126, 127]. First GlmZ, together with the chaperone 
Hfq activates translation of the glmS mRNA through the opening of a stem 
loop secondary structure to reveal the ribosome binding site. Secondly 
GlmY acts to stabilise the GlmZ sRNA by sequestering the RNA-
processing protein YhbJ, thereby indirectly activating expression of glmS 
by increasing the levels of the sRNA GlmZ [47, 128]. 
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Figure 1.6 Translational activation mediated by sRNAs. 
Long 5’ UTRs of mRNA can fold into auto-inhibitory stem loop structures, which 
prevent ribosome access. Interaction of a sRNA with the mRNA results in 
translation activation by dissolving the fold-back structure, for example  rpoS 
mRNA and the sRNA DsrA [129]. 
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1.10 6S RNA 
Although the most common mode of action for sRNAs is through base 
pairing, some sRNAs bind proteins to inhibit their (regulatory) activities. 
The best studied example is that of E. coli 6S RNA, which binds the 
housekeeping form of RNA polymerase (70-RNAP) (reviewed in [130]). 
This sRNA was first identified in 1967 but its function was not discovered 
until more than 30 years later.  
Co-migration studies demonstrated that 6S sediments with RNAP in 
glycerol gradients [131] binding tightly to the σ70 but not the σs holoenzyme 
[132]. The secondary structure of 6S RNA mimics that of DNA during 
transcription initiation (i.e. an open promoter complex) competing for 
RNAP, blocking access of the DNA promoter to the RNAP active site [130] 
thereby broadly down regulating transcription (Figure 1.7). However, 
down-regulation is only observed for a subset of 70 –controlled genes 
when 6S is expressed indicating that 70 -RNAP activity is modified in a 
fine tuning manner and not just inhibited.  
In E. coli 6S RNA has been shown to regulate transcription of relA, which 
encodes a guanosine (penta) tetraphosphate (p) ppGpp synthase. The 
decreasing availability of amino acids upon entry into stationary phase is 
mainly sensed by RelA. The uncharged tRNAs accumulate as a result of 
decreasing amino acid pools causing RelA to be activated and 
synthesizes ppGpp.ppGpp binds to RNAP along with the transcription 
factor DksA [133] to alter transcription of genes with σ(70)-dependent 
promoters sensitive to ppGpp such as genes involved in amino acid 
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biosynthesis and rRNA. In gram negative bacteria RelA and SpoT are 
responsible for the production of (p)ppGpp, but in M. tb only the single 
homolog RelA produces (p)ppGpp [134]. The mechanism of rRNA control 
in mycobacteria, which lack DksA is unknown but the essential protein 
CarD has been identified as a regulator of rRNA transcription [135]. It has 
been observed in E. coli that induction of relA leads to increased ppGpp 
levels in early stationary phase in cells lacking 6S [136]. 
Deletion of 6S RNA in E. coli has no obvious detrimental effects during 
exponential growth but is important for optimal survival during stationary 
phase growth when 6S accumulates within the cell [137]. During outgrowth 
from stationary phase, under conditions of nutritional up shift when NTPs 
are no longer limiting, the 6S RNA acts as a template for a short product 
RNA (pRNA). These pRNAs of 14-20 nucleotides destabilize the 6S RNA-
RNAP complex, which leads to the ejection of the pRNA-6S RNA hybrid 
[138] thereby recycling the RNAP for re use. 
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Figure 1.7 Sequestering of RNAP by 6S RNA  
6S RNA acts as a mimic of the DNA in open promoter conformation suppressing 
housekeeping transcription by binding to σ⁷⁰ RNA polymerase holoenzyme (core 
polymerase + σ⁷⁰) causing widespread down regulation of σ⁷⁰ genes. 
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1.11 Dual Function sRNAs 
sRNAs are in general considered to be non-coding. However, examples do 
exist of sRNAs that can both regulate mRNA through base pairing, and encode 
proteins. In E. coli the 227bp sRNA SgrS helps cells recover from glucose 
phosphate stress. SgrS negatively regulates translation and stability of the 
mRNA ptsG, which encodes a major sugar phosphate transporter, by a base 
pairing mechanism that requires Hfq [139]. It was found that the sRNA 
contained a small open reading frame (ORF) of 43 amino acids encoding SgrT 
[140]. SgrT is encoded upstream of the nucleotides involved in base pairing and 
is translated under glucose phosphate stress, inhibiting the glucose transporter 
PtsG. [140]. It was concluded that SgrT reinforces the regulation of SgrS by 
independently down regulating glucose uptake by interacting directly with PtsG 
protein to inhibit its activity, possibly by plugging the transporter [140]. 
 
1.12 Riboswitches 
A 5’ UTR is the region from the transcriptional start site to the translational start 
site of a gene. It is in this region that riboswitches and RNA thermo sensors are 
usually found. Riboswitches can bind small molecules, which result in an 
alternative secondary structure of the RNA. This change in structure can lead to 
either transcriptional or translational repression or activation of the downstream 
sequence by blocking or revealing the RBS. [141].  
Homology searches using the consensus sequence and structural model for the 
coenzyme B12 class of riboswitches revealed that M. tb contains two such 
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riboswitches. This type of riboswitch is often found upstream of genes involved 
in the synthesis and transport of cobalamin. One example is that of the B12 
riboswitch found upstream of MetE, which codes for the B12-dependent 
methionine synthase [142]. The other B12 riboswitch is found upstream of the 
operon containing PPE2, cobQ1 and cobU.  
In addition to the above riboswitches M. tb also contains two copies of the 
magnesium sensing riboswitch known as an Mbox. One is found upstream of 
Rv1535  [3, 143] which is up regulated in response to magnesium starvation 
[144]. The other Mbox is found upstream of a putative operon containing four 
PE-PPE genes. The B. subtilis Mbox when bound to Mg2+ results in attenuation 
of transcription, and this is the likely mechanism in M. tb. Rv1535 is also co-
transcribed with a downstream riboswitch that binds uncharged tRNAs, (TBox) 
[145] this TBox is in the 5’UTR of ileS a tRNA synthase.  
Gene expression has also recently been demonstrated to be directly affected by 
c-di-AMP-responsive riboswitches in the 5’ UTR’s of many mRNAs in bacteria. 
The important resuscitation promoting factor (rpfA) was identified as having one 
such riboswitch in M. tb [146]. 
1.13 sRNAs in Mycobacterium tuberculosis pathogenesis 
Many sRNAs are post-transcriptional regulators of gene expression induced in 
response to external stimuli or stress and they have been found to be 
differentially regulated under a variety of growth conditions [54]. Stress 
conditions that have been shown to induce sRNA expression include low iron 
[147, 148], low temperature [149], changes in glucose concentration [107], 
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changes in glucose-phosphate levels [49], and outer membrane stress under 
the control of σE [108]. This additional layer of control that complements 
transcriptional regulation affords the bacteria a method of rapid response to 
stress. 
Regulation of sRNAs has been implicated in the stress response and virulence 
of many pathogens other than M. tb including Listeria monocytogenes, S. 
aureus, and Salmonella [58, 150-152]. It is therefore reasonable to expect that 
sRNAs play a role in the pathogenesis of M. tb.  
Until the accessibility of high-throughput sequencing and tiling arrays, the 
complete potential contribution of non-coding RNA to gene regulation in M. tb 
could not be appreciated. This was due to the fact that techniques such as 
traditional microarrays focused on annotated, mainly protein coding genes. It 
had been firmly established from studies in other bacteria that transcriptional 
control alone was not solely responsible for gene regulation. A post-
transcriptional regulatory network exists that is dependent on sRNAs.  
The contribution of sRNAs to gene regulation in M. tb was first assessed in 
2009 with the discovery of nine putative sRNAs found by cDNA cloning [153]. 
This approach was also taken by another group with the model organism BCG. 
The study revealed 34 novel sRNAs with putative homologues for many of the 
sRNAs identified found to exist in M. tb and M. smegmatis [2] . 
In 2011 Arnvig et al, using high throughput sequencing technology found the M. 
tb genome to contain an abundance of non-coding RNA, including 5’ and 3’ 
UTRs, antisense transcripts and intergenic sRNAs, [3]. Some of these have 
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shown markedly varied expression profiles in M. tb under different in vitro 
growth phases and stress conditions [153]. For example: M. tb sRNA 
ncRv11733 (MTS1338), is highly expressed during stationary phase, nutrient 
starvation and infection [154]; ncRv12659 is induced by nutrient starvation and 
during mouse infection [155]; and ncRv13661 (MTS2823) is elevated in 
stationary phase bacteria and infection [3].  
Of the 20 intergenic sRNAs that have been identified and confirmed by northern 
blotting [153, 155, 156] some are unique to the M. tb complex while others are 
more widely conserved in mycobacteria and actinomycetes [154].  
Mcr7 is the first sRNA in M. tb to be assigned a function. Mcr7 is expressed 
under the control of PhoP, and the sRNA binds to the 5’ end of the tatC mRNA 
preventing ribosome loading and therefore translation. Proteomic analysis has 
shown the sRNA to have a role in Tat-dependent secretion of well-known 
tuberculosis antigens such as Ag85 complex. It was shown that this control was 
at the post transcriptional level and no impact on the amounts of mRNA was 
observed [156]. This sRNA completed the link between the PhoPR two-
component system and Tat-dependent secretion, demonstrating the importance 
of mcr7 in the virulence of M. tb. 
The adaptation of M. tb to environmental changes during the course of infection 
has mostly been monitored at the level of gene expression. To date gene 
expression studies have concentrated on the expression of mRNA [157, 158], 
and largely in tissue culture systems [159] and animal models [160] that do not 
completely replicate all features of M. tb infection in humans. Two studies have 
assessed the issue of in vivo adaptation. Garton et al., assessed sputum prior 
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to patient treatment using PCR based microarrays [161]. Another study looked 
at the transcripts associated with proteins from infected human lungs [162]. 
While these studies were very informative, they were concentrated on mRNA 
and annotated ORFs, so the contribution of sRNAs remains unknown. 
Recent work has shown that some M. tb sRNAs are highly induced in M. tb 
infected mouse lungs [3, 155] and ongoing studies aim to identify the specific 
functions of these sRNAs both in vitro and in vivo.  
1.14 Defining sRNA Regulons 
The low conservation of sRNAs across bacteria and their reduced 
complementarity to mRNA targets make it difficult to predict sRNA targets. 
However, algorithms such as targetRNA2 can aid in the identification of 
possible targets [163]. TargetRNA2 works by taking the sequence of a sRNA 
and searching for targets within a specified genome. Features that are taken 
into account are conservation of the sRNA in other (related) bacteria, the 
secondary structure of the sRNA, the secondary structure of each candidate 
mRNA target, and the hybridization energy between the sRNA and each 
putative mRNA target [163, 164]. The latest version now also allows for 
integration of RNA seq and microarray data into the prediction of targets by 
considering differential gene expression therefore improving the accuracy of 
target identifications.  
However, part of the search criteria for sRNA targets relies on conservation of 
sRNAs in other bacteria, this can make target searches difficult. For example, 
the E. coli RhyB [147] and the Pseudomonas aeruginosa functional homologues 
[165] share very little sequence similarity.  
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Experimental and computational approaches have been used to define currently 
known sRNA regulons. The experimental approaches have included studies of 
sRNA dependent changes in gene expression (microarrays, RNA seq or 
comparative protein analyses), changes in reporter gene expression or altered 
growth phenotypes. Both direct targets of sRNAs, along with downstream 
effects will be detected by approaches that assess altered gene expression 
complicating the elucidation of sRNA function. 
Due to the complete sequence of the M. tb genome being available, global 
analysis of gene expression has become routinely possible through both 
microarray and RNA seq. Microarrays use gene specific hybridisation probes to 
quantify the relative abundance of specific transcripts and have been used to 
assess responses of M. tb to different environmental conditions and stages of 
infection [166] along with strain comparisons [167]. This method has the 
advantage of being relatively cheap in comparison with RNA seq. The data 
obtained from RNA seq has the advantage over most microarray technology in 
providing much more precise and higher resolution levels of transcripts [168]. 
However, microarrays and RNA seq should be viewed as hypothesis-generating 
tools from which possible regulons can be inferred [169]; possible interacting 
partners must be tested in detail by more definitive methods such as 
electrophoretic mobility shift assays (EMSA) or reporters.  
1.15 non coding RNA Nomenclature in M. tb 
The identification of sRNAs in M. tb in recent years has led to a number of 
different methods of nomenclature. The first identification of non-coding RNA 
(ncRNA) in M. tb resulted in annotation referring to the sequenced clone from 
53 
 
which they were identified e. g B11, C8 and F6 [153]. Later reports numbered 
the sRNAs by chronological order [2] or by intergenic regions [3, 170], both with 
different prefixes. This lack of consistency led to a need for a defined method of 
annotation for ncRNA in M. tb. It was suggested that ncRNA were annotated 
with a prefix of 'nc' for non-coding, followed by a locus identifier that indicates 
the sRNA location in relation to neighbouring ORFs [171]. sRNAs in this study 
will be referred to using the new nomenclature. 
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1.16 Hypotheses & Aims 
The focus of this study is to determine the roles of selected sRNAs in M. tb 
pathogenesis, by identifying their function and mode of regulation. Four 
candidate sRNAs were selected for study and these are detailed in each 
individual chapter. A summary of their characteristics can be found in Table 1.1 
The hypotheses under investigation are 
 That sRNAs will control a set of genes in response to a specific stimulus. 
 That sRNAs are important in pathogenesis. 
To address the hypothesis that sRNAs have regulons and are important in 
pathogenesis the project aims to  
 Identify genes or proteins that are regulated directly or indirectly by the 
sRNAs under investigation. 
 Identify the expression conditions of the selected sRNAs both in vitro and 
in vivo. 
 Characterise the phenotypes of M. tb strains in which the sRNAs are 
inactivated or over expressed. 
Figure 1.8 details the experimental plans to achieve the aims listed above. 
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sRNA Method of 
identification 
Known 
Induction 
Conditions 
Notable 
Features 
ncRv10243 cDNA cloning 
(Arnvig, 2009) 
Starvation and 
Acid stress 
Over expression 
in M. tb results in 
slow growth 
ncRv11690 cDNA cloning 
(Arnvig, 2009) 
Exponential and 
Stationary 
Phase 
Over expression 
in M. tb is lethal 
ncRv13661 RNA seq (Arnvig, 
2011) 
Stationary 
Phase and 
Mouse infection 
Most abundant 
RNA after 
ribosomal RNA 
ncRv12659 RNA seq (Arnvig, 
2011) 
Stationary 
phase 
Cis-encoded 
sRNA found 
antisense to 
Rv2660c locus 
induced during 
starvation 
 
Table 1.1 Key Characteristics of the sRNAs chosen for further investigation 
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Figure 1.8 Experimental Workflow for elucidating the roles of the sRNAs 
under investigation. 
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 Materials and Methods 
 
Full composition of all media and buffers are listed in Appendix I. 
 
2.1 Bacterial Strains and Growth Media 
 
Mycobacterial strains were grown on 7H11 agar plus 10 % OADC (Becton 
Dickinson). Liquid cultures were grown in standard Middlebrook 7H9 
medium supplemented with 0.5% glycerol, 10% Middlebrook ADC (Becton 
Dickinson) and 0.05% Tween-80 at 37°C in a roller bottle (Nalgene) rolling at 
2 rpm or 50 ml falcon tubes (Corning) in an SB3 Tube Rotator (Stewart) at 
28 rpm. For propionate utilisation experiments glycerol, ADC and Tween 
were replaced with 0.1% sodium propionate 0.5% Albumin fraction V and 
0.05% Tyloxapol respectively. Kanamycin was added where required at 25 
µg/ml and X-Gal where required at 50 µg/ml. 
Escherichia coli (E. coli) strain DH5was used for plasmid construction and 
grown in Luria-Bertani (LB) Agar or Broth using kanamycin at 50 µg/ml and 
X-Gal where necessary at 200 µg/ml. Details of all strains and plasmids 
used and constructed in this study are listed in Tables 2.1 and 2.2 
respectively. 
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Strain or Plasmid Relevant Characteristics Source or 
Reference 
M. tuberculosis 
strain 
 
M. tuberculosis wildtype H37Rv used for 
the construction of all mutant strains 
[172] 
M. tuberculosis 
strain 
Clinical isolates N0031, N0052, N0072, 
N0145, N0153 
[173] 
M. bovis strain M. bovis BCG Pasteur NIMR 
DH5α sub cloning 
efficiency cells 
E. coli cloning strain 
Genotype F– Φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 
relA 
Invitrogen 
 
Table 2.1 Bacterial Strains used in this study 
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Table 2.2  Plasmids used and constructed in this study 
Strain or 
Plasmid 
Relevant Characteristics Source or 
Reference 
pBackbone Mycobacterial suicide vector 
(kanamycinR and ampicillinR) 
Gopaul, (2002) 
pGOAL17 Plasmid containing the sacB/lacZ 
cassette (ampicillinR) 
Parish & 
Stoker, (2000) 
pKP186 Integrating mycobacterial cloning 
vector that does not contain integrase 
(kanamycinR) 
Rickman et al., 
(2005) 
PBSInt Mycobacterial suicide vector containing 
integrase, electroporated in conjunction 
with pKP186 and its derivatives. 
Springer et al., 
(2001) 
pMSC12659 ncRv12659 expressed from native 
promoter 
Houghton et 
al., (2013) 
pKA302 pMV261 derived replicating over 
expression vector containing M. 
smegmatis rrnB (-200/-8) 
Arnvig et al., 
(2009) 
pKA303 pMV261 derived replicating over 
expression vector containing M. 
smegmatis rrnB (-80/-8) 
Arnvig et al., 
(2011) 
pKA305 XbaI-ClaI fragment from pKA302 
cloned into pKP186 giving rise to an 
integrating over expression vector. 
Dr. Kristine 
Arnvig, 
unpublished. 
pKA306 XbaI-ClaI fragment from pKA303 
cloned into pKP186 giving rise to an 
integrating over expression vector. 
Dr. Kristine 
Arnvig, 
unpublished. 
pJHP01 Targeting plasmid for removal of 
ncRv12659 in M. tuberculosis 
pBackbone containing ncRv12659 5′ 
and 3′ flanking regions, and the 
sacB/lacZ cassette. 
This Study 
60 
 
Strain or 
Plasmid 
Relevant Characteristics Source or 
Reference 
pJHP02 Targeting plasmid for removal of 
ncRv13661 in M. tuberculosis 
pBackbone containing ncRv13661 5′ 
and 3′ flanking regions, and the 
sacB/lacZ cassette 
This Study 
pJHP03 Targeting plasmid for removal of 
ncRv11690 in M. tuberculosis 
pBackbone containing ncRv11690 5′ 
and 3′ flanking regions, and the 
sacB/lacZ cassette 
This Study 
pJHP04 Targeting plasmid for removal of 
ncRv10243 in M. tuberculosis 
pBackbone containing ncRv10243 5′ 
and 3′ flanking regions, and the 
sacB/lacZ cassette 
This Study 
pJHP05 ncRv13661 complementing plasmid. 
pKP186 derivative containing 625bp 
coordinates 4100449-4101296.  
This Study 
pJHP06 ncRv10243 complementing plasmid. 
pKP186 derivative containing 448bp 
coordinates 293428-293876.  
This Study 
pJHP07 ncRv11690 complementing plasmid. 
pKP186 derivative containing 381bp 
coordinates1914888-1915269.  
This Study 
pJHP09 pKA305 derivative containing XbaI-ClaI 
fragment cut from pKA302 containing 
G2 (Arnvig et al., 2009) 
This Study 
pJHP10 pKA306 derivative containing XbaI-ClaI 
fragment cut from pKA303 containing 
G2 (Arnvig et al., 2009) 
This Study 
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2.2 Recombinant DNA techniques 
All general molecular cloning techniques were carried out according to 
standard methods (Sambrook 2001), using commercially available 
kits/enzymes where stated. 
2.2.1 Polymerase chain reaction (PCR) 
For PCR reactions where the product was required for downstream use a 
proofreading DNA polymerase was used. Primers were designed using 
the DNAstar lasergene program primer select, and synthesised by 
Sigma-Aldrich. All primers used in the study are listed in Appendix II. 
PCR Reactions were performed in a final volume of 50 μl consisting of 1 
x Pfx buffer, 1 x PCR Enhancer Solution, 1 mM MgSO4, 300 μM each 
dNTP (Promega), 300 nM each primer (Sigma-Aldrich) and 2.5U of Pfx 
enzyme (Invitrogen). 
Colony PCR’s were performed in a final volume of 20 µl 1 x REDTaq 
ReadyMix PCR mix, which includes 1.5 mM MgCl2, 200 μM each dNTP 
and 1.5 U Taq DNA polymerase (Sigma-Aldrich), 5 % DMSO, 300 nM 
each primer, a single colony resuspended in the PCR mix as template or 
1-2 µl of an instagene matrix preparation (BioRad) from M. tb. 
DNA amplification was performed in an Applied Biosystems Veriti Cycler 
using a touchdown cycle. Cycles consisted of denaturation at 95°C for 5 
minutes followed by touchdown cycles from 65°C to 56°C for 30 seconds 
followed by extension at either 68°C (for proofreading DNA polymerase) 
or 72°C (for non-proofreading DNA polymerase) for one minute per 
kilobase of product. 25 cycles were performed with the lowest annealing 
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temperature and completed with a final extension for 7 minutes. PCR 
products were analysed by agarose gel electrophoresis. 
2.2.2 Agarose Gel Electrophoresis 
DNA was separated on 0.8-2% agarose gels using 1 X TBE with 0.5 
µg/ml ethidium bromide (Bio-Rad) to allow visualisation of the DNA. 
1 x loading buffer was added to samples where necessary (30% glycerol, 
0.25% bromophenol blue, 0.25% xylene cyanol) and run alongside 10 µl 
of a 1 kilobase ladder (Hyperladder I, Bioline). Gels were run at 100 V 
until the DNA had migrated sufficiently by observation of the Dye Fronts. 
DNA was visualised on a UV transilluminator (BioDoc-It Imaging 
System). 
2.2.3 DNA Gel Extraction and PCR purification 
DNA fragments were isolated using QIAquick Gel Extraction Kit (Qiagen) 
either straight from the PCR reaction or following agarose gel 
electrophoresis according to the manufacturer’s instructions. Agarose 
pieces containing DNA were excised over a UV light box and solubilised 
in a binding buffer. This was bound to a silica membrane on a spin 
column and contaminants washed away. DNA was eluted in 30 µl of 
dH20. 
2.2.4 Plasmid DNA Extraction 
Plasmid DNA was extracted from 5 ml of stationary phase E. coli cultures 
using the QIAprep Spin Miniprep Kit (Qiagen) according to 
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manufacturer’s instructions. Cells were lysed under alkaline conditions 
with SDS to denature proteins and DNA, and to solubilise phospholipids 
of the cell membrane. Lysates were neutralised and adjusted to high salt 
conditions resulting in contaminants precipitating out and plasmid DNA 
staying in solution. Plasmid DNA was adsorbed to a silica membrane on 
a spin column and contaminants were washed away. DNA was eluted in 
50 µl of dH20. 
2.2.5 Restriction endonuclease digestion of DNA 
Restriction digestion of DNA was performed in 30 µl reactions for 30 
minutes at 37°C using FastDigest Enzymes (Fermentas). Reactions 
contained 1 µl of each enzyme, 1 X FastDigest buffer (Fermentas), and 1 
µg of DNA. For vector digests reactions also contained Antarctic 
Phosphatase (Fermentas) to prevent vector re-ligation. The reaction was 
inactivated by incubation at 65°C for 20 minutes. 
2.2.6 Ligation of DNA 
Ligations were performed using the Roche Rapid Ligation Kit according 
to manufacturer’s instructions. Briefly 20 µl reactions containing 1 x 
Ligation buffer, 1 µl Ligase and 1:3 ratio of vector: insert DNA. Ligations 
were performed at room temperature for 15 minutes. 
2.2.7 Transformation of chemically competent E. coli 
2 µl of ligated DNA was transformed into 25 µl E. coli chemically 
competent sub cloning efficiency cells DH5α (Invitrogen). DNA and cells 
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were mixed and placed on ice for 30 minutes. Cells were heat shocked 
for 45 seconds at 42°C and placed back on ice for 2 minutes. Cells were 
allowed to recover at 37°C before plating on to selective media. 
2.2.8 Sequencing of plasmid DNA 
All plasmid constructions were sequenced to verify their identity. 100 
ng/µl of construct was supplied to BioSource Sequencing Ltd with vector 
specific sequencing primers. 
2.2.9 Site directed mutagenesis (SDM) 
SDM oligonucleotides were designed with the desired mutation in the 
middle with approximately 20 nucleotides of complementary sequence 
both sides and a melting temperature of approximately 78°C. Primers 
were synthesised and purified using HPLC by Sigma. PCR amplifications 
were performed in 50 µl reactions volumes containing Pfx Amplification 
buffer, 1 X Enhancer buffer, 0.3 mM dNTPs, 100 ng of each 
oligonucleotide, 1 mM MgSO4, 100 ng template plasmid DNA and 2.5 U 
Pfx (Invitrogen). The reaction mixture was incubated in a PCR 
thermocycler (Veriti applied biosystems) with an initial denaturation step 
at 95 °C for one minute followed by 18 to 25 cycles of 95 °C for 50 
seconds, an annealing step of 60 °C for 50 seconds and a 68oC 
extension temperature for two minutes per kb of plasmid and then 
completed by a final extension at 68°C for seven minutes. Original 
template methylated DNA was then digested by addition of 1 µl DpnI 
(Fast Digest, Fermentas) and incubated at 37°C for 15 minutes. DNA 
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was then ethanol precipitated and the resulting plasmid transformed into 
chemically competent E. coli Supercompetent cells (Bioline)  
2.3 DNase treatment and purification of RNA 
Contaminating DNA was removed from RNA preparations using Turbo 
DNase (Ambion) according to the manufacturer’s guidelines. Briefly, 10 µg 
of RNA was treated with 2 µl of Turbo DNase for a total of 1 hour as 
described in the protocol for a heavily contaminated sample. DNase was 
removed from the sample using acidified phenol: chloroform pH4.5 (Ambion) 
at a 1:1 ratio, vortexed and centrifuged at 17,100 xg for 10 minutes. The 
aqueous phase was removed and RNA precipitated with 1/10 volume of 3 M 
sodium acetate and 2.5 x volume of ethanol. 
2.4 cDNA synthesis 
First Strand cDNA synthesis was performed using superscript III Reverse 
Transcriptase (Invitrogen) according to the manufacturer’s instructions using 
a reaction temperature of 50 ºC for 30 minutes followed by 55 ºC for 30 
minutes. 
2.5 qRT-PCR 
Primers (supplied by Sigma-Aldrich) were designed using the Applied 
Biosystems software Primer Express and sequences listed in Appendix II. 
After cDNA synthesis, 1:100 and 1:10,000 dilutions were prepared. Each 20 
µl qRT-PCR reaction, contained 1 x SYBRgreen (Applied Biosystems) 900 
nm each primer and 5 µl of template cDNA of appropriate dilution. A 
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standard curve of genomic DNA was generated for each experiment to allow 
absolute quantitation. All genes were normalised to 16S measured using a 
1:10,000 dilution of cDNA. mRNA or sRNA was quantified using a 1:100 
dilution. 
2.6 Northern Blotting 
Northern blots were performed using 6-8% denaturing acrylamide gels 
(Appendix I). Depending on the abundance of the sRNA a total of 500 ng-10 
µg RNA was loaded per well. Each sample contained 1 x Gel loading buffer 
II (Ambion8547) and was heated at 80 °C for 2 minutes before loading. 10 µl 
of RNA marker low (Abnova) for size determination was loaded alongside 
the samples. The RNA was transferred onto Ambion’s brightstar membrane 
for 1 hour in 0.5 x TBE by electroblotting at 1.5 mA per cm2 of membrane. 
After transfer the RNA was crosslinked to the membrane by UV before 
visualising using 0.3 M sodium acetate containing 0.03% methylene blue. 
Membranes were pre hybridised with Ultrahyb Buffer (Ambion) for at least 
30 minutes at 65 °C before the addition of the riboprobe. Riboprobes were 
made using oligo templates and the mirVana miRNA probe construction kit 
(Ambion) and left to incubate with the membrane overnight. Membranes 
were washed twice with 2 X SSC + 0.1% SDS, once with 0.2 X SSC + 0.1% 
SDS and once with 2 x SSC. Membranes were visualised using a 
phosphoimager screen and storm860 scanner. 
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2.7 Rapid Amplification of cDNA ends (RACE) 
2.7.1 5’ Rapid Amplification of cDNA ends (RACE) 
5’ RACE was performed using the GeneRacer kit (Invitrogen). 5 µg of M. 
tb RNA was treated with tobacco acid pyrophosphatase to digest the 
triphosphate group at the 5´ end of all transcripts, generating 5´-
monophosphorylated transcripts. The GeneRacer™ RNA Oligo RNA was 
added to 0.25 μg GeneRacer RNA Oligo and heated at 65 ºC for 5 
minutes. The 10 μl ligation reaction was performed in 1 x ligase buffer, 
with 10 nm ATP, 40 U RNaseOut and 5 U T4 RNA ligase; samples were 
incubated at 37 ºC for 1 hour. RNA was extracted with acidified phenol: 
chloroform and ethanol precipitated with 2.5 volumes with 1/10 3 M 
sodium acetate. RNA was re-suspended in DEPC-treated H2O, to which 
100 ng random primers and 0.5 mM each dNTP were added, and 
incubated at 65ºC for 5 minutes.  
The reverse transcription (RT) reaction was performed with the addition 
of primer mixture, 1 x First Strand buffer, 5 mM DTT, 40 U RNaseOut 
and 200 U SuperScript III RT. Incubation was initially at 25 ºC for 5 
minutes followed by 1 hour at 50 ºC. RT was inactivated at 70 ºC for 15 
minutes, 2 U RNase H was added to remove the RNA/DNA Hybrids and 
incubated for 20 minutes at 37 ºC.  
cDNA was amplified using the GeneRacer 5’ Primer and a gene-specific 
reverse primer (GSP), using Platinum Pfx DNA polymerase. The PCR 
was conducted as a touchdown, starting with a high annealing 
temperature and decreasing one degree each cycle. Cycle parameters 
were an initial 94 ºC denaturation step, 5 cycles of 94 ºC for 30 seconds 
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and 72 ºC for 1 minute/kb DNA, 5 cycles of 94 ºC for 30 seconds and 70 
ºC for 1 minute/kb DNA followed by 25 cycles of 94 ºC for 30 seconds, 
65 ºC for 30 seconds and 68 ºC for 1 minute/kb DNA. The cycle finished 
with an elongation step of 68 ºC for 10 minutes. Only cDNA containing 
the GeneRacer™ sequences will be PCR amplified.  
PCR products were analysed by agarose gel electrophoresis, gel 
extracted, TOPO cloned and sequenced. Transcriptional start sites were 
identified as directly adjacent to the GeneRacer RNA Oligo sequence.  
2.7.2 3’ RACE 
5 µg of M. tb RNA was poly-A tailed using 1 x poly-A polymerase buffer, 
2 U poly-A polymerase, 10 nM ATP, and water to 25 µl. The reaction was 
incubated for 1 hour at 37 °C. 50 µM oligo d (T) primer from the 
GeneRacer kit was added to the poly-A tailed RNA before precipitating 
with 1/10 volume of 3 M sodium acetate, and 3 x volume of ethanol. 
Reverse transcription was performed on the resulting RNA using 
Superscript III using a reaction temperature of 50ºC for 30 minutes 
followed by 55 ºC for 30 minutes.  
cDNA was amplified using the GeneRacer 3’ Primer and a gene-specific 
reverse primer (GSP), using Platinum Pfx DNA polymerase. The PCR 
was conducted as a touchdown, starting at 68°C and decreasing one 
degree each cycle. Cycle parameters were an initial 94 ºC denaturation 
step, 5 cycles of 94 ºC for 30 seconds and 72 ºC for 1 minute/kb DNA, 5 
cycles of 94 ºC for 30 seconds and 68 ºC for 1 minute/kb DNA followed 
by 25 cycles of 94 ºC for 30 seconds, 62 ºC for 30 seconds and 68 ºC for 
1 minute/kb DNA. The cycle finished with an elongation step of 68 ºC for 
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10 minutes. Only cDNA containing the GeneRacer™ sequences will be 
PCR amplified.  
PCR products were analysed by agarose gel electrophoresis, gel 
extracted, TOPO cloned and sequenced. Transcriptional start sites were 
identified as directly adjacent to the poly-A tail.  
2.8 Western Blotting 
Protein samples were run on a 10% Bis-Tris Gel (Invitrogen) for 50 minutes at 
200 V in MOPS buffer. The gel was placed in semi-dry transfer buffer for 5 
minutes. The PVDF Immobilon-P membrane (Millipore) was prepared by 
washing in methanol for a few seconds, then with dH2O before placing in the 
semi dry transfer buffer for 5 minutes. Proteins were then electro-blotted onto 
the prepared membrane using a semi-dry blotter at 1 mA per cm2 for 1 hour. In 
order to detect specific proteins, the membrane was incubated in blocking buffer 
(see Appendix I) overnight at 4 ºC. The membrane was washed three times with 
TTBS for 5 minutes before incubation with the primary antibodies for RNAP β 
(Santa Cruz 8RB13) and α (Santa Cruz 4RA2) at 1:1000 in blocking buffer for 2 
hours. The three wash steps were then repeated and the membrane then 
incubated in blocking buffer containing the secondary antibody goat anti-mouse-
HRP) for 1 hour followed by a further three wash steps.  
Detection was via ECL Western blotting detection reagents (GE Healthcare). 
Equal volumes of reagents 1 and 2 were mixed and poured onto the protein 
side of the membrane. After 1 minute excess liquid was removed, the 
membrane was wrapped in SaranwrapTM and exposed to autoradiograph film 
(GE Healthcare). Films were developed using an automatic developer (Fujifilm). 
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2.9 Mycobacterial Specific Techniques 
All manipulations of M. tb were performed in Containment level III facilities in a 
Class I hood. 
2.9.1 Preparation of mycobacterial competent cells 
Rolling cultures of mycobacteria were grown to OD600nm of 1.0, 0.1 
volumes of 2 M glycine were added and the culture left incubating 
overnight. The next day the cells were collected by centrifugation at 
2,100 xg for 10 minutes at 4°C. They were subsequently washed three 
times with 0.5 x volume of cold 10% glycerol finally resuspending in 1/10 
of the original culture volume. Cells were then electroporated according 
to published protocols (Jacobs et al., 1991). 
2.9.2 RNA Isolation 
Exponential phase cultures were harvested at an optical density 
(OD600nm) of between 0.5-0.8, whilst stationary phase cultures were 
harvested 1 week after OD had reached 1.0. When ready, cultures were 
cooled rapidly with addition of ice and pelleted at 2,100 xg for 10 
minutes. RNA was isolated from the pellet using the FastRNA Pro Blue 
Kit from MP Biomedicals following the manufacturer’s instructions. RNA 
concentration was measured by ND-1000 spectrophotometer (nanodrop) 
and RNA integrity measured by the 2100 Bioanalyzer using a Nano chip. 
2.9.3 Genomic DNA Extraction 
Half a plate of confluent M. tb was scraped into 300 µl of TE Buffer and 
heat killed at 80°C for 1 hour.  Cells were lysed using lysozyme and 
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lipase at a final concentration of 2 mg/ml each for 2 hours at 37°C with 
the addition of DNase-free RNase. Samples were snap frozen on dry ice 
and ethanol before incubating at 75 °C for 10 minutes. Proteinase K was 
added to a final concentration of 0.5 mg/ml with SDS at 0.5% and 
incubated for 1 hour at 50°C. DNA was extracted with phenol: 
chloroform: isoamyl alcohol. The sample was spun to separate the 
phases and then the aqueous phase was twice extracted with chloroform 
only. DNA was then precipitated with 1/50 volume 5 M NaCl and 2.5 
volumes of ethanol. 
2.9.4 Instagene Preparations of M. tb 
Quick DNA preparations from M. tb suitable for PCR were achieved 
using the BioRad Instagene Matrix solution. The matrix adsorbs cell lysis 
products that could interfere with the PCR reaction. A loopful of bacteria 
was picked into 200 µl of Instagene Matrix solution, vortexed, and heated 
at 56°C for 15 minutes. Finally the each sample is then boiled at 98°C for 
8 minutes before spinning at 17,100 xg to remove the cell debris. 
Approximately 2 µl of the resulting supernatant can then be used in a 50 
µl PCR reaction 
2.9.5 M. tb Cell Free Extract 
M. tb exponential phase cultures were grown to an OD600 of between 0.5-
0.8, whilst stationary phase cultures were grown for 1 week after OD600 
had reached 1.0. The cultures were pelleted at 2,100 xg for 10 minutes 
washed twice in PBS before re-suspending in buffer. Cells were lysed in 
a fast prep instrument at a setting of 6.0 for 30 seconds three times using 
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150-212 micron glass beads. Lysates were centrifuged at 17,100 xg for 
10 minutes and the cleared lysate filtered using a 0.22 µM filter 
(Millipore) for removal from Cat III. 
2.9.6 Sample Preparation for Proteomic Analysis 
M. tb was grown to exponential phase and stationary phase as detailed 
in M. tb cell free extract. The cultures were pelleted at 2,100 xg for 10 
minutes and washed twice with PBS. Cultures were re-suspended in the 
same original culture volume of PBS and incubated at 37ºC. At time 
points 0, 24 and 96 hours 30 mls of cell suspension were pelleted at 
2,100 xg before lysing of cells as detailed in M. tb cell free extract. The 
following Lysis Buffer was used; 0.1 M Ammonium bicarbonate buffer 
containing 8 M Urea and 0.2% Rapigest (Waters). 
Samples were sent to ETH, Zurich Institute of Molecular Systems Biology 
and analysed by Olga Schubert by Mass Spectroscopy.  
2.9.7 Sucrose Gradients 
M. tb was grown to exponential phase and stationary phase as detailed 
in M. tb cell free extract. Cultures were then treated with 50nM 4-thio 
uridine and incubated overnight for incorporation. Cells were 
concentrated into 10 mls by centrifugation at 2,100 xg. The concentrated 
cells were then placed in a petri dish on ice and cross-linked with ultra 
violet light 3 times at 1200. Cell pellets were collected at 2,100 xg 
ribolysed 3 times in a chilled rotor at setting of 6.0 for 30 seconds in a 
volume of 600 µl. Lysis was performed in the following lysis buffer: 20 
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mM Tris, 150 mM KCl, 10 mM MgCl2, 1 mM DTT, and 10 µl of Superase 
Inhibitor (Ambion). The sucrose gradient buffers contained Roche 
complete protease inhibitor cocktail, 20 mM Tris, 150 mM KCl, 10 mM 
MgCl2 and 1 mM DTT. 400 µl of lysate was layered carefully onto the top 
of a 5-30% sucrose gradient in Ultra-Clear tubes and spun in a SW41 
rotor for 16.5 hours at 154,000 xg at 4ºC. 
600 µl fractions were collected by AKTA connected to a 254 nm and 280 
nm filter. Each fraction was divided into 300 µl for RNA extraction and 
300 µl for protein extraction as detailed in 2.9.8 and 2.9.9. 
2.9.8 RNA extraction from sucrose gradient fractions 
RNA was extracted from each fraction using acidified phenol: chloroform 
pH4.5 (Ambion) at a 1:1 ratio, vortexed and spun down at 17,100 xg for 
10 minutes. The aqueous phase was removed and RNA precipitated with 
1/10 volume of 3 M sodium acetate and 2.5 x volume of ethanol. 
 
2.9.9 Protein extraction from sucrose gradient fractions 
Protein was extracted by adding 1 x volume 50 mM Tris pH8.0 and 25% 
final volume of Pyrogallol Red-molybdate. Solution was left to precipitate 
overnight at 4°C and centrifuged at maximum speed of 17,100 xg for 20 
minutes to collect the precipitate. The supernatant was aspirated and 
discarded immediately due to pellet instability. 
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2.9.10 Creating Deletion Strains in M. tb 
Allelic replacement techniques were used to generate M. tb knockout 
mutants  as per published protocol [174]. Briefly, approximately 1kb 
flanking each region of deletion was cloned into suicide vector 
pBackbone containing a kanamycin resistance cassette and a 
LacZ/SacB fragment to allow for selection of single crossover and double 
cross over events. 
2.9.11 Macrophage Infection 
Bone marrow derived macrophages (BMDMs) were generated from 6-8 
week old Balb/C mice in RPMI-1640 (Gibco) containing 10% foetal calf 
serum, 20 µM L-glutamine, 1 mM sodium pyruvate, 10 µM HEPES and 
50 nM β-mercaptoethanol. The cells were then grown and differentiated 
in complete RPMI-1640 supplemented with 20% L929 cell supernatant 
for 6 days at 37°C in 5% CO2. The differentiated cells were seeded at a 
density of 2 x 105 cells/well in 1 ml complete RPMI-1640 supplemented 
with 5% L929 cell supernatant and incubated overnight prior to infection. 
 
M. tb strains for infection were grown to an OD600 of 0.5-0.8 and inocula 
prepared by washing and resuspending the cultures in PBS, to produce a 
single cell suspension. This was used to infect BMDMs at a multiplicity of 
infection (MOI) of 0.1:1. After 4 hr, the cells were washed to remove all 
extracellular bacilli, and medium was replaced and incubation continued. 
Macrophages were lysed with water-0.05% Tween 80 to release 
intracellular bacteria after 4, 24, 72, 120 and 168 hr post-infection. Bacilli 
were serially diluted in PBS-Tween and plated on 7H11 with OADC. 
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Plates were incubated for 3-4 weeks to obtain counts of surviving 
bacteria. 
2.9.12  Aerosol infection of mice with M. tb 
Strains of M. tb for infection were grown to mid log in 7H9 and then 
supplied to Angela Rodgers (a trained animal licensee) for infection of 
the mice. Groups of 6–8 week old Balb/C mice were infected by low-dose 
aerosol exposure with M. tb using a Glas-Col (Terre Haute, IN) aerosol 
generator calibrated to deliver approximately 100 bacteria into the lungs. 
Bacterial counts from the lungs (n = 5) at each time point were 
determined by plating serial dilutions of individual lung homogenates on 
duplicate plates of 7H11. CFUs were counted after 3–4 weeks incubation 
at 37°C.  
Balb/C mice were bred and housed under specific pathogen free 
conditions at the Medical Research Council, National Institute for Medical 
Research. Protocols for experiments were performed, under project 
license number 80/2236, in accordance with Home Office (United 
Kingdom) requirements and the Animal Scientific Procedures Act, 1986. 
2.9.13 Microarray Analysis 
Microarray Analysis was performed using arrays on ncRv13661, 
ncRv10243, and ncRv11690 mutants against H37Rv wild type using 
RNA extracted from exponential phase cultures. Over expression of 
ncRv11690 and ncRv12659 was also compared against vector control 
under exponential conditions. Whole genome M. tb microarray slides 
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were purchased from Agilent Technologies through the Bacterial 
Microarray Group at St. George's (BμG@S), University of London. For 
cDNA synthesis 2 µg of RNA was labelled individually with both Cy-3 and 
Cy-5 dyes (GE Healthcare) using Superscript III reverse transcriptase 
(Invitrogen). Dye swaps were performed and the cDNA hybridized to an 
8-Chamber Agilent slide at 65°C for 16 hours before washing the slide 
with Oligo aCGH Wash Buffer 1 (Agilent) for 5 minutes at room 
temperature and Oligo aCGH Wash Buffer 2 (Agilent) for 1 minute at 
37°C. Slides were stabilized using Agilent's Stabilisation and Drying 
Solution according to manufacturer's instructions. 
Slides were scanned at 5 microns using an Agilent Technologies 
Microarray Scanner at BμG@S. Txt files created by the Agilent scanner 
were analysed using Genespring 12.0 filtering on flags and expression. 
T-test against zero was performed and p-value selected as p<0.05, 
correcting for multiple comparisons using Benjamini-Hochberg. The array 
design is available in BμG@Sbase (Accession No. A-BUGS-41; 
http://bugs.sgul.ac.uk/A-BUGS-41) and also ArrayExpress (Accession 
No. A-BUGS-41).  
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 Investigating a function for the starvation induced sRNA ncRv10243  
3.1 Introduction 
The sRNA originally termed F6 was first identified from cDNA cloning of size 
fractionated total RNA from M. tb. Out of 192 clones, 3 possessed the intergenic 
region between fadA2 and fadE5 containing F6 (Figure 3.1), which was isolated 
from both exponential and stationary growth phases [153]. This study showed 
by 5’ and 3’ RACE that a primary transcript of 102 nucleotides existed. Northern 
blotting revealed a shorter ~55 nucleotide transcript of greater abundance which 
could be due to processing of the primary transcript. In the same study, reverse 
transcription PCR (RT-PCR) showed this sRNA to be co transcribed with the 
upstream gene fadA2. 
F6 was also identified from a screen in BCG by using a dual approach of cDNA 
cloning and in silico prediction to identify novel sRNAs, and was termed Mcr14. 
The two names for the same sRNA arose due to the lack of guidelines for sRNA 
annotation. To avoid confusion a new nomenclature has been suggested [171] 
and from now on F6 will be referred to as ncRv10243 as per the new guidelines.  
When ncRv10243 was first discovered, a putative SigF promoter was identified 
upstream of the 5′ end [153]. This was later confirmed by ChIP-on-chip with 
SigF which was found to give a very strong signal at the sRNA promoter [175]. 
Although ncRv10243 and fadA2 were found to be co transcribed, no expression 
of the sRNA is observed in a SigF deletion strain by northern blotting indicating 
that the co transcription observed by RT-PCR was probably read-through from 
the fadA2 promoter (Houghton & Arnvig unpublished). 
SigF was initially found in BCG to be a stationary phase response sigma factor 
that is also induced upon cold shock and nitrogen depletion. However in M. tb 
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only nutrient starvation shows some induction of sigF. This non-essential sigma 
factor is conserved in most mycobacteria, and deletion leads to an attenuation 
in mice and guinea pig models of infection [176-178]. sRNA ncRv10243 is also 
highly conserved in pathogenic mycobacteria, with the 3′ end being less well-
conserved in non-pathogenic mycobacteria.  
As bacterial gene expression is differentially regulated in response to stress, it 
can be useful to model the stresses encountered within the mycobacterial host 
environment in order to assess whether a particular gene product could be 
important for pathogenesis. Initial studies of ncRv10243 expression showed a 
two-fold induction in response to acid stress [153] indicating that this sRNA 
could indeed be important for pathogenesis, as is the case for other pathogens 
[151].  In particular M. tb encounter acid stress upon phagosome lysosome 
fusion [179], or through acidification of the phagosome when macrophages are 
stimulated by IFN-γ [180]. 
In M. tb over expression of ncRv10243 resulted in extremely slow growth with 
pin prick colonies visible only after 3–4 weeks. The expression of ncRv10243 
did not result in any apparent growth defects in M. smegmatis although the 5’ 
end and central loop containing part of this sRNA are conserved [153].  
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     Figure 3.1 Genomic location of sRNA ncRv10243 in the M. tb genome as viewed in Tuberculist  
         (http://tuberculist.epfl.ch/)
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3.2 Hypotheses and Specific Aims 
It is difficult to speculate on possible targets for trans-encoded sRNAs but 
genome locations can give clues. As well as being co-transcribed with 
fadA2, whose transcription is down regulated in macrophages [181], 
ncRv10243 is located within a region encoding enzymes involved in lipid 
metabolism.  
Phenotypic changes resulting from experimental manipulation of sRNA 
expression levels provide an alternative route to target identification. In 
this study we aimed to take an unbiased approach to identifying the 
function and possible regulons of ncRv10243 by removing the 
chromosomal copy from M. tb and performing gene expression analysis. 
This approach was taken due to the previously observed deleterious 
phenotype of over expression [153]. 
Many sRNAs regulate their targets by masking the ribosome binding sites 
in order to inhibit ribosome entry on mRNA (see Section 1). Since the half-
life of bacterial mRNAs is strongly affected by the association with 
ribosomes [182], translation inhibition is often coupled to the decay of the 
repressed target,  e.g., by accelerating RNase E-mediated mRNA 
turnover. Therefore if a sRNA that represses translation of an mRNA is no 
longer expressed, the abundance of that message would be increased. 
Microarrays can be used to assess the relative abundance of mRNAs in 
both wildtype and deletion strains in order to identify possible sRNA 
targets. 
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3.3. In vitro and In vivo expression levels of ncRv10243 
ncRv10243 had previously been shown to be up regulated two-fold in 
response to acid stress [153]. In order to identify additional stimuli for 
ncRv10243, quantitative RT-PCR (qRT-PCR) was performed as described 
in section 2.8, to assess the expression conditions from a variety of growth 
conditions. RNA extracts from M. tb H37Rv were prepared from 
exponential phase cultures, starvation cultures, and M. tb isolated from the 
lungs of infected mice at 21 days post infection Figure 3.2. The qRT-PCR 
primers used can be found in Appendix II. 
The results show that while ncRv10243 is well expressed in exponential 
phase, it is up regulated 6-fold in response to infection of mice lungs, and 
even further up regulated in response to 96 hours starvation in PBS (20-
fold on average) when compared to exponential phase expression.  
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Figure 3.2 Expression levels of ncRv10243 in M. tb  
ncRv10243 expression levels were measured using qRT-PCR, in each instance 
ncRv10243 levels are expressed relative to 16S rRNA control. ncRv10243 is a 
well expressed sRNA in exponential phase that is up regulated upon (96 hours) 
starvation in PBS. Analysis of M. tb RNA from the lungs of three week infected 
mice showed ncRv10243 to also be up regulated in response to infection. Data 
represents the mean and standard deviations of three biological replicates for each 
condition.  
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3.4 Creation of a ncRv10243 deletion strain 
This study set out to identify possible targets of ncRv10243 through the 
creation of a deletion strain in which the sRNA is entirely removed from the 
chromosome. Creation of a deletion strain relies on allelic exchange by 
which homologous recombination causes the chromosomal copy of a 
gene or genes to be replaced by a mutated/modified version of the gene. 
The mutation was introduced by using a non-replicating suicide vector [7] 
in a two-step process. Initially, a single cross-over (SCO) recombinant was 
isolated from the electroporation of M. tb with the targeting construct. 
These colonies were screened to verify a successful recombination event 
and only SCO candidates subjected to counter-selection in order to obtain 
double crossovers (DCO) generated by a second recombination event. 
PCRs to screen both SCO and DCO are represented in Figure 3.3A. The 
markers sacB and lacZ on the targeting construct allow for blue/white 
screening of colonies and make counter-selection for sucrose sensitivity 
possible, this ease of screening and selection thereby greatly increases 
the efficiency of creating deletion mutations in M. tb [183]. 
3.4.1 Design and creation of the deletion plasmid 
In order to delete ncRv10243 from the chromosome of M. tb the strategy 
was to remove the sRNA from the chromosome in an unmarked manner. 
This is to avoid possible effects of an antibiotic cassette which are 
unrelated to the sRNA. For homologous recombination to occur between 
the deletion plasmid and the bacterial chromosome, approximately 1.5 kbp 
from either side of ncRv10243 was cloned sequentially into the suicide 
vector pBackbone before removing the sRNA by site directed mutagenesis 
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(SDM). From the 5’ flank the bases from coordinates 292520-293605 were 
first PCR amplified and then cloned, followed by the 3’ flank 
encompassing the bases from coordinates 293709-294600. 
In addition to the Kanamycin resistance (KanR) cassette already included 
in the pBackbone plasmid, was the inclusion of the sacB/lacZ cassette. 
The sacB gene encodes for levansucrase, responsible for hydrolysis of 
sucrose to glucose, and the lacZ gene encodes for β-galactosidase, which 
hydrolyses X-Gal in the media to a blue precipitate. 
3.4.2 Screening of single and double crossover candidates 
The SCO selection uses KanR and blue/white screening. Blue colonies on 
Kanamycin media indicate that the cells express β-galactosidase and are 
resistant to kanamycin and therefore a possible single recombination 
event has occurred. After removal of selective pressure by streaking onto 
non-selective media, SCO candidates can be resuspended and plated to 
single colonies on 7H11 containing sucrose, which is toxic when sacB is 
expressed. A second recombination event will generate DCOs in which 
the plasmid backbone containing the KanR   and sacB genes are lost along 
with the wildtype region targeted for deletion. The result is that the cells 
are now kanamycin sensitive and sucrose resistant.  
After electroporation with the targeting plasmid into M. tb H37Rv, cells 
were plated onto 7H11 containing Kanamycin and X-Gal. After incubation, 
4 blue colonies were screened by PCR to identify true SCOs from random 
integrations Figure 3.3B. As the region of deletion in this instance was only 
~150bp, it was difficult to differentiate wildtype bands from SCO bands. 
Therefore the resulting PCR products were gel extracted and sent for 
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sequencing. Sequencing revealed 1 SCO, which was then streaked onto 
non-selective 7H11 for the second recombination event to occur. Full loss 
of the backbone of the deletion plasmid was confirmed by streaking out 
onto 7H11 plus Kanamycin and X-Gal, and also 7H11 without antibiotic, 
plus X-Gal. Only 1 Colony (#4) from DCO selection was white and 
Kanamycin sensitive. This DCO candidate was screened by PCR 
amplification and sequencing of the PCR product, which confirmed the 
deletion of the sRNA from the M. tb genome. 
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Figure 3.3A Schematic of PCR reactions for screening M. tb SCO and DCO 
strains 
Diagram indicates the three PCR reactions used to distinguish between a) wild 
type M. tb, b) single crossovers of either orientation or c) double crossovers. 
Primer pairs are gene specific, numbered according to the target region and 
designated either pair2 or pair3. Primer sequences can be found in Appendix II. 
PCR screening was performed on Instagene preparations from streaked out 
colonies. PCR reactions are designed so that orientation of a crossover event can 
be identified. Importantly a random integration can be discerned from a SCO as 
phenotypically they result in the same characteristics on agar. 
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Figure 3.3B PCR screening for the construction of the ncRv10243 deletion 
strain. 
PCR reactions were designed using the strategy outlined in Figure 3.3A. Expected 
sizes of products for each primer pair are indicated. Due to the small size of 
deletion, these PCR products were consequently gel extracted as detailed in 
section 2.2.3 and sequenced directly. SCO = single crossover; DCO = double 
crossover; M = Bioline Hyperladder I DNA marker. 
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3.5 Complementation of the ncRv10243 mutant 
As the aim of this study was to characterise the phenotype of a 
ΔncRv10243 deletion strain, it was essential to complement the loss of the 
sRNA by replacing the lost chromosomal copy.  
In order to achieve this the sRNA and its promoter were PCR amplified 
along with a portion of upstream and downstream sequence (for 
coordinates see table 2.2), before cloning into pKP186. The resulting 
plasmid pJHP06 was electroporated into the mutant strain and presence 
selected for using kanamycin 7H11 agar. Presence of the complementing 
plasmid was confirmed by PCR from Instagene preparations. 
The complementing strain should in theory have the same phenotype as 
wildtype M. tb H37Rv and any non-complemented phenotypes could be 
due to a secondary mutation elsewhere in the genome or to an antisense 
effect as a result of the ncRv10243 promoter transcribing across and into 
fadE5. The ΔncRv10243 strain was also whole genome sequenced to 
identify any possible mutations that would result in a change of expression 
or amino acid. 
3.6   Full Genome sequencing of the ncRv10243 mutant 
High Quality genomic DNA was extracted from the mutant and the 
parental H37Rv strain (as per Section 2.4). Sequencing libraries were 
prepared from both strains and sequenced by the HTS sequencing facility 
at NIMR. The resulting reads were aligned to the H37Rv reference 
genome by Graham Rose (NIMR) and single nucleotide polymorphisms 
(SNPs) were identified. There are two types of SNPs; a synonymous SNP, 
which does not change protein function as the nucleotide change does not 
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result in an amino acid replacement, and a nonsynonymous SNP, which 
has the potential to alter protein function as the nucleotide change results 
in an amino acid substitution in the protein.  
Alignment of the genomic sequence of ΔncRv10243 identified 6 SNPs in 
the DCO selected for use (Appendix III). Two of these were due to the 
XbaI site being inserted into the chromosome from the removal of the 
sRNA. Two SNPs were found in Rv0279c PE_PGRS4, which is a repeat 
region and therefore could be excluded from analysis due to unreliability. 
There was 1 nonsynonymous SNP in Rv2541; a hypothetical alanine rich 
protein, and finally an intergenic SNP at coordinate 4178146 between 
Rv3728 and Rv3729. As no known function for these regions exist it is 
impossible to predict the effect of such SNPs on the phenotype of M. tb. 
However, if a phenotype was observed in the deletion strain and it cannot 
be complemented, it is a possibility that it could be due to these mutations. 
3.7 Assessment of ncRv10243 expression in deletion and 
complement strains 
To confirm the removal of the sRNA and to assess the degree of 
complementation achieved, RNA extracts were prepared from H37Rv, 
ΔncRv10243, and the complemented strain. cDNA was prepared after 
removal of contaminating DNA, and expression of ncRv10243 was 
assessed by qRT-PCR as detailed in the materials and methods section 
2.7. Reverse transcriptase negative reactions (RT-) were prepared and 
assessed in parallel with reverse transcriptase positive reactions (RT+). 
RT- absolute values were subtracted from RT+ absolute values before 
normalising to 16S. This allows for any contribution from DNA 
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contamination to be removed from the final calculation. The normalisation 
results in a value of relative expression to 16S and provides an internal 
control for differences in efficiency of first strand cDNA synthesis. 16S was 
chosen as a suitable gene for normalisation due to its lack of variation in 
abundance. qRT-PCR showed that ncRv10243 was undetectable in the 
ΔncRv10243 strain (Figure 3.4). There was no statistical significance in 
the expression level of ncRv10243 between the wild type and complement 
strain (Figure 3.5; Unpaired t-test, p>0.05). 
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Figure 3.4 qRT-PCR confirmations of ncRv10243 deletion and 
complementation 
Each strain was grown to exponential phase in standard 7H9 media and RNA then 
extracted. qRT-PCR was performed as described in section 2.8. In each instance 
sRNA expression is expressed relative to 16S, an rRNA control. Data represents 
the averages and standard deviations of three biological replicates for each strain.   
  
 
92 
 
3.8 In vitro phenotype analysis of growth compared to wildtype 
In the first instance the ΔncRv10243 strain was assessed for an in vitro 
growth phenotype by comparing growth of the deletion strain against 
wildtype and complement strain. Cultures were grown to exponential 
phase (OD600 ~0.6) in 7H9 media, and these cultures were used to 
inoculate fresh media to an OD600 = 0.05. The OD600 was monitored until a 
plateau of growth was reached. No significant difference was observed 
between the doubling times of the three strains (Figure 3.5) as assessed 
by Linear regression analysis, p>0.05, showing that deletion of ncRv10243 
has no effect on in vitro growth of M. tb under these conditions. 
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Figure 3.5 Growth of ΔncRv10243 in standard 7H9 media 
In vitro growth curves of wildtype M. tb H37Rv, the ΔncRv10243 deletion strain 
and the complement using standard 7H9 media in a rolling culture system. The 
data represents the averages and standard deviations of three biological replicates. 
No significant difference was observed between the slopes for each strain as 
tested by linear regression. 
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3.9 Growth is inhibited in the Wayne Model 
ncRv10243 is known to be under the control of SigF [175] a sigma factor 
which is induced in the Wayne model, developed by Lawrence Wayne as 
a simple in vitro model of dormancy for M. tb through oxygen limitation 
[30].The lack of growth defect observed in the deletion strain when grown 
under standard in vitro conditions along with the induction of SigF in the 
Wayne model, led to the hypothesis that a growth defect would be 
observed under low oxygen tensions (hypoxia). When grown in sealed 
tubes with slow stirring, tubercle bacilli cease replicating when oxygen 
concentrations decrease to the micro-aerobic level (1% oxygen saturation, 
~100 hours), at which time/stage they enter a state of non-replicating 
persistence (NRP-1). With continued incubation the oxygen levels 
decrease to anaerobic levels (0.06% oxygen saturation, ~200 hours) 
inducing the second state, NRP-2. To allow for differences in respiration 
rate, depletion of oxygen for each strain is monitored by a methylene blue 
indicator tube set up for each strain at the start of incubation. Upon 
depletion of oxygen the methylene blue becomes reduced and turns from 
blue to colourless. After 14 days, cultures were plated onto 7H11 agar for 
assessment of survival. Plates were incubated for 3 weeks and colony 
forming units (CFU) counted. In addition, the anaerobic cells were 
assessed for their ability to be resuscitated. This was done by diluting the 
cultures to OD600 = 0.05 in fresh media and monitoring growth (OD600). 
Enumeration of bacteria was necessary to ensure that an equal number of 
bacteria were inoculated into the growth curves to ensure an accurate 
phenotype would be observed. 
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There was no significant difference in CFU after incubation in the Wayne 
model between the wildtype H37Rv strain and either the ΔncRv10243 or 
the complemented strain indicating equal numbers of bacteria per unit of 
OD (Figure 3.6A). This validated the recovery experiment showing that an 
equal number of bacteria were used in the inoculation of fresh media. 
The growth curve however identified that the ΔncRv10243 strain was 
impaired for recovery following growth in the Wayne model. This 
phenotype was partially restored in the complemented strain resulting in 
an intermediate phenotype (i.e. between the wildtype and ΔncRv10243) 
(Figure 3.6B). It is also possible that the mutant possesses a longer lag 
phase that the wildtype or complementing strain as the difference in OD’s 
after 300 hours is less marked than at 200 hours post recovery. 
The attenuation seen in the Wayne model demonstrates that ncRv10243 
is important in recovery from the Wayne model, and is required for the 
resuscitation of the bacteria in order to recommence active growth.  
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Figure 3.6 Growth in the Wayne Model impairs recovery of ΔncRv10243. 
Wildtype M. tb H37Rv, ΔncRv10243 and complement strains were grown in the 
Wayne model until NRP-2 was reached. Cultures were serially diluted and plated 
for enumeration of viable bacteria. (A) Number of viable bacteria after incubation 
in the Wayne model. Significance was tested by One-way ANOVA p>0.05. All 
cultures were then adjusted to an OD600nm = 0.05 in fresh media and the growth 
measured over 14 days (B). All data represents the averages and standard 
deviation of three biological replicates. It was observed that there was a 
significant difference between the recovery of the wildtype and that of the 
deletion strain, as tested by linear regression analysis p>0.05. A significant 
difference was also observed between the slopes for wildtype and complement 
although the growth observed was an intermediate phenotype of the two. 
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3.10 Transcriptional Microarray analysis in exponential phase and 
starvation. 
Microarrays can be used as a screening tool to allow comparative analysis 
of the entire transcriptome in an organism simultaneously. As the targets 
of ncRv10243 were unknown, an initial unbiased approach was taken to 
generate a hypothesis as to the functional role of ncRv10243. Since 
ncRv10243 is strongly induced in starvation as a consequence of SigF 
induction it was anticipated that deletion of ncRv10243 would result in an 
altered starvation transcriptome.  
Starvation differs from stationary phase markedly. Stationary phase is 
often due to a growth-limiting factor such as the depletion of an nutrients, 
and/or the formation of an inhibitory product for example propionate. This 
results in the growth rate and death rate being equal and this state is 
reached gradually. Starvation in the model used here however, is the 
complete deprivation of all nutrients by washing and replacing culture 
media with PBS.  RNA was isolated from exponential cultures as well as 
from starved cultures (24 hours in PBS was used instead of 96 hours as 
the latter results in poor RNA quality). Differential gene expression from 
exponential and starved cultures was investigated by transcriptomics.  
cDNA microarrays were used to analyse any differences in global gene 
expression between ncRv10243 and H37Rv.  
Briefly, RNA from wild type and mutant was reverse-transcribed and the 
cDNA labelled before mixing and competitively hybridising against an 
array. Three biological replicates for each strain were prepared and they 
were carried out in technical duplicate (dye-swaps) to account for any bias 
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in the labelling efficiencies of the Cy-dyes. A t-test against zero was 
performed for each data set and changes were considered to be 
significant if the p-value was less than 0.05 and changed 2-fold or greater. 
Tables 3.2A and 3.3B show the gene changes observed in the exponential 
and starvation microarray respectively. Of the genes found to be 
differentially expressed in both arrays only one, Rv0169 is known to be 
differentially expressed under starvation conditions. It would have been 
expected that if ncRv10243 were part of the starvation response that 
genes known to be involved would be altered in the deletion strain. 
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Gene 
Number 
Gene 
Name 
Gene Product Fold 
Change 
P-value 
Rv0694 
 
lldD1 
 
L-lactate dehydrogenase 2.53 
 
0.008 
 
Rv1130 
 
prpD Methyl citrate dehydratase 2.12 
 
0.017 
 
Rv0169 
 
mce1A Unknown but thought to be 
involved in host cell invasion 
2.08 
 
0.021 
 
Rv0693 
 
pqqE 
 
coenzyme PQQ synthesis 
protein E 
2.0 
 
0.031 
 
Table 3.2A Genes down regulated > 2-fold in ΔncRv10243 in exponential 
phase 
 
Gene 
Number 
Gene 
Name 
Gene Product Fold 
Change 
P-value 
Rv0440 
 
 
groEL2 60 kDa chaperonin 2 4.08 
 
0.035 
Rv3418c 
 
groES 10 kDa chaperonin GroES 3.38 0.049 
Rv0991c 
 
 Unknown 2.81 
 
0.032 
Rv0990c 
 
 Unknown 2.52 
 
0.037 
Table 3.2B Genes found to be up regulated > 2-fold in ΔncRv10243 after 
24hrs starvation 
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3.10.1 Confirmation of Microarrays by qRT-PCR 
Microarray results were confirmed by qRT-PCR using RNA extracted from 
three biological replicates of each strain. The complement was included in 
the analysis in order to assess whether the changes in gene expression 
could be complemented. qRT-PCR was performed according to section 
2.8 and the primers used can be found in Appendix II. Results are shown 
in Figure 3.7 and 3.8. 
All mRNA observed in the exponential microarray showed no statistical 
significant difference between wild type and deletion strain when tested by 
qRT-PCR. However, the complement was significantly different to wild 
type for Rv1130 although ncRv10243 expression between the strains was 
not significantly different.  
Genes indicated to be differentially expressed between wild type M. tb and 
ΔncRv10243 in the starvation microarray were groES, groEL2, Rv0990c 
and Rv0991c which were all found to be up regulated. All but Rv0990c 
could be confirmed by qRT-PCR and found to be at least partially 
complemented in each case. The transcriptional regulator Rv0990c, could 
not be confirmed by qRT-PCR but has been previously shown to be co 
transcribed with Rv0991c [184], which was confirmed as up regulated. 
GroES, groEL2 and Rv0991c are all heat shock proteins known to be 
under the control of the repressor HrcA (Rv2374c) [185]. The up regulation 
of all of these genes suggests an indirect effect from a change in this 
regulator. It was hypothesised that expression of the repressor could be 
affected in the mutant.  
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hrcA was measured by qRT-PCR in all strains to identify if the mRNA was 
changed in the mutant, but had been lost in the filtering analysis of the 
microarray. Expression levels of hrcA were not found to be significantly 
different between any of the 3 strains Figure 3.8. 
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Figure 3.7 qRT-PCR to confirm the gene expression changes observed in the 
exponential microarray.  
qRT-PCR was performed as detailed in section 2.8. Each Figure shows the 
expression level of the gene normalised to 16S. All data represents the mean and 
standard deviation of three biological replicates for each strain. Significance tested 
with one-way ANOVA and only the complement found to be significantly 
different from the wildtype in Rv1130 expression p> 0.05. 
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Figure 3.8 qRT-PCR confirmations of gene expression changes observed in 
the starvation microarray 
qRT-PCR was performed as detailed in section 2.8. Each bar shows the 
expression level of the gene normalised to 16S. All data represents the mean and 
standard deviation of three biological replicates for each strain. * = p value 
>0.05 with significance tested with one-way ANOVA. 
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3.11 Analysis of the ΔncRv10243 proteome 
The possibility that the altered expression of the heat shock family genes 
in the mutant could be as a result of post transcriptional regulation of the 
repressor HrcA. This was investigated by proteomic analysis of whole cell 
extracts and analysed by mass spectrometry. If ncRv10243 was 
responsible for altered expression of heat shock family genes through 
regulation of HrcA translation then a decrease in the protein abundance 
would be observed. 
Whole cell extracts from 96 hour starved cultures of H37Rv, ΔncRv10243 
and the complement were prepared in triplicate and analysed using mass 
spectrometry by Olga Shubert. Peptide abundance was further analysed 
using MSstats and fold-changes > = 1 or -1 (in log2 scale) with a p-value < 
0.01 were considered statistically significant.  
No statistically significant changes were observed in protein abundance 
between the wildtype and the deletion strain suggesting that the increase 
in the mRNA transcripts observed in the microarray did not result in 
increased translation. The observation that HrcA abundance was not 
significantly reduced leads to the remaining conclusion that ncRv10243 
could be acting to sequester the repressor HrcA by binding the protein, or 
by directly targeting mRNA and stabilising them. This hypothesis remains 
to be tested in future work. 
 
3.12 in vivo Analysis of ΔncRv10243 compared to wildtype M. tb 
M. tb is an intracellular pathogen that is subjected to a variety of stresses 
within the host, including but not limited to oxidative stress and nutrient 
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deprivation. Due to the fact that ncRv10243 is induced under oxidative 
stress, starvation, and infection in addition to being impaired for recovery 
from the Wayne model, the effect of its deletion on M. tb in vivo survival 
was assessed. It was expected that the deletion strain would be impaired 
for growth due to previous in vitro phenotypes being observed. It is also of 
note that loss of the alternative sigma factor SigF, which controls 
ncRv10243, was found to decrease the virulence of M. tb in mice, as well 
as disease associated tissue damage in mice and guinea pigs [176] [177] 
[178]. 
3.12.1 Deletion of ncRv10243 had no effect on the ability of M. tb to 
survive within either naïve or activated macrophages. 
The ΔncRv10243 strain, wildtype M. tb H37Rv and complement strains, 
were used to infect both naïve and activated murine BMDMs (as detailed 
in section 2.13). Macrophages were pre-activated with 10 ng/ml IFN-γ and 
incubated overnight and infected alongside naive macrophages at an MOI 
of 0.1:1 (bacteria: macrophages). The infection was allowed to continue 
for 7 days with five time points. At each time point the macrophages were 
lysed and plated for CFUs. For both the naive and activated macrophages, 
there were no significant differences between the three strains (Figure 
3.9). This would suggest that ncRv10243 does not result in attenuation in 
the mouse macrophage model. A lack of attenuation has been observed in 
a study of a sigF mutant in human monocyte derived macrophages [176]. 
However, the macrophage model of infection does not completely 
replicate the conditions encountered by the bacteria in the more 
complicated whole animal models of infection.  
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Figure 3.9 Survival of the ΔncRv10243 in a macrophage model of infection  
Survival of Wild type M. tb H37Rv, ΔncRv10243, and complementing strains 
within naive and IFN-γ activated BMDM over a time course of infection. 
Significance was tested with One-way ANOVA p>0.05. Data is the mean and 
standard deviation of triplicate infections. Data is representative of 3 independent 
experiments. 
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3.12.2 Deletion of ncRv10243 does not affect the ability of M. tb to 
survive in a mouse model of infection. 
In order to assess the role of ncRv10243 in pathogenesis in a more 
complete model of infection, wildtype M. tb H37Rv, ncRv10243, and the 
complemented strain were used in a mouse model of infection. Balb/C 
mice were infected with approximately 100 CFU via the aerosol route and 
the infection followed for 143 days. At time points 0, 30, 78, 100 and 143 
days, lungs and spleens were harvested for bacterial enumeration. No 
significant difference was observed in CFUs between the wildtype M. tb 
H37Rv and ΔncRv10243 at any of the time points (Figure 3.11). 
The lack of an obvious phenotype observed during the mouse infection 
does not necessarily mean that ncRv10243 does not play a role during 
infection and pathogenesis. A phenotype for the sigF mutant (the sigma 
factor known to control ncRv10243) was only detected through a time to 
death experiment in mice, along with observations on differences in 
histology of the lungs of guinea pigs and spleen size in mice [176-178]. No 
difference in the spleen size was noted for the deletion strain group at any 
time point during the infection. 
It is of note that a mouse model of infection does not replicate that of an 
M. tb infection in a human host. This is mainly apparent in the lack of 
ability of the mouse to form granulomas. Granulomas provide a unique 
niche for M. tb in which the environment is hypoxic and nutrients are 
limited. As these are conditions upon which ncRv10243 is induced, it is 
still possible that ncRv10243 plays a role in pathogenesis during 
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granuloma formation that could not be replicated in this study. A study in 
guinea pigs which do develop defined granulomatous lesions may provide 
an alternative phenotype. 
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Figure 3.10 Survival of ΔncRv10243 from aerosol infected mice. 
Survival of wildtype M. tb H37Rv, ΔncRv10243, and complement within the 
lungs and spleens of Balb/C mice. The data represents the averages and standard 
deviations from 5 mice per time point. Significance was tested with Two-way 
ANOVA. 
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3.12.3 ncRv10243 is expressed in M. tb isolated from the 
granulomas of infected macaques. 
To address the importance of ncRv10243 for M. tb residing within the 
granuloma, expression levels of ncRv10243 were measured by qRT-
PCR from M. tb within macaque granuloma samples (kindly supplied by 
JoAnne Flynn). Cynamologous macaques were infected with a low dose 
of M. tb (Erdman strain) and infection monitored by Positron emission 
tomography–computed tomography (PET/CT) imaging and identified 
granulomas of interest were consequently surgically removed. The 
samples were immediately flash frozen for RNA and paired samples 
were plated for CFU estimation. RNA was extracted from the M. tb 
isolated from the granulomas by homogenisation. A summary of the 
samples can be found in table 3.2. 
Although the level of RNA retrieved from the samples was relatively low 
and contained a large percentage of host RNA (as observed on the 
Bioanalyzer), qRT-PCR showed ncRv10243 to be detectable in all the 8 
samples tested, Figure 3.11. Expression levels observed were found to 
be comparable with that observed in the mouse even in instances where 
the estimated CFU’s were zero. This indicates that ncRv10243 is 
important in persistence within the granuloma due to expression in 
bacteria that are not actively replicating, or cells which lack the ability to 
be resuscitated. It is possible that the primers had some non-specific 
binding to macaque sequence producing non-specific amplification. 
However, qRT-PCR primers were tested on human leukocyte RNA prior 
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to use and found to result in no amplification. In addition RT- samples for 
each granuloma also resulted in no amplification.  
It was observed that the different types of lesions did not cluster for 
ncRv10243 expression indicating that the populations within the 
classified granuloma were not homogeneous. 
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Macaque 
Granuloma 
No. 
Status-CFU Total RNA yield (ng) 
3  Active - 24250 161 
4 Active - 282000 831 
5 Latent likely sterile 301 
6 Latent likely sterile 311 
7 Latent -3315 381 
8 Latent -0 151 
9 4 wk -580000 60 
10 4 wk - 211250 641 
 
Table 3.2 Summary of Macaque granuloma status and RNA yield 
RNA was extracted from M. tb Erdman present in the granulomas of low dose 
aerosol infected cynomolgus macaques. Granulomas were scored on their status 
by observations using PET/CT imaging. 
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Figure 3.11 Expression of ncRv10243 in the granulomatous lesions of 
Macaques. 
qRT-PCR was performed as detailed in section 2.8. Each bar shows the 
expression level of ncRv10243 normalised to 16S for each individual granuloma. 
Expression level of ncRv10243 in the mouse has been included for comparison. 
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3.13 Discussion 
ncRv10243 is a well expressed sRNA in exponential phase that has 
previously been observed to be up regulated in stationary phase [153]. It 
was known that this sRNA is under the control of sigF [153, 175] but no 
function for the sRNA had been determined. In this study we aimed to 
further assess the expression conditions of this sRNA and to identify a 
functional role. 
Induction of sRNA ncRv10243 was observed to be up regulated during 
early murine infection (21 days post infection) and upon 96 hours 
starvation in PBS indicating that this sRNA is important for pathogenesis 
and in particular could be important for survival within the granuloma. 
During early infection bacteria are actively replicating and the innate 
immunity controls the growth of the bacteria through the use of 
macrophages where upon the M. tb is subjected to stresses such as high 
levels of the bactericidal compound nitric oxide. Around 21 days adaptive 
immunity begins and bacterial growth plateaus in the mouse. M. tb within 
the granuloma are deprived of nutrients; therefore, bacilli must shift their 
metabolism to conserve energy up regulating enzymes essential for 
survival during starvation and hypoxia.  
It is assumed that during nutrient starvation conditions; mycobacteria 
utilize lipids as a sole source of energy [186]. In general, a global 
metabolic shift is observed when bacilli undergo starvation conditions 
[187, 188]. 
M. tb has the ability to survive inside the host environment for decades in 
a latent state before reactivation. This can be modelled in vitro using the 
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Wayne model of dormancy. The ΔncRv10243 deletion strain was tested in 
the Wayne model due to the fact that slower growth was observed when 
oxygen was previously limiting. As predicted the ΔncRv10243 deletion 
strain was indeed impaired for recovery from the Wayne model (Figure 
3.7) but not for growth to NRP-2 (data not shown). As no differences were 
observed in the level of CFU’s post incubation it would indicate that the 
bacteria were alive but unable to replicate as efficiently in the deletion 
strain.  
Previously it has been observed that the sigma factor which controls 
expression of ncRv10243 is induced in the Wayne model [189]. SigF was 
first described in BCG as a stationary phase response sigma factor that is 
also induced upon cold shock in BCG [189], heat shock, acidic pH and 
oxidative stress in M. smegmatis, and nutrient starvation in M. tb [187]. 
Therefore it is hardly surprising that these are also conditions that induce 
the expression of ncRv10243. 
Microarray investigations of an M. tb ΔsigF mutant revealed that Rv3418c 
(groES, which codes for 10-kDa chaperonin) and Rv0991c (a hypothetical 
protein) were down regulated under exponential phase conditions [176]. 
24 hour starvation microarrays on the ΔncRv10243 strain showed up 
regulation of groES and Rv0991c along with Rv0440 (groEL2, which 
codes for 60kDa chaperonin2) as well as Rv0990c the downstream gene 
of Rv0991c. All of these genes except Rv0990c were confirmed by qRT-
PCR as being significantly different between the wildtype M. tb strain and 
the ΔncRv10243 deletion strain.  
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These genes have been shown to belong to the GroE/Hsp60 heat-shock 
protein family. The GroE chaperonin complex consisting of GroEL and 
GroES is involved in preventing cellular proteins from misfolding after 
temperature increase. Up regulation of this family of genes had previously 
been observed in a ΔhspR/ΔhrcA mutant in M. tb where they 
characterised the heat shock response [185].  
The heat-shock repressor HrcA acts as the main regulator for the heat 
shock protein family, controlling its targets through the binding site, 
controlling inverted repeat of chaperone expression (CIRCE), [185]. The 
CIRCE binding site can be found in the 5’UTRs of groES, groEL2 and 
Rv0991c which is thought to be co transcribed with the adjacent Rv0990c. 
GroEL2 is preceded by two CIRCE-like elements and both groES and 
Rv0991c by one. In addition to acting as a transcriptional repressor HrcA 
has also been shown to play a role in post-transcriptional control of mRNA 
stability. In B. subtilis it was demonstrated that CIRCE elements at the 5’ 
end of a transcript resulted in low stability [190], this was also observed in 
Rhodobacter capsulatus which does not possess a HrcA protein [191]. 
Therefore it is likely that the heat shock response in M. tb is controlled 
both transcriptionally and post-transcriptionally via the CIRCE element. If 
regulation of the GroE chaperonin was controlled by ncRv10243 it could 
be achieved by sequestering HrcA to relieve transcriptional repression. 
sRNAs binding directly to proteins has been previously reported, for 
example the CsrB family of sRNAs contain multiple binding sites for the 
protein CsrA [192]. CsrB RNA functions as a CsrA antagonist by 
sequestering this protein which functions as an RNA binding protein which 
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usually prevents translation and thereby activates mRNA decay through 
endonuclease attack.  
As no change in hrcA was found by qRT-PCR to evidence this, proteomic 
analysis of whole cell extracts comparing wildtype M. tb H37Rv and the 
ΔncRv10243 deletion strain were analysed. No difference in abundance of 
HrcA was observed at the proteomic level leading to the possibility that 
ncRv10243 directly targets GroES, GroEL and Rv0991c by binding to their 
5’ ends around the CIRCE element increasing stability of the mRNA. It is 
also possible that loss of ncRv10243 has some as yet unidentified effect 
that results in an increase in unfolded proteins resulting in a canonical 
heat shock response. 
As ncRv10243 was found to be induced by nutrient starvation in response 
to sigF induction, it was reasoned that the ΔncRv10243 deletion strain 
would be attenuated for growth in vivo. Infection of BMDM for 7 days and 
BALB/c mice for 143 days revealed no attenuation of the ΔncRv10243 
deletion strain. Studies of a sigF mutant however showed that ΔsigF can 
achieve high CFU counts in mice but is attenuated in causing tissue 
damage and in producing lethality in mice [176, 177]. 
Using an intravenous infection of mice a time-to-death study was 
conducted using the ΔsigF mutant. The mutant strain infected mice were 
able to survive for 334 days whereas the wildtype infected mice lasted 
only 184 days [176]. This could explain why no phenotype was observed 
for the ΔncRv10243 deletion strain. Another possibility is that attenuation 
could have been observed in a different animal system of infection such as 
the guinea pig model. Mice lack the ability to form granulomas which acts 
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as a starvation based environment. It was noted that when a ΔsigF mutant 
was used to infect guinea pigs by the aerosol route it exhibited ill-defined 
lung granulomas [178] suggesting that sigF responses are important for 
the bacterial interaction with the host. 
Adaptation to nutrient deprivation is essential for long-term survival of 
persistent bacteria. M. tb is capable of surviving under non growing 
starvation conditions for up to 2 years in vitro while maintaining the ability 
to be resuscitated [193]. In M. smegmatis carbon, nitrogen, and 
phosphorus-starved organisms have been shown to retain viability for over 
650 days [194]. Therefore correct adaptation to starvation enables 
bacteria to survive until conditions become more favourable.   
Due to ncRv10243 being identified as important for recovery from the 
Wayne model, it is possible that the lack of identified targets in this study 
could be due to the conditions studied. ncRv10243 could be required for 
the recovery from stress and therefore be accumulated within the bacteria 
until such time as it is required. This could explain why no targets or strong 
phenotype was observed for the deletion strain despite over expression of 
ncRv10243 in M. tb leading to reduced growth. However, when 
ncRv10243 is over expressed in M. smegmatis there is no obvious 
phenotype despite a homolog being present.  
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4 The constitutively expressed sRNA ncRv11690, may 
play a role in regulation of EsxA secretion 
4.1 Introduction 
The sRNA ncRv11690 was originally identified through cDNA cloning of 
size fractionated RNA and termed G2 after the corresponding clone [153]. 
It is a trans-encoded sRNA found in the intergenic region between lprJ (a 
probable lipoprotein) and tyrS (an essential tRNA synthase), Figure 4.1a). 
Further characterisation of the sRNA to identify 5’ and 3’ ends by RACE 
led to the calculation of a full-length transcript of 229bp with a possible 
SigC promoter upstream of one of the 5’ ends. Northern blotting shows a 
predominant transcript of 65 bp indicating substantial processing of this 
sRNA, Figure 4.1B.  
Very little was known about ncRv11690 and no possible function had been 
elucidated. It was known however that this sRNA was conserved only 
within the M. tuberculosis complex inferring a role in pathogenesis. If this 
sRNA was indeed also under the control of SigC this would also infer a 
role in pathogenesis as a SigC deletion mutant was shown to play a 
central role in the lethality of M. tb infected mice [195]. 
Functional characterisation was attempted through over expression in M. 
tb which proved lethal with two different strength promoters. This 
prompted the over expression in M. smegmatis, which resulted in defective 
growth, especially in liquid medium [153]. This phenotype was observed in 
spite of the fact that no obvious homologue of this sRNA is present in the 
faster growing mycobacterial strain indicating that possible targets are 
conserved. 
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Figure 4.1 Location and transcript size of ncRv11690 
a) Genomic position of sRNA ncRv11690 in the M. tb genome as viewed in Tuberculist (http://tuberculist.epfl.ch/) b) transcript size of 
sRNA ncRv11690 by northern blotting (adapted from Arnvig 2009) M = marker, E = exponential phase, S = stationary phase.
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4.2 Hypotheses and specific aims 
As mentioned previously in 3.2, it is difficult to speculate on possible targets for 
trans-encoded sRNAs. ncRv11690 is not co transcribed with any other genes 
as it is divergent to both flanking genes on the genome. Therefore, as with 
sRNA ncRv10243, an unbiased approach was taken in order to identify possible 
mRNA targets and therefore elucidate the function of ncRv11690. 
As experimental manipulation of sRNA expression levels can provide an 
alternative route to target identification, the aim of the study was to create both 
a sRNA deletion strain and an integrating over expression strain. These strains 
would then be used to perform gene expression analysis by microarray, which 
would allow the assessment of the relative abundance of mRNA in both the 
wildtype/vector controls and ncRv11690 deletion/over expression strain.  
In addition to this we planned to assess the virulence of M. tb upon removal of 
ncRv11690 from the genome. As this sRNA is potentially under the control of 
SigC, which was shown to be important in virulence, we predicted that 
ncRv11690 would also play a role in virulence of M. tb. 
 
Results 
4.3 In vitro and In vivo expression levels of ncRv11690 
ncRv11690 was known to be a well-expressed sRNA in exponential phase. This 
study showed that the sRNA is equally well expressed by M. tb in the infected 
lungs of mice after 21 days of infection an early point of infection where the 
bacteria are actively replicating. The sRNA was also observed in this study to 
be down regulated in both stationary phase and starvation. This would indicate 
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that the sRNA is involved in active growth of the bacteria. However, northern 
blot analysis shows induction of the sRNA in stationary phase, identifying a 
discrepancy between the two techniques. This is most likely due to the location 
of the probes for each technique.  
  
  
 
123 
 
 
 
Figure 4.2 Expression levels of ncRv11690 in M. tb  
ncRv11690 expression levels were measured using qRT-PCR, in each instance 
ncRv11690 levels are expressed relative to 16S rRNA control. Data represents the 
mean and standard deviations of three biological replicates for each condition. 
Expression during stationary phase, mouse infection and 96 hours starvation are 
significantly different from exponential phase expression when compared by One-
way ANOVA, p<0.05. 
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4.4 Creation of a ncRv11690 deletion strain 
This study set out to identify possible targets of ncRv11690 through the 
creation of a deletion strain in which the sRNA and its promoter are entirely 
removed from the chromosome. The deletion strategy was as described by 
[183] which uses a non-replicating suicide vector [7] in a two-step process 
as described in section 2.9.10 and 3.4. Briefly, a single cross-over (SCO) 
recombinant is isolated from the electroporation of M. tb with the targeting 
construct. SCO are then subjected to counter-selection in order to obtain 
double crossovers (DCO) generated by a second recombination event. The 
markers sacB and lacZ on the targeting construct allow for blue/white 
screening of colonies and make counter-selection for sucrose sensitivity 
possible [183] . 
4.4.2 Design and creation of the deletion plasmid  
In order to remove ncRv11690 from the chromosome of M. tb the aim was 
to remove the entire sRNA and its promoter. For homologous 
recombination to occur between the deletion plasmid and the bacterial 
chromosome, approximately 1kb of each of the 5’ and 3’ flanking regions 
must be included. The targeting constructed was created in this instance 
by cloning a large fragment of approximately 2.5 kbp encompassing 
coordinates 1913940-1916496 and the sRNA and its promoter removed 
by site directed mutagenesis (SDM). This created a deletion strain lacking 
coordinates 1914961-1915183. 
The PCR strategy for screening both SCO and DCO candidates are 
represented in Figure 3.3A.   
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4.4.3 Screening of single and double crossover candidates 
After electroporation with the targeting plasmid into M. tb H37Rv, cells 
were plated onto 7H11 containing Kanamycin and X-Gal for selection of 
SCO’s. After incubation, 4 blue colonies were screened by PCR to identify 
true SCOs from random integrations (Figure 4.3). As the region of deletion 
in this instance was only ~206bp, it was difficult to differentiate wildtype 
bands from SCO bands. Therefore the resulting PCR products were gel 
extracted and sent for sequencing. Sequencing revealed 1 SCO, which 
was then streaked onto non selective 7H11 for the second recombination 
event to occur. Full loss of the backbone of the deletion plasmid was 
confirmed by streaking colonies onto both 7H11 plus Kanamycin and X-
Gal, and also 7H11 without antibiotic, plus X-Gal. 8 colonies from DCO 
selection were white and Kanamycin sensitive. These DCO candidates 
were screened by PCR amplification and sequencing, which showed 
colony number 5, 6, 8, 11 and 12 to contain the deletion of the sRNA from 
the M. tb genome (Figure 4.3). 
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Figure 4.3 PCR screening for the construction of the ncRv11690 deletion 
strain. 
PCR reactions were designed using the strategy outlined in Figure 3.3A. Expected 
sizes of products for each primer pair are indicated. Due to the small size of 
deletion, these PCR products were consequently gel extracted as detailed in 
section 2.2.3 and sequenced directly. SCO = single crossover; DCO = double 
crossover; M = Bioline Hyperladder I DNA marker. 
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4.5 Complementation of the ncRv11690 mutant 
As the aim of this study was to characterise the phenotype of a 
ΔncRv11690 strain, it was essential to complement the loss of the sRNA by 
replacing the chromosomal copy with one supplied on a plasmid. The 
resulting strain should in theory have the same phenotype as wild type M. tb 
H37Rv.  
The sRNA was amplified by PCR with a portion of upstream and 
downstream region to include any possible regulatory elements and then 
cloned into the KanR plasmid pKP186. The double crossover was 
electroporated with the complementing plasmid along with a plasmid that 
separately supplies the integrase. Presence of the plasmid was confirmed 
by PCR analysis of Instagene preparations. 
4.6 Full Genome sequencing of the ncRv11690 mutant 
High Quality genomic DNA was extracted from the mutant and the parental 
H37Rv strain (as per Section 2.4). Sequencing libraries were prepared from 
both strains and sequenced by the HTS sequencing facility at NIMR. The 
resulting reads were aligned to the H37Rv reference genome by Graham 
Rose (NIMR) and single nucleotide polymorphisms (SNPs) were identified.  
Alignment of the genomic sequence of ΔncRv11690 identified 1 
synonymous SNP in the conserved hypothetical protein Rv1691 (Appendix 
III). As this was a synonymous SNP, this does not result in a change of the 
amino acid coded for by the sequence, and therefore should not affect 
function of the protein. 
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4.7 Assessment of ncRv11690 expression in deletion and 
complement strains 
To confirm the removal of the sRNA and to assess the degree of 
complementation achieved, RNA extracts were prepared from H37Rv, 
ΔncRv11690, and the complemented strain. The cDNA was prepared as 
previously described in 3.7 and assessed by qRT-PCR before normalising 
to 16S. qRT-PCR showed that ncRv11690 was undetectable in the 
ΔncRv11690 strain (Figure 4.4). There was no statistical significance in the 
expression level of ncRv11690 between the wildtype and complement strain 
(Figure 4.4; Unpaired t-test, p>0.05). 
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Figure 4.4 qRT-PCR confirmations of ncRv11690 deletion and 
complementation 
Each strain was grown to exponential phase in standard 7H9 media and RNA then 
extracted. qRT-PCR was performed as described in section 2.8. In each instance 
sRNA expression is expressed relative to 16S, an rRNA control. Data represents 
the averages and standard deviations of three biological replicates for each strain. 
Significance was tested by One-way ANOVA and the complement found to be 
significantly different from the wildtype with expression on average 2.5 fold that 
of the wildtype. 
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4.8 In vitro phenotype analysis of growth compared to wildtype 
In the first instance the ΔncRv11690 strain was assessed for an in vitro 
growth phenotype by comparing growth of the deletion strain against 
wildtype and complement strain. Cultures were grown to exponential phase 
(OD600 ~0.6) in 7H9 media, and these cultures were used to inoculate fresh 
media to an OD600 = 0.05. The OD600 was monitored until a plateau of 
growth was reached. No significant difference was observed between the 
doubling times of the three strains (Figure 4.5) as assessed by Linear 
regression analysis, p>0.05, showing that deletion of ncRv11690 has no 
effect on in vitro growth of M. tb. under these conditions. 
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Figure 4.5 Growth of ΔncRv11690 in standard 7H9 media 
In vitro growth curves of wildtype M. tb H37Rv, the ΔncRv11690 deletion strain 
and the complement using standard 7H9 media in a rolling culture system. The 
data represents the averages and standard deviations of three biological replicates. 
There was no siginificant difference between the growth of the strains as tested by 
linear regression analysis. 
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4.9 Transcriptional Microarray analysis in exponential phase 
As the targets of ncRv11690 were unknown, an initial unbiased approach 
was taken to generate a hypothesis as to the functional role of 
ncRv11690.  An M. tb whole genome microarray, generated by the 
Bacterial Microarray Group at St. George’s containing 4,410 gene-specific 
PCR products was used. Since ncRv11690 is most highly expressed in 
exponential phase, RNA was isolated from mid log cultures for 
investigation by transcriptomics.  
cDNA microarrays were used to analyse global gene expression changes 
between the ΔncRv11690 and wildtype H37Rv as described in section 
2.15 of the materials and methods.  
Briefly, 2µg of RNA from wild type and mutant was reverse transcribed to 
generate cy3 or cy5 labelled cDNA before competitively hybridising 
against an array. Three biological replicates for each strain were prepared 
in technical duplicate (dye-swaps) to account for any bias in the labelling 
efficiencies of the Cy-dyes. Gene expression changes were considered to 
be significant if the p-value was less than 0.05 and the fold change was 2 
or above. 65 genes in total were found to be differentially expressed in the 
ΔncRv11690 and those greater than 2.5 fold are shown in Tables 4.1 and 
4.2. The remainder of the list can be found in Appendix IV. 
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Gene No. Gene 
Name 
Gene Product Fold 
Change 
P-value 
Rv1535  Unknown protein 3.95 0.048 
Rv2699c  Conserved Hypothetical protein 3.53 0.048 
Rv3528c  Unknown protein 3.48 0.046 
Rv2299c htpG Probable chaperone protein 2.97 0.045 
Rv0097  Possible oxidoreductase 2.97 0.042 
Rv2582 ppiB Probable peptidyl-prolyl cis-trans isomerise B 2.94 0.041 
Rv0634B rpmG2 50S ribosomal protein L33 RpmG2 2.79 0.042 
Rv0846c  Probable oxidase 2.73 0.048 
Rv2520c  Conserved membrane protein 2.73 0.046 
Rv0761c adhB Possible zinc-containing alcohol 
dehydrogenase NAD dependent 
2.66 0.048 
Rv2289 cdh Probable CDP-diacylglycerol pyrophosphatase 2.63 0.042 
Rv2288  Hypothetical protein 2.63 0.048 
Rv2429 ahpD Alkyl hydroperoxide reductase D protein 2.59 0.05 
Rv2000  Unknown protein 2.59 0.042 
Rv1885c MtCM Chorismate mutase 2.55 0.042 
Rv1515c  Conserved hypothetical protein 2.54 0.048 
Rv3790 dprE1 Decaprenylphosphoryl-beta-D-ribose 2'-
oxidase 
2.53 0.041 
Rv1754c  Conserved protein 2.53 0.042 
Table 4.1 Genes up regulated > 2.5-fold in ΔncRv11690 in exponential phase 
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Gene 
No. 
Gene 
Name 
Gene Product Fold 
Change 
P-value 
Rv3229c desA3 Possible linoleoyl-CoA desaturase 6.70 0.048 
Rv3841 bfrB Bacterioferritin 2.94 0.048 
Table 4.2 Genes down regulated > 2.5-fold in ΔncRv11690 in exponential phase 
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4.9.1 Confirmation of Microarrays by qRT-PCR 
A selection of genes was chosen for confirmation of the 
microarray results by qRT-PCR using RNA extracted from three 
biological replicates of each strain. The complement was included 
in the analysis in order to assess whether the changes in gene 
expression could be complemented. qRT-PCR was performed 
according to section 2.8 and the primers used can be found in 
Appendix II. Results are shown in Figure 4.6.  
It was apparent from the genes identified in the microarray that 
there was a trend for genes linked to metal ions, with mRNA from 
both the Zur and Fur regulons. Furthermore the most up regulated 
gene Rv1535 is known to up regulated in response to magnesium 
starvation. This induction is due to the possession of a 
magnesium responsive riboswitch.  
Two genes known to be involved in molybdopterin synthesis 
Rv3116 and Rv2338c were also shown to be down regulated 
greater than 2 fold (Appendix IV). Genes of interest were selected 
for confirmation by qRT-PCR including those with the highest fold 
changes (desA3, Rv1535 and Rv3841)  
From the genes selected for confirmation five were shown to be 
significantly different in the ΔncRv11690 strain compared to the 
wildtype as tested by one-way ANOVA. These included desA3, 
Rv1535, Rv3841, Rv0761c and Rv0846c. Three genes were 
found to be either fully or partially restored to wildtype levels in the 
complement. These were desA3, Rv1535 and Rv3841. 
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Figure 4.6 qRT-PCR confirmation of the gene expression changes observed 
in the exponential microarray.  
qRT-PCR was performed on a selection of mRNA as detailed in section 2.8. Each 
bar shows the expression level of the gene normalised to 16S. All data represents 
the mean and standard deviation of three biological replicates for each strain.  * = 
p value >0.05 with significance tested with one-way ANOVA. 
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Due to the relatively large numbers of genes shown to be affected in the 
microarray a common regulator was searched for using the TbDb systems 
biology database. The TbDb database allows the identification of DNA binding 
sites for regulators that could affect transcription of mRNA. Therefore if the 
sRNA was affecting the abundance of a regulator, as opposed to individually 
targeting an mRNA, then the gene changes observed in the microarray would 
be due to indirect effects of action on the regulator by the sRNA and not direct 
targeting. 
Regulator candidates generated by TbDb were compared to the microarray 
results, which identified Rv0891c as a possible regulator of Rv1535 [196]. This 
mRNA was identified in the microarray as being 2.48 fold down regulated. 
Therefore mRNA levels were measured to confirm the result (Figure 4.7).  
Expression of Rv0891c was not found to be significantly different between the 
mutant and the wildtype. As the level of expression is low in all strains this could 
have resulted in a false positive in the microarray. It is also possible that the 
sRNA is acting post transcriptionally on Rv0891c in such a way that minimal 
effects on the abundance of the mRNA are observed.  
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Figure 4.7 qRT-PCR of the regulator Rv0891c 
qRT-PCR was performed as detailed in section 2.8. Each bar shows the 
expression level of the Rv0891c normalised to 16S. Data represents the mean and 
standard deviation of three biological replicates for each strain.  Significance was 
tested with one-way ANOVA. 
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4.10 ΔncRv11690 is not susceptible to changes in magnesium 
concentration. 
The observation that Rv1535 was up regulated upon deletion of 
ncRv11690 could indicate that the sRNA is involved in regulating bacterial 
homeostasis under magnesium deprivation. This hypothesis is borne from 
the knowledge that Rv1535 is up regulated in response to magnesium 
starvation due to the possession of a magnesium responsive riboswitch. 
The up regulation that was observed in the microarray could be interpreted 
as the deletion strain sensing magnesium starvation conditions. If 
ncRv11690 is responsible for regulating magnesium concentrations that 
results in an effect on Rv1535, then the deletion strain could be impaired 
for survival in media lacking magnesium. This hypothesis was tested by 
growing the wild type H37Rv along in parallel with the ncRv11690 deletion 
strain and complement in a minimal media (Sautons) with or without the 
addition of magnesium. No growth defect was observed with or without 
magnesium in the minimal media indicating that the deletion strain was not 
suffering from magnesium starvation. 
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Figure 4.8 Growth of ncRv11690 under different magnesium concentrations 
Strains were grown in Sautons media in rolling culture with a) 2 mM magnesium 
or b) without magnesium and OD600 monitored overtime. Data points represent 
three biological replicates per strain per time point. Slopes were found not to be 
significantly different from each other by linear regression analysis. 
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4.11 Over expression of ncRv11690. 
In order to gain further insight into the function of ncRv11690, over expression 
was attempted on an integrating vector in order to achieve a lower level of 
expression. The promoter, sRNA and synthetic terminator were digested from 
previous replicating over expression constructs [153] and ligated into the 
integrating plasmid pKP186. This gave rise to pJHP09 and pJHP10, which were 
the integrating strong and weak constructs respectively. 
The original over expression in a replicating vector proved lethal in M. tb. 
However, when the sRNA under the rrnB promoter was placed on an integrating 
vector, expression was reduced to such an extent that over expression was no 
longer lethal in wildtype H37Rv M. tb. This indicated that a tolerance threshold 
for the sRNA exists.  
No obvious growth defect for any of the strains was observed, and acid fast 
staining of the over expression revealed no differences in cell morphology by 
light microscopy. RNA was isolated from both the over expression and the 
vector control during exponential growth and used to measure the expression 
level of ncRv11690 Figure 4.9. 
It was observed that over expression of ncRv11690 was achieved to an 
astounding 22,000-fold that of wildtype vector control when expressed from the 
stronger rrnB promoter in pKA305. ncRv11690 expression increases therefore 
from 0.001% that of ribosomal RNA to approximately 20%. Over expression of 
this sRNA was still achieved to a large extent in the plasmid with the weaker 
promoter (pKA306), achieving approximately 18,000-fold over expression when 
compared to vector control. This would indicate that the expression of 
ncRv11690 in the replicating over expression background would have reached 
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or possibly exceeded that of rRNA. This is due to the fact that the plasmid 
based on pMV261 possessed an estimated copy number of five. Such a high 
level of expression would indicate that the sRNA was very stable and/or the 
degradosome (responsible for degradation of the sRNA) was probably 
saturated. This led us to investigate the stability of ncRv11690.  
  
  
 
143 
 
 
 
Figure 4.9 Over expression of ncRv11690 in M. tb 
ncRv11690 expression levels were measured using qRT-PCR and in each instance 
are expressed relative to 16S rRNA control. Each bar represents the mean of three 
biological replicates. Vector controls and over expression strains found to differ 
significantly from each other as tested by t-test, p<0.05. 
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4.12 Stability of ncRv11690 
It is important to ascertain the stability of a sRNA as its abundance under 
different conditions is a reflection of the rate of its synthesis and decay. The 
drug rifampicin is known to bind the RpoB subunit of RNA polymerase and 
inhibit new transcription [197]. Therefore the quantity of any RNA species in a 
cell following exposure to rifampicin is expected to remain unchanged and any 
changes due to degradation would reflect its stability. To gain insight into the 
stability of ncRv11690, cultures were grown to stationary phase and Rifampicin 
was added to the test cultures after diluting to OD600 = 0.3. Dilution of the 
culture back to a starting OD of 0.3 allows the culture to commence exponential 
growth under which active transcription can be observed.  
Samples were taken before and after treatment with rifampicin and at different 
time points to assess the sRNA stability by northern blotting, Figure 4.10. 
Northern blotting of rifampicin treated M. tb revealed ncRv11690 to be highly 
stable, with the sRNA being detectable for at least 6 hours. This is in stark 
contrast to the average half-life of mRNA measured in M. tb which was found to 
be approximately 9.5 min[198]. The increased stability is likely due to the stable 
secondary structure previously modelled [153]. It is worth remembering 
however that this is an artificial system. If the sRNA is usually degraded when in 
a duplex with its mRNA target then lack of target message will artificially 
enhance the stability of the sRNA due to the specificity of the nuclease required 
for degradation. 
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Figure 4.10 Stability of sRNA ncRv11690 +/- Rifampicin. 
Cultures were grown to stationary phase, and then diluted to OD600 = 0.3 with or 
without the addition of 1 µg/ml of rifampicin. RNA was extracted for analysis by 
northern blot as described in section 2.9 using a 33P radiolabelled probe at 0, 2, 4, 
6, 24 and 48 hours after dilution. 
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4.13 Analysis of the ncRv11690 expression proteomes 
As sRNAs are known to act on the post-transcriptional level it was of 
importance to assess the relative abundance of proteins within the various 
expression strains in order to identify targets of ncRv11690. It was expected 
that any changes observed in both the over expression and the deletion strain 
would represent targets for ncRv11690. To test this whole cell extracts were 
isolated from triplicate exponential phase cultures of H37Rv, ΔncRv11690, 
complement, ncRv11690 over expression and vector control. Samples were 
sent to Olga Schubert who performed Mass spectrometry and further analysed 
the results for statistical significance using MSstats. Protein abundance was 
considered to be significantly different with a fold change greater than 1 or -1 in 
log2 scale and with a p value less than 0.01.  
18 proteins were found to be differentially expressed between the deletion strain 
and H37Rv. However, all of these changes were also observed in a comparison 
of the complement against the wildtype H37Rv, indicating that these changes 
were not due to the loss of ncRv11690. The induction of DosR and genes 
belonging to the DosR regulon were observed to be up regulated indicating that 
the bacteria were under stress. 
 Analysis of the over expression strain revealed 10 proteins to be differentially 
expressed between the over expression and vector control strains. 8 proteins 
were up regulated while 2 were down regulated. Four of these proteins 
(Rv2007c, Rv3134c, Rv3131 and Rv2629) were also observed to be up 
regulated in the deletion strain analysis and therefore unlikely to be a specific 
effect of ncRv11690 expression.  
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Of the six remaining proteins 3 belong to the functional classification of cell wall 
and cell processes. These are Rv3866; an Esx-1 secretion associated protein, 
Rv1496; a possible arginine/ornithine transport system ATPase, and Rv2576c; 
a possible conserved membrane protein. The observed up regulation of Rv3866 
along with the down regulation of Rv2576c could suggest a change in the cell 
wall upon over expression. 
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Protein Δ/H37Rv  
Fold 
Change 
(Log2) 
Complement/ 
H37Rv  
Fold change  
(Log2) 
Δ/ 
H37Rv  
p value 
Complement/ 
H37Rv 
p value 
Rv2007c 6.75 7.17 <0.001 <0.001 
Rv2031c 6.54 7.04 <0.001 <0.001 
Rv0079 5.32 5.64 0.001 0.003 
Rv2626c 5.07 5.09 <0.001 <0.001 
Rv3134c 4.72 5.37 <0.001 <0.001 
Rv0569 4.56 5.56 0.001 0.008 
Rv2030c 4.51 4.91 <0.001 <0.001 
Rv1738 4.2 4.93 <0.001 0.001 
Rv2623 4.01 4.68 <0.001 <0.001 
Rv2032 3.56 4.3 <0.001 0.001 
Rv2005c 3.18 3.89 <0.001 <0.001 
Rv2629 3.16 3.66 <0.001 <0.001 
Rv3131 3.07 3.54 <0.001 <0.001 
Rv1996 2.86 3.69 <0.001 <0.001 
Rv3133c 2.53 2.91 <0.001 0.003 
Rv2383c 1.56 1.52 <0.001 <0.001 
Rv0081 1.46 1.48 0.004 0.009 
Rv3271c -0.74 -1.38 <0.001 0.008 
Rv3213c -0.77 -1.09 <0.001 0.009 
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Table 4.3 Proteins differentially expressed between either wild type and 
deletion strains or H37Rv and Complement.  
Whole cell extracts from exponential phase cultures were analysed by mass 
spectrometry for differential protein expression. Statistical significance was set at 
a fold change >1 or -1 in log2 scale with a p value < 0.01 
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Protein 
Rv number 
Gene name Over 
expression/vector 
Fold change (Log2) 
Over 
expression/vector  
p value  
Rv2007c fdxA 3.65 0.002 
Rv3134c USP 2.90 <0.001 
Rv3131 tgs 1.91 0.001 
Rv2482c plsB2 1.83 0.006 
Rv0458  1.27 0.004 
Rv2629  1.22 0.008 
Rv3866 espG1 1.19 0.001 
Rv1496  1.07 0.005 
Rv2576c  -1.02 0.008 
Rv2782c pepR -2.25 <0.001 
 
Table 4.4 Proteins differentially expressed between the over expression and 
vector control 
Whole cell extracts from exponential phase cultures were analysed by mass 
spectrometry for differential protein expression. Statistical significance was set at 
a fold change >1 or -1 in log2 scale with a p value < 0.01 
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4.14 in vivo Analysis of ΔncRv11690 compared to wildtype M. tb 
As ncRv11690 was shown to be well expressed during the early infection of 
Balb/C mice (Figure 4.2) the possibility that ncRv11690 may play a role in 
pathogenesis was investigated using in vivo models.  
4.14.1 Deletion of ncRv11690 had no effect on the ability of M. tb to 
survive within either naïve or activated macrophages. 
To investigate the function of ncRv11690 during very early infection we 
used a cell based model. Both naïve and IFN-γ activated macrophages 
were infected with wild type H37Rv, and ΔncRv11690 at an MOI of 0.1:1 
and the progress of infection was followed, (Figure 4.11). 
The wild type H37Rv strain reproducibly replicated to levels 
corresponding to an increase of approximately 2 logs in naive 
macrophages during the course of the experiment. Growth and survival 
of the ΔncRv11690 strain was very similar to that of the wild type with no 
significant difference detected at any time point. 
Growth of both H37Rv and ΔncRv11690 within IFN-γ activated 
macrophages was less than that observed in naive macrophages. An 
increase of approximately 1 log would indicate successful activation of 
the macrophages due to the control of proliferation. However, there was 
only a significant difference between the two strains at 120 hours, which 
was not replicated at later time points. This would suggest that 
ΔncRv11690 is not attenuated for growth in either naive or activated 
macrophages. 
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Figure 4.11 Survival of the ΔncRv11690 in a macrophage model of infection  
Survival of Wild type M. tb H37Rv, ΔncRv11690, and complementing strains 
within naive and IFN-γ activated BMDM over a time course of infection. 
Significance was tested with Two-way ANOVA p>0.05. Data is the mean and 
standard deviation of triplicate infections.  
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4.14.2 Deletion of ncRv11690 had no effect on the ability of M. tb to 
survive in a mouse model of infection 
The lack of an attenuation for the mutant strain in macrophages led to 
the assessment of the importance of the sRNA in establishing an 
infection in mice. Groups of mice were infected by the aerosol route as 
described in section 2.8.12, with 5 mice per strain sacrificed at each time 
point for bacterial enumeration. 
Infection of the mice showed that the ncRv11690 deletion strain was not 
defective in its ability to establish or maintain an infection (Figure 4.12). 
The first infection hinted at an increase in virulence in the later time 
points for the ΔncRv11690 strain. However, when the infection was 
repeated this was not observed. 
ncRv11690 in this model of infection does not result in attenuation as 
measured by CFUs. It remains possible though, that ncRv11690 may still 
play a role in pathogenesis that does not result in lowered CFUs.  
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Figure 4.12 Survival of ΔncRv11690 from aerosol infected mice. 
Survival of wildtype M. tb H37Rv, ΔncRv11690, and complement within the 
lungs and spleens of BALB/C mice. The data represents the averages and standard 
deviations from 5 mice per time point and is representative of two independent 
experiments. Significance was tested with one-way ANOVA. 
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4.15 Discussion 
This study set out to address the role of ncRv11690 in the pathogenicity of M. tb 
by targeting ncRv11690 for inactivation in the wildtype strain H37Rv. Through 
expression and infection studies the aim was to elucidate a function for 
ncRv11690 and assess the virulence of the deletion strain.  
Successful deletion of ncRv11690 from the M. tb chromosome revealed the 
sRNA to be non-essential in vitro despite the sRNA being well expressed in 
exponential phase. ncRv11690 expression has been observed to be highest in 
exponential growth and during mouse infection. It is down regulated upon 
stationary phase and starvation. This suggested that the sRNA was important 
for active growth. In vitro growth in 7H9 however, revealed that the deletion 
strain was not attenuated for growth under standard conditions. This could 
suggest that the precise induction conditions are yet to be determined.  
Many sRNAs are induced in response to stress [93, 199] yet ncRv11690 is 
down regulated in both stationary phase and starvation. Therefore in order to 
explore the possible function of ncRv11690 gene expression microarrays were 
used. 
Transcriptional Analysis of ncRv11690 under exponential conditions revealed 
desA3 and Rv3841 to be down regulated. These genes are from the Zur and 
IdeR transcriptional regulons respectively [200-202]. These regulons are known 
to control zinc and iron homeostasis indicating an effect on the intracellular 
metal concentrations in ΔncRv11690. This was further evidenced in the up 
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regulation of Rv1535 which possesses a magnesium responsive riboswitch that 
results in up regulation upon magnesium starvation [154].  
Two major mechanisms are involved in metal ion homeostasis and resistance. 
Firstly the uptake or efflux of heavy metal ions across the membrane [203], 
secondly the specific chelating of the metals by intracellular chaperones, e.g. 
metallothioneins [204]. These genes are tightly controlled by the metal sensing 
transcriptional regulators such as Zur and IdeR which bind iron and then 
interact with the DNA to control transcription of target genes [205, 206]. 
Iron is an essential nutrient for most pathogens, and iron limitation at infection 
sites is an important means of host defence. Expression of a number of M. tb 
genes are regulated in response to reduced iron levels [205, 207, 208]. 
Importantly M. tb virulence has been observed to be reduced in strains that lack 
the ability to adapt to iron limitation [207, 209, 210]. 
The ability of the mutant to survive under magnesium starvation conditions was 
tested to assess the ability of the strain to adapt. No attenuation of the 
ncRv11690 deletion strain was observed however indicating that it was not 
suffering from magnesium starvation. The ability of the ΔncRv11690 strain to 
adapt to iron limiting conditions was not tested in this study but could be 
included in further studies. However, the reduction of BfrB is most likely 
compensated for by an increase in expression of the homologue BfrA and 
therefore unlikely to result in attenuation. 
Global analysis of the proteome from the deletion strain during exponential 
phase showed ncRv11690 deletion resulted in no statistically significant 
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changes. This would indicate that the induction conditions required for 
ncRv11690 function were not met under the conditions examined. Analysis of 
the over expression proteome however, identified three proteins involved in cell 
wall and cell processes. Rv3866, an ESX-1 secretion associated protein was 
found to be up regulated while the membrane protein Rv2576c was down 
regulated. ESX-1 secretion is important for intracellular survival and virulence 
and is responsible for the secretion of ESAT-6 and CFP-10. The major virulence 
determinant and ESX-1 substrate, EsxA, arrests phagosome maturation and 
lyses cell membranes, resulting in tissue damage that ultimately results in 
spread of the disease.  
The EsxA inhibitor BBH7 affects M. tb metal-ion homeostasis and revealed zinc 
stress as an activating signal for EsxA secretion [211]. Interestingly in a 
bioinformatic search for targets using TARGETRNA2, predicted base pairing to 
occur upstream of Rv3870 (eccCa1) a conserved ESX component; at bases-12 
to -28. This would suggest regulation by translational inhibition. However, target 
prediction did not identify any of the mRNA highlighted in either the 
transcriptomic or proteomic analyses. 
If ncRv11690 is involved in the regulation of EsxA this could explain why DesA3 
from the Zur regulon [200] was found to be down regulated (6.7 fold) upon 
deletion of ncRv11690.  
Deletion of ncRv11690 did not result in attenuation in the macrophage or mouse 
model of infection when measured by CFUs. It is still possible though that the 
pathogenicity of the M. tb deletion strain was altered. Attenuation of some 
mutants has only become apparent when tested using a time to death study in 
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mice, as observed with a sigF mutant [177]. Differences in virulence can also be 
observed under different host genetic backgrounds. Traditionally, Balb/C mice 
and C57BL6 mice have been regarded as Th2- and Th1-skewed strains, 
respectively. Th1 cells are associated with cell-mediated immunity and 
characteristically produce IL-2, IFN-γ, and TNF-β. Th2 cells regulate humoral 
immunity, can moderate Th1 responses [212], and produce cytokines IL-4, IL-5, 
and the anti-inflammatory cytokine IL-10. Therefore the Balb/C mice used for 
the ΔncRv11690 could influence the M. tb phenotype observed, and therefore it 
is possible that were the infection to be repeated with C5BL6 mice or immune 
deficient SCID mice, that a different phenotype could have been observed.  
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5 Deletion of ncRv13661, the most abundant sRNA in M. tb has 
pleiotropic effects on transcription 
5.1 Introduction 
MTS2823 (or ncRv13661 according to the new nomenclature), was discovered 
through the full transcriptome analysis of M. tb by RNA seq [3]. It is located 
between Rv3661 and Rv3662c (genome co-ordinates 4100669 - 4100988) 
Figure 5.1, and was observed to have the highest reads per kilobase of 
transcript per million reads mapped (RPKM) excluding that of rRNA peaks in 
exponentially growing cultures. Its expression during stationary phase is 
increased a further 10-fold reaching approximately 50,000 RPKM in contrast to 
the most highly expressed mRNA with an RPKM of 6,566 [3].  
The abundance of ncRv13661 suggests that this sRNA may be interacting with 
some major machinery of the cell such as the ribosome or RNAP rather than 
with low copy number mRNAs. Highly abundant RNAs of known function 
include for example, 16S and 23S. These are components of the ribosome 
known as ribosomal RNAs, and are highly conserved between different species 
of bacteria and archaea [213].  Another abundant regulatory RNA is 6S, which 
interacts with RNAP under certain conditions to control transcription as 
described in section 1.10. 
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Figure 5.1 Genomic location of ncRv13661 in the M. tb genome as viewed in Tuberculist (http://tuberculist.epfl.ch/) 
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E. coli 6S RNA was the first sRNA shown to inhibit transcription by binding 
directly to the housekeeping holoenzyme form of RNAP. It is ubiquitously 
expressed although it is most abundant in stationary phase. No homologue for 
6S RNA has been found in M. tb. Structural analysis of ncRv13661 revealed 
some similarity to the canonical 6S RNA, but failed to match the criteria of a 
genuine 6S homologue [214]. Ms1, the corresponding sequence in M. 
smegmatis, was initially identified in a bioinformatic screen for 6S RNA but was 
also found to lack key structural characteristics of 6S RNA [214]. Figure 5.2 
shows the predicted secondary structures of the M. tb sRNA alongside 6S RNA 
from E. coli for comparison. During the preparation of this thesis, Ms1 was 
reported to interact with the RNAP core enzyme [215]. This is in contrast to the 
conventional binding of 6S RNA to the σ70 holoenzyme that has been observed 
in other bacteria [132]. These findings suggest that ncRv13661 may have a 
functional role related to that of 6S RNA. 
Over expression of ncRv13661 in M. tb during exponential phase, resulted in a 
small but significant growth defect [3]. Transcriptional profiling identified down 
regulation of a panel of genes including those encoding key methylcitrate cycle 
enzymes PrpC, PrpD and Icl1. The methylcitrate cycle plays an important role in 
preventing accumulation of toxic intermediates generated during -oxidation of 
odd chain fatty acids and growth on cholesterol [216]. The down regulation of 
these genes suggests that ncRv13661 may be involved in control of lipid 
metabolism in M. tb.  
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Figure 5.2 Structural comparisons of the highly expressed RNAs 
Predicted structure ncRv13661 compared to the canonical 6S RNA structure. Both 
RNAs are long double-stranded hairpins.  However, ncRv13661 has one central 
bubble that is pinched whereas 6S RNA contains two large central bubbles. 
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5.2 Hypothesis and specific aims 
The abundance of ncRv13661 suggests that rather than base-pairing with 
specific target mRNAs, it may be performing a regulatory role in conjunction 
with the major machinery of the cell such as the ribosome or RNAP. Initial 
transcriptional profiling of an over expressing strain suggests that ncRv13661 
may function in the regulation of lipid metabolism. To test the hypothesis that it 
performs a role resembling that of 6S RNA in transcriptional reprogramming 
during transition to a non-replicating state, ncRv13661 was assessed for 
potential interactions with major protein complexes and effects on cell viability 
and gene expression were characterised in a strain from which ncRv13661 had 
been deleted.  
 
Results 
5.3 Expression of ncRv13661 
The abundance of ncRv13661 during exponential growth is approximately 2% 
that of 16S ribosomal RNA when measured by qRT-PCR. This increased to 20-
30% of rRNA in stationary phase and in response to starvation. In a mouse 
infection model, the level of ncRv13661 was found to be equivalent to that of 
ribosomal RNA at a three-week time point (Figure 5.3). Over expression of 
ncRv13661 was measured to be 25% that of rRNA during exponential phase in 
7H9 media. 
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Figure 5.3 Expression levels of ncRv13661 in M. tb  
ncRv13661 expression levels were measured using qRT-PCR, in each instance 
levels are expressed relative to 16S rRNA control. RNA was isolated from 
exponential phase, stationary phase (one week after OD600 = 1.0), 96 hours 
starvation in PBS and from M. tb in the lungs of three week infected mice. Data 
represents the mean and standard deviations of three biological replicates for each 
condition. Expression levels differ significantly from each other for each growth 
phase as tested by One-way ANOVA. 
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5.4 Creation of an ncRv13661 deletion strain 
ncRv13661 and its promoter region were deleted from M. tb using a non-
replicating suicide vector [7] in a two-step process as described in section 
2.9.10 and 3.4. Briefly, a single crossover (SCO) recombinant was isolated from 
the electroporation of M. tb with the targeting construct, and subjected to 
counter-selection in order to obtain double crossovers (DCO) generated by a 
second recombination event. The markers sacB and lacZ on the targeting 
construct allow for blue/white screening of colonies and make counter-selection 
for sucrose sensitivity possible [183] . 
5.4.1 Design and creation of the deletion plasmid  
Fragments corresponding to 4099524-4100643 from the 5’ flank and 
4101050-4102096 from the 3’ flank of ncRv13661 were cloned 
sequentially into the targeting construct. The PCR strategies for screening 
SCO and DCO candidates are represented in Figure 3.3A.   
5.4.2 Screening of single and double crossover candidates 
After electroporation of the targeting plasmid into M. tb H37Rv, cells were 
plated onto 7H11 agar containing kanamycin and X-Gal for selection of 
SCOs. Generation of SCOs for the construction of this particular mutant 
proved extremely difficult; electroporation of M. tb with the targeting 
construct had to be repeated a total of 8 times.  
After incubation, 5 blue colonies along with 3 white colonies as controls 
were screened by PCR to identify SCOs (Figure 5.4). Only pair 1 PCR 
reactions resulted in correct PCR products and so at this stage SCOs 
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could not be distinguished from random integrations, and all potential 
candidates were taken to the next stage of selection.  
SCOs 1 to 5 were plated onto non-selective 7H11 for the second 
recombination event to occur. After plating on selective media, four of the 
SCO parents generated potential DCOs that were white and kanamycin 
sensitive. Five colonies of potential DCOs from each SCO parent were 
screened by PCR amplification and clone 3.21 was characterised by 
whole genome sequencing. 
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Figure 5.4 PCR screening for the construction of the ncRv13661 deletion 
strain. 
PCR reactions were designed using the strategy outlined in Figure 3.3A. Expected 
sizes of products for each primer pair are indicated. SCO = single crossover; DCO 
= double crossover; M = Bioline Hyperladder I DNA marker,  
+ = wildtype genomic DNA control. 
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5.4.3 Whole genome sequencing of DCO 3.21 
High quality genomic DNA was extracted from the DCO 3.21 and from the 
parental H37Rv strain to confirm the deletion and to identify any possible 
background mutations. Sequencing libraries were prepared from both strains 
and sequenced by the HTS sequencing facility at NIMR. The resulting reads 
were aligned to the H37Rv reference genome by Graham Rose (NIMR) 
(Appendix III). SNPs in repeat regions such as PE_PGRS were discarded due 
to unreliability along with 2 SNPs created by deletion of the sRNA. This left 
seven SNPs which mapped to various regions in the genome. Three SNPs 
mapped to Rv2940c (mycocerosic acid synthase, mas); two were synonymous 
and one was nonsynonymous, causing a change from TTC to TTT at position 
3278390 and two changes at positions 3278390 and 3278391 resulting in a 
change from GTG to GGC. Shotgun proteome analysis of DCO 3.21 by Olga 
Schubert (ETH Zurich) recorded a 6-fold reduction in Mas (p-value 0.0243 by t 
test), suggesting that the mutation had a deleterious effect on protein stability. 
Mas is a polyketide synthase that is responsible for the synthesis of methyl-
branched lipids, mycocerosates [217, 218], which are esterified with phthiocerol 
to generate PDIMs, complex cell wall lipids implicated in the virulence of M. tb 
[219-222]. Spontaneous PDIM mutations have previously been shown to confer 
an in vitro growth advantage for H37Rv [223]. Four other SNPs were identified 
in intergenic regions of the genome with two mapping upstream of a second 
polyketide synthase, pks3, at positions 1313338 and 1313339, though there 
was no detectable effect on the level of pks3 expression measured by 
microarray profiling (not shown).  
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SCOs 1-3 and DCO’s 1.1-1.4, 2.5, 3.17-3.21 and 5.2 were checked for 
mutations in mas by PCR amplification of a 2kb region surrounding the 3 
previously identified SNPs. Consequently these PCR products were sequenced 
for screening of mutations. It was found that SCO 1 and DCO 1.1, 1.3 and 1.4 
were the only clones without any mas mutations present. As this method only 
identifies SNPs in a small region of mas and this screening does not identify 
other possible regions of mutation further sequencing was required. For this 
reason whole genome sequencing was performed on DCOs 1.1, 1.3 and 1.4. 
5.4.4 Whole genome sequencing of DCO 1.1-1.4 
High quality genomic DNA was extracted from the DCOs 1.1, 1.3 and 1.4 along 
with the parental strain to identify any possible background mutations. 
Sequencing libraries were prepared from all strains and sequenced by the HTS 
sequencing facility at NIMR. The resulting reads were aligned to the H37Rv 
reference genome by Teresa Cortes (NIMR) Table 5.1. As with the previous 
analysis, the SNPs identified in repeat regions were discarded along with 2 
SNPs created by deletion of the sRNA. 
This left 1 non synonymous SNP in Rv2692c (a glycosyl transferase) that was 
present in all strains and a synonymous SNP in Rv3661 that was present in 
DCOs 1.1 and 1.3 only. Due to DCO 1.4 containing only 1 SNP in Rv2692c this 
clone was selected for further investigation and electroporated with the 
complementing plasmid. DCO 1.4 was not observed to result in any difference 
in expression of Rv2692c on the transcript level (Tables 5.2 and 5.3) or protein 
level Table 5.7. The possibility that this SNP could affect enzyme function 
however cannot be excluded. Therefore for all experiments the complement 
was included for comparison and confirmation of ncRv13661 specific effects. 
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Table 5.1 SNP analysis of ΔncRv13661 DCOs 1.1, 1.3 and 1.4. 
SNP position H37Rv 1_1 1_3 1_4 Gene Synonym Orientation Change Type annotation 
336718 A C M M Rv0279c 
 
PE_PGRS4 - F786V nonsynonymous 
SNV 
PE-PGRS 
467501 T G G G Rv0388c PPE9 - S167S synonymous 
SNV 
PPE 
3314422 G A A A Rv2962c - - T234I nonsynonymous 
SNV 
glycosyl 
transferase 
3934733 G G C G Rv3508 PE_PGRS54 +   PE-PGRS 
3934734 G G A G Rv3508 PE_PGRS54 +   PE-PGRS 
3949383 C G C C Rv3514 PE_PGRS57 + A1197G nonsynonymous 
SNV 
PE-PGRS 
4100432 T A A T Rv3661 - + T262T synonymous 
SNV 
hypothetical 
protein 
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5.5 Transcriptional profiling of DCO 1.4 
The transcription profile of ΔncRv13661 DCO 1.4 in exponential culture 
was compared to the wildtype parent by oligonucleotide microarray 
analysis using Cy dye-labelled cDNA. 78 probes, corresponding to 48 
genes, were identified as being differentially expressed by greater than 2-
fold between wildtype and ΔncRv13661 (Tables 5.2 and 5.3).  
The 23 transcripts present at higher abundance in the absence of 
ncRv13661 including the methylcitrate cycle genes prpC and prpD that 
were previously found at decreased abundance when ncRv13661 was 
over expressed during exponential growth. Six genes from the arginine 
biosynthesis operon (Rv1652-Rv1659) were also up regulated in 
ΔncRv13661. The arginine operon is regulated by the ArgR repressor 
[224] and is markedly down regulated in the starvation model. Rv1813c 
which is known to be in both the MprAB and DosRST regulons was found 
to be up regulated [225]. Five genes from the mas/pks15 locus (Rv2940 to 
Rv2947c) were up regulated in the knockout, though conversely ppsD 
(Rv2934) was down regulated. Other down regulated genes included the 
mmpSL5 transporter and the associated transcriptional regulator Rv0678 
[226]. qRT-PCR validation of the microarrays for the highest ranking 
transcripts led to the observation that only the up regulated genes could 
be confirmed and generally complemented (Table 5.2). This pattern of 
expression would be in agreement with only down regulation observed for 
the over expression of ncRv13661. A comparison of the over expression 
and deletion microarrays can be found in Figure 5.5. 
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Gene  Gene Name FC Δ/WT 
Average of 
probes 
p-value Fold change 
by qRT-PCR 
 Δ/WT 
Fold Change 
by qRT-PCR 
Comp/WT 
Rv1130 prpD 2.7 0.009 5.8 2.3 
Rv1131 prpC 2.7 0.018 3.6 1.6 
Rv2931 ppsA 2.4 0.011 2.6 1.2 
Rv1813c - 2.3 0.016 3.1 1.4 
Rv2948c fadD22 2.3 0.007 3 1.3 
Rv3919c gidB 2.3 0.01   
Rv1656 argF 2.2 0.007   
Rv1657 argR 2.2 0.004   
Rv2949c - 2.2 0.005   
Rv3920c - 2.2 0.011   
TBFG_13135 
 
- 2.2 0.017   
Rv1047 - 2.1 0.012   
Rv1653 argJ 2.1 0.007   
Rv1654 argB 2.1 0.005   
Rv1655 argD 2.1 0.007   
Rv1658 argG 2.1 0.009   
Rv2189c - 2.1 0.005   
Rv2632 ppsB 2.1 0.009   
Rv2947c pks15 2.1 0.016   
Rv2666 - 2 0.032   
Rv2782c - 2 0.007   
Rv2940c Mas 2 0.002   
 
Table 5.2 Genes up regulated > 2-fold upon deletion of ncRv13661 in 
exponential phase 
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Gene  Gene Name FC Δ /WT 
Average of 
probes 
p-value Fold change by 
qRT-PCR 
Δ /WT 
Fold Change 
by qRT-PCR 
Comp/WT 
MT3762 ncRv13661 147.5 <0.001   
Rv1935c echA13 11.9 0.005 1.1  
Rv2598 - 5.6 0.005 1.1  
Rv0676c mmpL5 2.5 0.007 1.9 2.2 
Rv0678  2.5 0.009 1.5 2.3 
Rv2428 ahpC 2.5 0.005 2.2 1.9 
Rv2934 ppsD 2.4 0.006 1.1 0.6 
Rv0677c mmpS5 2.3 0.005   
Rv1592c - 2.3 0.005 2.0 3.0 
Rv2913c - 2.3 0.005   
MT1627  2.2 0.006   
Rv1039c ppe15 2.2 0.02   
Rv1040c PE8 2.2 0.023   
Rv2429 ahpD 2.2 0.005   
Rv0096 PPE1 2.1 0.009   
Rv0410c pknG 2.1 0.007   
Rv1218c - 2.1 0.004   
Rv2244 acpM 2.1 0.007   
Rv2386c Mbtl 2.1 0.014   
Rv2780 Ald 2.1 0.034   
Rv3534c hsaF 2.1 0.007   
Rv0097  2 0.007   
Rv0440 groL2 2 0.011   
 
Table 5.3 Genes down regulated > 2-fold upon deletion of ncRv13661 in 
exponential phase  
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Figure 5.5 Venn diagram representing the common transcriptional changes 
between over expression and deletion of ncRv13661 during growth on 7H9.  
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5.6 Transcriptional profiling during growth on propionate 
The concordance between down regulation of methylcitrate cycle genes in 
response to over expression of ncRv13661 and up regulation in the 
deletion strain could reflect a direct effect of the sRNA on the individual 
mRNA transcripts or an indirect effect mediated by a metabolic change. 
The prpDC operon (Rv1130-1131) is subject to conventional regulation by 
the adjacent Rv1129c transcription factor (which is in turn regulated by 
SigE) and is induced during growth on propionate. To determine whether 
growth on propionate would override control by the sRNA, the effect of 
ncRv13661 over expression was assessed by microarray profiling of 
propionate cultures.  
In total 114 probes on the array were found to be differentially expressed 
between the vector control and the over expression strain with a fold 
change of 2.5 or greater. This amounted to a change in the mRNA levels 
of 78 genes (Appendix V). As previously observed during growth on 
glycerol/glucose [3], the majority of the probes were found to be down 
regulated in the over expression strain (Appendix V). 29 mRNA were 
found to overlap with the previous published over expression of 
ncRv13661 in 7H9 (Figure 5.6). Surprisingly neither prpDC nor icl1 was 
present in the list of genes with altered expression, as ncRv13661 was 
previously found to down regulate the genes involved in the methyl citrate 
cycle. Both assays did identify among others down regulation for sigB, G 
and sigE along with the anti-sigma factor E (rseA) and Rv1406 (fmt) 
(Appendix V). In addition there were a large number of genes that were 
down regulated involved in DNA replication and repair. As the overlap 
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between these arrays is not extensive, it would suggest that ncRv13661 is 
not targeting a specific set of mRNAs through a standard base pairing 
mechanism.  
In contrast to growth in glycerol/glucose, 41 probes (25 genes) were up 
regulated when ncRv13661 was over expressed in propionate cultures 
(Table 5.3). Several of the up regulated genes overlapped with genes that 
were down regulated in the knockout. In addition to mmpSL5, these 
include a second transporter operon, Rv1216c-Rv1218c, that is regulated 
by the adjacent transcription factor encoded by Rv1219c (raaS) [227]. Up 
regulation of the raaS operon is an indication of intracellular accumulation 
of fatty acyl-CoA molecules [227]. 
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Figure 5.6 Venn diagram representing the overlapping transcript changes between 
growth on 7H9 and growth on propionate for the ncRv13661 over expression. 
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Gene  Gene Name FC OE/Vector 
Average of probes 
p-value qRT-PCR Fold 
Change 
MT3630 ncRv13528 2.2 0.049  
MT3762 ncRv13661 35.2 0.006 30 
Rv0118c oxcA 2.7 0.006  
Rv0166 fadD5 2.3 0.031  
Rv0167 yrbE1A 2.2 0.028  
Rv0169 mce1A 2.2 0.046  
Rv0280 PPE3 2.3 0.017  
Rv0631c recC 5.9 0.048  
Rv0676c mmpL5 2.3 0.024  
Rv0677c mmpS5 2.5 0.017  
Rv0678 - 2.5 0.006  
Rv0696 - 2.1 0.037  
Rv0697 - 2.0 0.008  
Rv0867c rpfA 3.7 0.022  
Rv0885 - 2.2 0.013  
Rv1216c - 2.6 0.014  
Rv1217c - 3.4 0.016 4.7 
Rv1218c - 2.8 0.009 3.5 
Rv1219c raaS 2.7 0.009 3.4 
Rv1856c - 2.2 0.017  
Rv2035 - 2.1 0.018  
Rv2406c - 2.1 0.014  
Rv2485c lipQ 2.3 0.014  
Rv2780 ald 2.2 0.016  
Rv3197A whiB7 2.1 0.031  
Table 5.4 Genes up regulated in the over expression strain > 2 fold during 
growth on propionate 
  
 
179 
 
5.7  Transcriptional profiling during stationary phase 
The abundance of ncRv13661 increases 10-fold during transition to 
stationary phase and it might be anticipated that sRNA deletion would 
result in a more extensive transcriptional phenotype. To address this, 
microarrays were performed to see if this was the case.  In fact, only 40 
genes were differentially expressed in a comparison of stationary phase 
ΔncRv13661 and wildtype cultures (Tables 5.5 and 5.6). Only two genes 
were differentially regulated in both stationary phase and exponential 
culture; Rv1935 (echA13) and Rv2598. Both genes registered a large fold-
change that could not be confirmed by qRT-PCR due to very low baseline 
expression. Two genes that were down regulated in ΔncRv13661 – 
Rv0631c (recC) and Rv0867c (rpfA) – were reciprocally up regulated 
when ncRv13661 was over expressed (Table 5.4). The highest ranking 
changes were selected for confirmation by qRT-PCR and fold changes 
shown in Table 5.5. Fold changes observed by qRT-PCR were not 
significant for the majority of genes and were low in comparison to those 
gained in the microarray due to a low baseline expression. Rv2140c and 
Rv0721 (rpsE) were found to be significantly different by t-test but could 
not be complemented. Again this pattern is inconsistent with a model in 
which ncRv13661 targets a discrete set of mRNAs. 
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Gene Gene Name FC Δ/WT 
Average of probes 
p value Fold change by 
qRT-PCR 
Δ/WT 
Fold change by 
qRT-PCR 
Comp/WT 
MT3762 ncRv13661 206.4 0.006   
Rv0086 hycQ 2.5 0.034   
Rv0270 fadD2 3.6 0.006 1.87 0.4 
Rv0631c recC 3.4 0.034   
Rv0721 rpsE 2.2 0.017 1.4 2.4 
Rv0845 - 2.2 0.026   
Rv0860 fadB 3.4 0.016   
Rv0867c rpfA 12.8 0.01 1.25 0.8 
Rv0940c - 2 0.034   
Rv0941c - 2.4 0.018   
Rv0942 - 2.2 0.025   
Rv1252c lprE 17 0.006 1.2 0.4 
Rv1284 - 2.1 0.019   
Rv1446c opcA 2.2 0.035   
Rv1572c - 2.5 0.037   
Rv1870c - 2.3 0.035   
Rv1935c echA13 19.2 0.021   
Rv1937 - 2.9 0.036   
Rv2140c TB18.6 3.4 0.008 2.8 4.8 
Rv2342 - 29.6 0.001 1.7 0.4 
Rv2598 - 79.2 0.012   
Rv2692 ceoC 6.6 0.006 1.3 1.2 
Rv2725c hflX 3.6 0.036 1.4 0.4 
Rv2884 - 3.1 >0.001 2.72 0.1 
Rv3110 moaB1 2.2 0.033   
Rv3146 nuoB 3.2 0.018   
Rv3389c htdY 2.2 0.043   
Rv3662c - 2.2 0.03   
Table 5.5 Genes down regulated > 2-fold upon deletion of ncRv13661 in 
stationary phase 
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Gene  Gene Name FC Δ/WT Average of 
probes 
p value 
Rv0289 espG3 2.1 0.012 
Rv0290 eccD3 2.7 0.048 
Rv0791c - 2.2 0.018 
Rv1255c - 2.2 0.03 
Rv1256c cyp130 3.2 0.024 
Rv2053c fxsA 2.1 0.011 
Rv2601A vapB41 2.3 0.022 
Rv2602 vapC41 2.3 0.013 
Rv2710 sigB 2.1 0.029 
Rv3051c nrdE 2 0.016 
TBFG_11168 
 
Rv1146 3.3 0.007 
 
Table 5.6 Genes up regulated > 2-fold upon deletion of ncRv13661 in 
stationary phase 
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5.8 Proteomic analysis of deletion strain during growth on 7H9 
Proteomic analysis of whole cell extracts was analysed from exponential 
phase cultures of the deletion strain, complement and H37Rv in order to 
ascertain if the changes in the transcriptional profile resulted in altered 
translation. Only 4 proteins were found to be differentially expressed 
between H37Rv and ΔncRv13661. Up regulation of prpD in the deletion 
strain, along with 3 proteins from the transcriptional unit Rv2930-papA5 
were found to be down regulated in the deletion strain. None of these 
changes could be complemented meaning that either a mutation existed in 
the deletion strain, or the replacement of ncRv13661 on a plasmid was 
insufficient to allow full complementation. This is demonstrated by the 
complementation that was achieved on the transcriptional level for prpD. 
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Protein ΔncRv13661/ 
H37Rv 
Fold Change 
(log2) 
Comp/ 
H37Rv 
Fold Change 
(log2) 
ΔncRv13661/
H37Rv 
P value 
Comp/H37Rv 
P value 
Rv1130- prpD 3.54 3.67 0.005 0.004 
Rv2939- papA5 -1.06 -1.03 0.001 0.001 
Rv2935- ppsE -1.90 -1.68 <0.001 <0.001 
Rv2933- ppsC -3.06 -2.68 <0.001 <0.001 
 
Table 5.7 Proteins differentially expressed in ΔncRv13661 
Whole cell extracts were prepared and analysed by mass spectrometry and fold 
changes of deletion strain against either H37Rv or complement was generated by 
analysis with MSstats. 
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5.9 Proteomic analysis of over expression during growth on 7H9 
Due to the lack of translational effects in the deletion strain it was of 
interest to ascertain the translational effects of over expression. Over 
expression of ncRv13661 in exponential phase leads to a massive down 
regulation of genes involved in exponential growth [3]. It was hypothesised 
that the transcriptional changes would be reflected in the proteome 
resulting in a large number of proteins being less abundant in the over 
expression strain. 
Whole cell extracts were analysed by shotgun proteomics and significance 
was set at a fold change of 0.75 (log2 scale) with a p value of <0.01. 
Twenty proteins were differentially expressed between vector and over 
expression. As expected, more proteins were down regulated than up 
regulated with only four proteins being up regulated; Rv2576c, Rv3842c 
(glpQ1), Rv3241c and Rv1865c. Of these, Rv3241c was up regulated 1.26 
fold and has been identified as a hibernation factor in M. smegmatis 
named RafS (for ribosome associated factor during stasis) [228]. Of the 
down regulated proteins, half belong to the classification information 
pathways. There was a large representative of genes involved in DNA 
repair including Rv2592c (ruvB), Rv1638 (uvrA) and Rv2737c (recA), with 
recA being one of the most down regulated genes. 
  
  
 
185 
 
Protein Over 
expression/vector 
Fold Change 
(log2) 
Over 
expression/vector 
p value 
Rv2576c 1.51 0.003 
Rv3842c-glpQ1 1.33 0.002 
Rv3241c 1.26 <0.001 
Rv1865c 1.09 0.005 
 
Table 5.8 Proteins up regulated in the ncRv13661 over expression 
Whole cell extracts were prepared and analysed by mass spectrometry and fold 
changes of over expression against vector control were generated by analysis with 
MSstats. 
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Protein Over 
expression/vector 
Fold Change (log2) 
Over 
expression/vector 
p value 
Rv1638-uvrA -0.75 <0.001 
Rv0412c -0.79 0.005 
Rv2790c-ltp1 -0.82 0.001 
Rv3161c -0.84 0.004 
Rv0182c-sigG -0.84 0.001 
Rv2592c-ruvB -0.86 0.001 
Rv3888c -0.91 <0.001 
Rv1316-ogt -0.92 <0.001 
Rv1279 -0.95 <0.001 
Rv1833c -0.98 0.004 
Rv0404-
fadD30 
-1.0 <0.001 
Rv1406-fmt -1.06 <0.001 
Rv1527c-pks5 -1.07 <0.001 
Rv2737c-recA -1.23 <0.001 
Rv0263c -1.4 0.004 
 
Table 5.9 Proteins down regulated in the ncRv13661 over expression 
Whole cell extracts were prepared and analysed by mass spectrometry and fold 
changes of over expression against vector control were generated by analysis with 
MSstats. 
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5.10 Mechanism of regulation by ncRv13661  
Transcriptional profiling of ncRv13661 deletion and over expression 
strains suggest that the sRNA has a pleiotropic effect on up- and down 
regulation of multiple mRNA transcripts and that the particular set of 
transcripts varies during different phases of growth and during growth on 
different carbon sources. Together with the stoichiometric argument that 
ncRv13661 is present at a vastly higher copy number than the regulated 
transcripts, data from transcription profiling are consistent with a model in 
which ncRv13661 acts in conjunction with some central cellular machinery 
rather than as a conventional mRNA base pairing sRNA. To test this 
hypothesis, density gradient sedimentation was used to screen for 
evidence of interactions between ncRv13661 and protein complexes. 
Hnilicova et al have recently reported that Ms1, the M. smegmatis 
homologue of ncRv13661, co migrates with RNA polymerase during 
density gradient fractionation, suggesting a parallel with 6S RNA [215].  
 
Whole cell extracts from stationary phase cultures of M. tb were 
fractionated by centrifugation in 5-35% sucrose gradients at 30,000 rpm 
for 16.5 hours and ncRv13661 and RNAP were localised in resulting 
fractions by Northern blot and Western blot staining (Figure 5.7). Both 
molecules migrated as distinct peaks in the upper half of the gradient but, 
in contrast to the report of Hnilicova et al, the two peaks were not 
coincident; with ncRv13661 reaching a maximum in fraction 10, just above 
RNAP in fractions 11 and 12.  
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Two peaks for RpoB were observed on the western blot and this could 
reflect the different sedimentation rates of both free RpoB and that in 
complex with the rest of RNAP. It is also possible that there is more than 
one form of RNAP present, with core and holoenzyme having different 
sedimentation patterns.  
Alternatively, if ncRv13661 does not interact with RNAP it is possible that 
ncRv13661 interacts with some other multimolecular machinery within the 
cell; other abundant sRNAs interact with ribosomes (ssrA), signal 
recognition particle (ffs) and RNase P (rnpB), for example. In light of the 
transcriptional responses described above, it would be attractive to 
envisage a role in multienzyme complexes. To test this hypothesis, 
ncRv13661 fractions from the density gradient were screened for other 
major protein components. A major band was visualised by Coomassie 
staining (Figure 5.8) and characterised by mass spectrometry; it was 
identified as the alpha-crystallin chaperone HspX (Rv2031c). To test the 
possibility that ncRv13661 forms a complex with HspX, density gradient 
fractionation was repeated using an extract from the ΔncRv13661 strain. 
The migration pattern of HspX was identical in the absence of the sRNA, 
suggesting that the native alpha-crystallin multimer [229] is fortuitously co-
sedimenting with ncRv13661 rather than forming a protein: RNA complex.  
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Figure 5.7 Sedimentation of ncRv13661 and RNAP using sucrose gradient 
ultracentrifugation shows ncRv13661 does not specifically migrate with 
intact RNAP 
Following sucrose gradient ultracentrifugation of whole cell extracts, the gradient 
was fractionated into 600µl fractions. Each fraction was split and RNA and 
protein were isolated. Northern blots with 33P were used to detect ncRv13661 and 
5S (middle and top panel), while Western blots were used to detect α and β 
subunits of RNAP (bottom panel). ncRv13661 Appears as multiple bands on the 
northern blot indicating extensive processing and/or degradation 
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Figure 5.8 Sedimentation of ncRv13661 and M. tb proteins using sucrose 
gradient ultracentrifugation  
Following sucrose gradient ultracentrifugation of whole cell extracts, the gradient 
was fractionated into 600µl fractions. Each fraction was split and RNA and 
protein were isolated. Northern blots with 33P were used to detect ncRv13661. 
Isolated protein was run on an SDS-PAGE with a cell free extract control 
alongside dual precision marker plus before staining using Coomassie. 
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5.11 Role of ncRv13661 in cell viability 
It was previously shown that over expression of ncRv13661 resulted in a 
decreased growth rate for H37Rv in regular 7H9 culture medium [3]. In 
contrast, deletion of ncRv13661 had no detectable effect on exponential 
growth. To test whether loss of ncRv13661 had an effect on stationary 
phase survival of M. tb, cultures of wild type and ΔncRv13661 were 
maintained over a six-week period, diluted into fresh medium and allowed 
to re-grow. No difference was observed in the pattern of re-growth (Figure 
5.9). 
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Figure 5.9 Recovery of ΔncRv13661 after six weeks in stationary phase. 
In vitro growth curves of wildtype M. tb H37Rv, the ΔncRv13661 deletion strain 
and the complement using standard 7H9 media after six weeks in stationary 
phase. The data represents the averages and standard deviations of three biological 
replicates. There was no statistical difference between the growth of the strains as 
assessed by linear regression analysis. 
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5.12 Effects of ncRv13661 deletion on in vivo survival 
It was of interest to determine whether deletion of ncRv13661 had an 
effect on the ability of M. tb to grow in macrophages or in a mouse model. 
A series of experiments to test this were set up with the original DCO 3.21 
prior to identification of the mas mutation. The results of these 
experiments are shown in Appendix VI; no differences were observed in 
CFUs in either model. While these experiments are clearly flawed by the 
use of a PDIM mutant, we reasoned that any effect of this mutation was 
likely to reduce rather than enhance virulence, and that the negative result 
was strong evidence that deletion of ncRv13661 in a clean background 
was unlikely to impair virulence. For this reason we decided not to repeat 
the experiments with DCO 1.4. It is however possible that modulation of 
the lipid profiles could result in an increase in virulence and/or a change in 
the pathology of the ncRv13661 deletion strain as has been observed for 
other pathogen deletion strains [230, 231]. Therefore, if the experiment 
were to be repeated in the future it would be important to monitor the 
pathology of the lungs and spleen.  
5.13 Discussion 
 
Initial functional characterisation of the sRNA ncRv13661 by over 
expression, showed a transcriptional response very similar to that of a 
persister model due to the observation that a large number of genes 
involved in exponential growth were down regulated [3].  
The current study identified transcriptional responses implicating 
ncRv13661 in long-term mycobacterial survival in agreement with previous 
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work on the over expression strain. Transcriptomic analysis of the over 
expression strain would indicate that ncRv13661 contributes to the change 
in carbon flux associated with transition from replicating to non-replicating 
culture as seen by Shi and colleagues [232]. It is proposed that 
ncRv13661 blocks fatty acid degradation for energy and growth promotion 
and diverts carbon units to form complex storage lipids. When this is 
activated by over expression in exponential phase, propionate is driven 
away from the methylcitrate cycle by prpCD down regulation [3] which 
results in the accumulation of fatty acyl-CoAs. This accumulation of acyl-
CoAs causes the activation of raaS. RaaS is a transcriptional regulator 
that has been shown to be important in the long-term survival of M. tb 
[227] and has been identified along with its regulon more than once in this 
study. RaaS has been shown to improve mycobacterial survival after 
treatment with ethambutol [227], a drug that targets cell wall biosynthesis. 
The ATP-dependent efflux pump Rv1218c under the control of the 
repressor RaaS was found to be up regulated in the over expression strain 
during growth on propionate and co-ordinately down regulated in the 
deletion strain indicating that ncRv13661 is involved in persistence 
through regulation of the cell wall constituents. The repressor RaaS has 
been shown to use the acyl-CoA oleoyl-CoA as a ligand [227] although it 
is possible that longer acyl-coAs or complex lipids which contain fatty 
acids could fit into the binding pocket affecting the DNA binding activity of 
RaaS. Mycobacteria are able to produce and export many lipids containing 
fatty acids [233, 234], and interestingly DrrC which may be regulated by 
RaaS has been implicated in the export of PDIM’s in M. tb.  
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The mycolic acid containing PDIM’s are an important constituent of the M. 
tb cell envelope. The complex structure of the cell envelope protects 
against degradation by host enzymes and the action of antibiotics, and 
toxic molecules produced by the host [235]. The mycobacterial cell 
envelope is lipid rich and includes the major lipid constituents the mycolic 
acids [236]. In this study we demonstrated that ncRv13661 has been 
shown to affect the expression of PDIM associated genes, ppsA-D. The 
complementation of these changes was not always observed and genome 
sequencing revealed that the first deletion strain obtained had mutations in 
mas, undoubtedly affecting the PDIM profile in the strain. The second 
mutant that was isolated, lacked mas mutations but possessed a mutation 
in a glycosyl transferase which is involved in mycothiol biosynthesis. The 
apparent role for ncRv13661 in the regulation of cell wall lipids added to 
the SNPs identified make it difficult to isolate specific effects of deletion. 
The lack of ncRv13661 could have resulted in compensatory mutations 
occurring in the genome before the complementing plasmid could be 
electroporated in. It is also possible that a ncRv13661 deletion strain could 
only be obtained in a PDIM altered background. Loss of PDIM in 
laboratory strains of M. tb is quite common and arise in the absence of 
selection pressure, and so complementation is important for assessing 
deletion specific effects [237]. It is of note however that other sRNA 
deletion strains were made in parallel during this study using the same 
electrocompetent cells and/or parental strain and none of those were 
found to contain SNP’s involved in PDIM synthesis, indicating that this 
could be a specific trait of the M. tb lacking ncRv13661. 
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Proteomic analysis of the over expression strain showed a down 
regulation of proteins involved in DNA repair, with one of the most down 
regulated proteins being Rv2737c (recA). In both M. tb and E. coli recA is 
involved in homologous recombination and is controlled by the repressor 
lexA [238]. LexA also regulates ruvAB (also identified as down regulated) 
[239-241]. Interestingly lexA was shown to bind upstream of ncRv13661 in 
a CHIP seq analysis of lexA binding sites [239]. In a target search for 
mRNA regulated by ncRv13661 using TargetRNA2, recA was identified as 
the top candidate for sRNA binding with predicted pairing at the 5’ end of 
recA at nucleotides 3-18 [164]. This would be indicative of translation 
repression of RecA by prevention of ribosome binding. Down regulation of 
DNA damage repair mechanisms upon ncRv13661 deletion could suggest 
that fewer lesions are being generated due to a slower rate of RNAP.  
Sucrose gradient ultracentrifugation revealed that ncRv13661 did not co 
migrate with intact RNAP contradicting the findings of Hnilicova and co-
workers. The deletion of ncRv13661 also did not result in an impaired 
ability to recover from stationary phase further indicating that it does not 
function in a 6S manner. The possibility exists however that ncRv13661 
could interact with a subpopulation of RNAP. It is difficult to exclude the 
possibility that ncRv13661 could interact with some particular form of 
RNAP. The stoichiometry for RNAP core to ribosomes is approximately 
1:1. RpoZ and sigma factors have half of that copy number and therefore if 
ncRv13661 was interacting with a subpopulation of RNAP, it would only be 
with ~10% of the copies making detection difficult. In contrast when 6S is 
induced in late stationary phase the majority of Eσ70 is found in a complex 
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with 6S RNA [132, 137, 138]. When nutrient availability increases the 
RNAP can then be recycled upon exit from stationary phase by the 
generation of pRNAs ejecting 6S from the Eσ70 complex [136]. 
The ability to recommence growth after periods of non-replicating 
persistence is not only mediated by interactions with RNAP but also by 
interactions with the ribosome. Down regulation of translation without the 
need for altering ribosomal numbers have great energy benefits for 
bacteria. A hibernation-promoting factor rafS (Rv3241c) was identified as 
being up regulated in the over expression strain and its homologue in M. 
smegmatis (MSMEG_1878) has been shown to associate to the ribosome 
during hypoxic and carbon starved stasis [228]. It is possible that 
ncRv13661 could associate with Rv3241c to increase translation as a 
mechanism for ribosome stabilisation. Importantly the expression 
conditions of Rv3241c are also those known to induce the expression of 
ncRv13661. 
In addition to hibernation factors, the survival of M. tb during times of 
nutrient deprivation is aided by mechanisms such as the stringent 
response [134]. RelA and CarD act in the stringent response to down 
regulate ribosomal RNA synthesis and RNA ribosomal protein genes to 
conserve energy at times when nutrients are limiting [135]. The two 
component system MprAB also allows the regulation of numerous stress 
responsive genes [242]. When activated, MprAB regulates expression of 
>200 genes, directly regulating sigma factors sigB and sigE, and the α-
crystallin-like gene acr2. 
  
 
198 
 
In addition to the potential mRNA base pairing interaction with recA, a 
further role for ncRv13661 must exist. The high level of expression of 
ncRv13661 during infection and stress conditions suggest that this sRNA 
is performing a central function, expressed to a high level in preparation 
for its regulatory requirement. It is possible that ncRv13661 is acting in a 
stress response mechanism such as the stringent response by some as 
yet unidentified mechanism. 
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6 Is ncRv12659 responsible for the starvation-induced signal 
attributed to Rv2660c? 
6.1 Introduction 
ncRv12659 (originally termed MTS2048) was identified through the recent 
study into the transcriptome of M. tb [3, 171]. It is encoded opposite the 
hypothetical protein Rv2660c and flanked by a hypothetical protein and a 
probable integrase Figure 6.1. 
Rv2660c has been reported to be the most highly up regulated gene during 
starvation using a PCR-based microarray [187]. In addition to this it has 
also been reported to be up regulated in response to hypoxia-induced non-
replicating persistence, and the enduring hypoxic response [243, 244]. It is 
envisaged that inclusion of antigens expressed by persisting populations in 
vaccines will result in protection against reactivation of the disease.  
H56 is a TB subunit vaccine currently under clinical trials [245]. It was 
designed to include antigens that are associated with long-term infection 
and it has been shown that the H56 vaccine gives the best protection of any 
vaccine to date. H56 contains Rv2660c in addition to Ag85B and ESAT-6, 
which are two antigens secreted in the acute phase of infection. The 
increased efficacy of this vaccine over others is considered to be due to the 
addition of the "latency-associated protein" Rv2660c. 
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Figure 6.1 Genomic position of sRNA ncRv12659 in the M. tb genome
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6.2 Hypotheses and specific aims 
Due to the overlapping of ncRv12659 with the Rv2660c locus we aimed to 
characterise the sRNA and assess its contribution to the antigen in the 
H56 vaccine. As a potential cis-encoded RNA it should function to regulate 
the target for which it is antisense. Early work has suggested that the 
starvation-induced signal attributed to Rv2660c arises from the plus strand 
and not that of Rv2660c encoded on the minus strand (Figure 6.2). 
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Figure 6.2 RNA seq of the Rv2660c locus as viewed in the genome browser 
Artemis. 
The forward strand is represented in green and the antisense strand in red. The top 
panel shows expression of ncRv12659 during exponential phase and the bottom 
panel in stationary phase. Both growth phases lack any detectable expression of 
Rv2660c on the opposite strand.  
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Results 
6.3 Comparison of RNA sequencing profiles 
Rv2660c was originally highlighted as the most up regulated transcript in 
the microarray analysis of M. tb starved for 24 and 96 hours in PBS [187]. 
It was annotated as a hypothetical protein directly adjacent to a prophage 
element termed PhiRv2. This prophage is one of two possessed by 
H37Rv; it is inserted into the valU tRNA gene and is present in many 
strains of M. tb. Some of the prophage genes of PhiRv2 including the 
phage integrase Rv2659c, were also observed to be up regulated in the 
starvation microarray study [187]. 
Expression from both strands was investigated by RNA seq profiling 
comparing exponential growth and 24 hours starvation in PBS. Strand-
specific sequencing showed that transcription did indeed occur on the 
forward strand and not the reverse strand where Rv2660c is annotated 
Figure 6.2A. RNA seq library construction and bioinformatic analysis was 
carried out by Teresa Cortes. 
6.4 Mapping of transcript termini by 5’ and 3’ RACE 
 
The sRNA transcript was mapped by 5’ and 3’ RACE as described in 
section 2.7 in order to obtain the boundaries of the transcript and establish 
origin of the sequence. 5’ RACE identified a transcriptional start site (TSS) 
at position 2980911 which lies between the TSS of the integrase Rv2659c 
and the boundary of the phage marked by the attR duplication. This was 
confirmed by RNA sequencing based TSS mapping [246]. It was also 
observed that the peak height of ncRv12659 was increased in response to 
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starvation as seen in the TSS mapping performed by Teresa Cortes 
Figure 6.2B. 
3’RACE identified seven 3’ ends from eight sequenced clones. The 
primary co-ordinate was at position 2981083 which was identified twice. 
Other termini were mapped to positions 2981010, 2981011, 2981026, 
2981047, 2981055 and 2981077. However, this did not lead to the 
identification of any canonical intrinsic terminators such as a stem loop 
followed by a poly-U stretch. These co-ordinates establish the transcript as 
being 173 nucleotides in length.  
In order to confirm the transcript size, northern blotting was performed on 
RNA extracted from both exponential and stationary phase cultures of M. 
tb as described in section 2.6. Northern blot analysis revealed that the 
largest prominent transcript was approximately 170 nucleotides in length 
confirming the RACE results Figure 6.2C. Multiple smaller transcripts were 
observed on the blot including a dominant one of 120 nucleotides in 
stationary phase. Due to the identification of a single TSS these smaller 
transcripts and also possibly the primary transcript are formed as a result 
of processing at the post-transcriptional level. 
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Figure 6.2 Mapping of ncRv12659 in M. tb H37Rv (taken from [150])  
A. Total RNA seq visualised in the genome browser Artemis. Forward strand 
reads are blue and reverse strand reads are red. Yellow boxed section on the map 
of the locus represents the valU tRNA insertion point. B. Transcription start site 
(TSS) mapping shows the ncRv12659 transcript to begin 62 nucleotides 
downstream of the TSS of Rv2659c. C. Northern blot analysis of ncRv12659. 
Expression of ncRv12659 in RNA extracted from (e) exponential and (s) 
stationary phase cultures of M. tb H37Rv using 20µg of total RNA. 
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Using these coordinates, the transcript ncRv12659 was revealed as 
consisting of 60 nucleotides of PhiRv2 sequence, followed by 28 
nucleotides of duplication from the 3’ end of the valU in addition to 85 
nucleotides of host M. tb sequence, Figure 6.3. Further analysis of the 
region reveals that the 61 bp sequence succeeding the sRNA is duplicated 
at the attL end of PhiRv2, annotated as Rv2645. 
Annotations in Tuberculist [247] are based on predictions and therefore a 
search for alternative annotations in this region was undertaken. It was 
found that in Mycobacterium canettii there is an open reading frame 
annotated to the forward strand which has homology to part of a protein 
sequence found in Salmonella typhimurium (VBIMycCan 278382_3386) 
which is marked in blue in Figure 6.3. 
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Figure 6.3 Annotation of the ncRv12659 locus (taken from [155]) 
Sequence detail surrounding ncRv12659 which detail relevant annotations 
referred to in the text. Repeat regions are shown in yellow. Locations of qRT-PCR 
primers used in the study are indicated.  
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6.5 Expression of ncRv12659 in clinical isolates 
Analysis of the genomic region of ncRv12659 revealed that the sRNA 
consisted in part of phage sequence. This suggested that ncRv12659 
would only be expressed in strains where the PhiRv2 region was present. 
This also led to the hypothesis that in PhiRv2 positive strains the creation 
of an antisense RNA may have led to the silencing of the complementary 
strand Rv2660c and this repression could be relieved in PhiRv2 negative 
strains. 
To test these theories RNA profiles of five clinical isolates, along with the 
PhiRv2 negative BCG vaccine strain were compared. N0072 and N0153 
were selected as being PhiRv2 negative while N0031, N0052 and N0145 
were selected as PhiRv2 positive, (a summary of which can be found in 
Table6.1). 
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Strain     Lineage      PhiRv2       TSS    RNAseq      Northern qRT-PCR 
M. tb H37Rv 4 + Y Y Y Y 
M. tb N0031 2 + N (Y) N N 
M. tb N0052 2 + N Y Y N 
M. tb N0072 1 - N (Y) Y Y 
M. tb N0145 2 + (Y) Y N N 
M. tb N0153 1 - Y Y N N 
M. bovis BCG 6 - (Y) (Y) Y N 
 
Table 6.1 Strains used in this study (adapted from [155]) 
Y/N indicates yes/no for whether experimental methods were applied to that particular strain, with brackets indicating  
that the experiment was performed but the data is not shown.
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RNA seq profiles of the PhiRv2 positive strains showed no detectable 
signals from the reverse strand Figure 6.4A. Interestingly, the N0052 strain 
showed a higher level of expression of ncRv12659. The RNA seq profile of 
the PhiRv2 negative strain N0153 showed that a low number of reads 
which could be mapped to the region downstream of the tRNA valU Figure 
6.4B.  
Northern blots were performed in order to confirm the RNA seq findings, 
probing for the 3’ end of the transcript to ensure that detection was 
possible in both PhiRv2 positive and negative backgrounds, Figure 6.4C. 
A faint signal of approximately 300 nucleotides was seen however in the 
PhiRv2 negative background probably corresponding to the unprocessed 
tRNA transcript. It was observed that there was no signal attributable to 
Rv2660c in either a PhiRv2 positive or negative background 
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Figure 6.4 RNA profiling of the Rv2660c locus in M. tb clinical isolates (taken 
from [150]) 
A. RNA seq profiles of PhiRv2 positive strains indicating no detectable 
transcriptional signal of Rv2660c. Reads are normalised to the total number of 
reads 
B. RNA seq profiles of PhiRv2 negative isolate shows no Rv2660c 
transcript even in the absence of a competing antisense ncRv12659 RNA. Only a 
transcript initiated from the tRNA promoter is evidenced. 
C. Northern blot analysis. 20 µg of total RNA from each isolate was used to 
probe for ncRv12659 at the 3’ end to allow detection in the PhiRv2 negative 
background. 
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6.6 Proteomic Analysis during starvation 
Due to the original up regulation of Rv2660c observed during starvation, 
protein extracts were analysed to determine expression at the proteomic 
level. Both exponential and stationary phase cultures were prepared and 
protein extracts made as described in section 2.8.6. This protocol was 
optimised for selected reaction monitoring (SRM), which allows the 
detection of low abundance proteins within mixed populations by mass 
spectrometry [248]. SRM results in 70% of the proteome being detectable 
within unfractionated cell lysates from liquid culture, with the detection limit 
being below 10 copies per cell [249, 250]. 
With this level of sensitivity we failed to detect any of the three tryptic 
peptides belonging to Rv2660c that are compatible with the analysis. It is 
of note that synthetic peptides ran as controls could be detected further 
indicating the absence of Rv2660c, Figure 6.5. 
Taken together the absence of both a detectable transcript and 
corresponding protein for the hypothetical Rv2660c from either 
exponential or starved cultures, can only lead to the conclusion that the 
previously observed starvation signal is attributable to the sRNA 
ncRv12659 and has little or no contribution from Rv2660c.  
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Figure 6.5 SRM analysis of tryptic peptides from Rv2660c. (Taken from 
[155]) 
SRM traces over 96 hours of a PBS starvation experiment show three tryptic 
peptides from Rv2660c and a peptide derived from Rv3457c which acts as a 
positive control.  
The first column shows the SRM signals of the synthetic reference peptides 
spiked into the first time point. The other three columns show the SRM signals in 
samples without reference peptides spiked in. No signal for the targeted peptides 
was detected. 
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6.7 Expression of ncRv12659 during mouse infection 
Due to the success of the H56 vaccine it was important to assess the 
expression of ncRv12659 during infection using the mouse model 
employed in the H56 vaccine study [245]. 
Mice were infected with either the PhiRv2 positive H37Rv or the PhiRv2 
negative N0072 for 31 days. Subsequently mice were sacrificed and RNA 
extracted from the lung tissues and then assessed by qRT-PCR in a 
comparison with in vitro cultures. Two primer sets were used in order to 
distinguish between the PhiRv2 positive ncRv12659 RNA, and the PhiRv2 
negative tRNA. These were termed the 5’ and 3’ amplicons. 
The 5’ amplicon consisted of a forward primer within the PhiRv2 derived 
part of the sequence and hence would only be detected in the presence of 
the PhiRv2 region such as in H37Rv. The 3’ amplicon contains primers 
downstream of the tRNA repeat and is therefore present in both PhiRv2 
positive and negative strains Figure 6.6. The 5’ amplicon baseline was set 
at the level of background detectable in the PhiRv2 negative background 
as this level was considered noise in the absence of target sequence. 
Expression of the 5’ amplicon was found to increase 50 fold in response to 
starvation and 6 fold in response to infection when compared against 
exponential phase levels in M. tb H37Rv, Figure 6.6. 
The 3’ amplicon was observed at much lower levels than the 5’ amplicon 
with a 2 fold reduction observed in comparison to the 5’amplicon for 
H37Rv in exponential phase. During starvation and infection the 3’ 
amplicon dropped below baseline Figure 6.6. In the PhiRv2 negative 
N0072 samples the 3’ amplicon was detected at very low levels in 
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exponential phase and reduced further under starvation conditions 
indicating that read through from the tRNA operon has a minimal 
contribution to the signals observed and importantly only the PhiRv2 
promoter is induced by starvation. Due to the nature of the qRT-PCR 
design, the amplicons observed also show that there is no detectable 
Rv2660c transcript in the PhiRv2 negative N0072 strain during infection. 
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Figure 6.6 Expression of ncRv12659 during infection (taken from [150]) 
qRT-PCR was performed on RNA extracted from  in vitro culture in exponential 
and starvation phase in addition to extraction from the lung tissue of infected 
mice. Both 5’ and 3’ amplicons were measured as depicted in the schematic. Data 
represents the mean and standard deviation of three biological replicates 
  
H37Rv N0072 
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6.8 Over expression of ncRv12659 
M. tb H37Rv contains two prophage elements PhiRv1 and PhiRv2 both 
possessing a similar arrangement of integrase and repressor like proteins; 
with inward and outward facing promoters, Figure 6.7. 
PhiRv2 is a prophage element and therefore lacks the full complement of 
genes to act as an active phage within M. tb. However, analysis with other 
temperate bacteriophages shows that the promoter of ncRv12659 is 
probably responsible for driving expression of the phage genes in its 
circular chromosome, Figure 6.7.  
For 51 amino acids from the phage gene ORF of Rv2647 structural 
homology was identified for a potential binding site of a korB repressor 
from plasmid RP4 [251]. Repeat sequences of 14 nucleotides were 
identified upstream of several phage genes which represent potential 
repressor binding sites, and are represented by red boxes in Figure 6.7. 
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Figure 6.7 PhiRv2 represented as a circular virion (taken from [155]). 
After phage integration into the M. tb genome at the valU tRNA gene the 
promoter upstream of Rv2645 drives outward expression of the sRNA. Potential 
repressor binding sites are shown in red. 
 
  
  
 
219 
 
As the sRNA is a mixture of both host and phage sequence in addition to 
the conservation of the sequence within the lysogen it was hypothesised 
that ncRv12659 could have a functional impact on M. tb, especially in light 
of the activation of the promoter under starvation conditions. To test this 
hypothesis an over expression strain was constructed using a replicating 
plasmid that contained the sRNA under its own promoter called 
pMSC12659. This plasmid contained portions of downstream and 
upstream sequence in order to include any regulatory elements including 
potential termination signals (base pairs 1-471 in Figure 6.4). 
The plasmid was electroporated into both the PhiRv2 positive H37Rv and 
PhiRv2 negative N0072. Following successful transformation, cultures 
were grown to exponential phase and RNA extracted. Analysis of the 
samples by qRT-PCR showed that over expression of ncRv12659 was 
around 1000-fold in both strains, reaching around 10% of 16S rRNA levels 
Figure 6.8A. This resulted in a small but significant reduction in the growth 
rate of both strains Figure 6.8B.  
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Figure 6.8 Analysis of ncRv12659 over expression (adapted from [155]) 
 
A. Expression levels of ncRv12659 in three strains upon over expression of 
ncRv12659. Expression was normalised to 16S rRNA and data represents the 
mean and standard deviation of three biological replicates. 
B. Growth of the ncRv12659 over expressing strains where H37Rv is a PhiRv2 
positive background and N0072 PhiRv2 negative. Each data point represents 
mean and standard deviation from three biological replicates.  
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In order to assess the function of ncRv12659, microarray analysis was 
performed on the H37Rv strain harbouring the over expression using 
Oligonucleotide arrays, as described in section 2.8.13 using AMADID 
027543. A fold change cut off of 2 with a p-value of 0.05 was initially 
selected and this resulted in differential expression of more than 100 
probes. In order to focus our search we increased the fold change to 4 
with a p-value of 0.05. This resulted in 27 probes of which 6 corresponded 
to sequence contained in the over expression construct and so were 
discarded from the analysis. This left 21 probes which corresponded to 11 
genes Table 6.2. Thirteen of the probes identified could be aligned with 
Rv0257. These repeat loci have been linked to hypothetical protein 
products in various genomic locations, although frame shifts present 
indicate that the coding capacity is not conserved between each locus. 
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Gene 
Name 
Fold Change 
OE/WT 
Average of 
probes 
Regulation Repeat 
Locus 
MT1650.1 113.3 113 Up 4 
MT1560.1 80.5 80 Up 3 
MT0270.2 50.3 50 Up 1 
Rv1137c 31.8 32 Up 2 
Rv3613c 8.3 8 Up 6 
MT2423.1 95.8 6 Up 5 
MT2423.1 81.5 - - - 
MT2423.1 62.6 - - - 
Rv0257 90.4 6 Up 1 
Rv0257 86.2 - - - 
Rv0257 21.9 - - - 
Rv3612c 5.8 6 Up 6 
Rv3612c 5.7 - - - 
Rv2659c 4.5 4 Up N/A 
Rv2659c 3.8 - - - 
Rv2658c 4.6 4 Up N/A 
Rv2658c 3.8 - - - 
Rv2658c 3.6 - - - 
Rv3229c 4 7 Down N/A 
Rv3229c 8 - - - 
Rv3229c 9 - - - 
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Table 6.2 Gene expression changes by microarray upon over expression of 
ncRv12659 (adapted from [155]) 
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Five probes associated with the PhiRv2 region were identified in the array 
with an observed up regulation of Rv2659c and Rv2658c 4 and 5-fold 
respectively, Figure 6.9A. Although over expression resulted in a reduction 
in growth rate, only one gene, Rv3229c was observed to be down 
regulated more than 4 fold. Analysis by qRT-PCR confirmed down 
regulation with a fold change of 8.2.  
As desA3 was the only down regulated gene observed, the PhiRv2 
negative strains N0072 and BCG were also used to construct over 
expression strains using pMSC12659 to determine if this was a phage 
specific phenomenon. Analysis of desA3 in the different backgrounds 
revealed a reduced down regulation of between1.5 - 2 fold in the PhiRv2 
negative background of N0072 and BCG, Figure 6.9B. This would suggest 
that the greater down regulation observed in the PhiRv2 positive H37Rv is 
due to the presence of PhiRv2 genes other than ncRv12659. 
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Figure 6.9 Expression analyses by qRT-PCR (taken from [155]) 
A. Expression level in the over expression strain compared to the empty vector 
control. Data represents mean and standard deviation of three biological 
replicates. 
B. Expression levels of desA3 in three different PhiRv2 backgrounds over 
expressing ncRv12659. Data represents mean and standard deviation of three 
biological replicates. All expression was normalised to 16S rRNA. 
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6.9 Discussion 
Both RNA seq and northern blot analysis have demonstrated that the 
transcriptional signals previously assigned to Rv2660c are in fact that of a 
sRNA encoded on the opposite strand of the DNA. This observation has 
also been observed by others [252]. By assessing a variety of culture 
conditions and strains we have failed to detect expression of Rv2660c on 
either the transcript or proteomic level. 
Investigations by other groups either during long term starvation [253] or 
high coverage proteomic mapping [250, 254] also failed to detect Rv2660c 
on the proteomic level. Only one group have suggested detection of 
Rv2660c peptides from BCG but only two out of thousands of mass 
spectra were detected leaving the existence of Rv2660c questionable but 
highly unlikely. 
The sRNA was created by the insertion of PhiRv2 into the genome of M. tb 
and it is therefore only found in strains which are PhiRv2 positive. Due to 
the loss of many of the genes required for a complete virion it would 
suggest that PhiRv2 infected an early ancestor. Subsequent selective 
pressures on M. tb have caused specific genes to be deleted which 
include tail proteins, and hence only the cryptic prophage remains. 
The starvation induction of the sRNA ncRv12659 along with the phage 
integrase Rv2659c is likely due to the release of a repressor that allows 
the initiation of phage lysis of the cell. The determinants for lysis and 
lysogeny have been shown by others to be closely linked to nutrient 
availability to the host and could explain why the induction of ncRv12659 
is so marked in response to starvation [255-257]. 
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ncRv12659 was observed to accumulate during infection with the 
observation that this was only at the 5’ end of the transcript suggesting 
processing, early termination, and or a lack of stability for the 3’ end of the 
transcript. It is possible that the tRNA portion of the sequence stabilises 
the transcript by increasing its secondary structure.  
ncRv12659 is not the only sRNA that has been observed to accumulate 
during infection  [3]. However, the starvation induction of this transcript 
provides a useful marker for cells that are starved for either nutrients or 
oxygen and which may be fated to become persisters [187, 243, 244]. 
Both phage and host sequence are present in the sRNA transcript and it 
was therefore possible that over expression of ncRv12659 could result in 
an effect on the physiology of M. tb. Over expression did result in a 
reduction of growth although the transcriptional changes observed showed 
down regulation of only one gene, desA3.  
Of the up regulated genes, those belonging to the phage were the most 
significantly changed along with probes for a novel repeat region. The 
induction of the phage integrase Rv2659c along with the strong over 
expression of ncRv12659 could be the result of a repressor being 
sequestered due to multiple binding sites being available. The novel 
repeat regions contained no upstream sequence similarity and their 
functions, whether coding or non-coding are yet to be identified.  
The findings of this study suggest that the 5’ end of ncRv12659 is a useful 
starvation marker for analysis of M. tb during infection, although this is 
limited to PhiRv2 positive strains. It seems unlikely that the up regulation 
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of this starvation induced locus would play a direct role in increasing the 
efficacy of the H56 vaccine.  
This raises the question that if Rv2660c is a misannotation, how does its 
inclusion in the vaccine enhance protection? It is possible that the 
recombinant Rv2660c protein elicits a T cell response which results in a 
cross reaction between an unidentified M. tb antigen. This theory is 
supported by the finding that T cells isolated from infected individuals 
show responses to stimulation with Rv2660c [258]. Interestingly, a greater 
response was elicited from T cells isolated from latently infected 
individuals as opposed to those with active disease [258]. 
It also remains possible although unlikely; that there is a specific and as 
yet unidentified condition under which Rv2660c is induced. If this was the 
case, this expression condition could provide the key to understanding 
latent infection. It is important to understand how Rv2660c improves the 
efficacy of the H56 vaccine. Further studies could also help explain why 
another vaccine candidate containing antigen 85A failed to induce 
protection [259, 260]. 
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7 Concluding Remarks 
The majority of documented sRNAs regulate through base-pairing with a 
target mRNA resulting in a change in translation and/or stability of the 
mRNA. It was for this reason that transcriptomic and proteomic profiles 
were studied upon generation of sRNA deletion mutants. It was expected 
that microarrays would indicate increases or decreases in mRNA stability, 
whereas proteomic analysis would show if regulation resulted in translation 
repression or activation. 
Unfortunately the sRNAs selected in this study did not result in clear defined 
mechanisms of action using these techniques. This study generated mutant 
strains of the 4 candidate sRNAs and assessed their transcriptomic and 
proteomic profiles in order to identify their regulatory targets. This approach 
did not result in the clear identification of targets as hoped. Transcriptomic 
and proteomic profiles for both ncRv11690 and ncRv10243 deletion strains 
in particular lacked any discernible targets. A summary of the findings of 
these studies can be found in Table 7.1 
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sRNA Key Findings 
ncRv10243  sRNA is non- essential under the conditions tested. 
 Expression is induced in mouse infection and starvation 
 Deletion results in a heat shock signature after 24hrs starvation 
 ΔncRv10243 is impaired in recovery from the Wayne Model 
 ΔncRv10243 is not attenuated in a macrophage or mouse model of 
infection. 
ncRv11690  sRNA is non- essential under the conditions tested. 
 ΔncRv11690 transcriptional changes indicate a role in metal ion 
homeostasis 
 Over expression results changes in cell wall and cell wall process 
proteins involved in regulation of EsxA 
 ΔncRv11690 is not attenuated in a macrophage or mouse model of 
infection 
ncRv13661  sRNA is non- essential under the conditions tested. 
 Transcriptional responses implicate involvement in long term 
persistence by diverting carbon from fatty acid degradation to storage 
lipids 
 Efflux pump Rv1218c is concordantly regulated in deletion and over 
expression strain indicating involvement in regulation of cell wall 
constituents 
 Deletion affects expression of PDIM associated genes ppsA-D. 
 Over expression results in a down regulation of DNA repair proteins of 
which one (recA) is a predicted target. 
 ncRv13661 does not exclusively co migrate with RNAP and is therefore 
not acting as a 6S homologue. 
 ΔncRv13661 is not attenuated in a macrophage or mouse model of 
infection 
ncRv12659  Induced by starvation and mouse infection 
 Rv2660c is not starvation induced 
 Over expression in PhiRv2 positive background results in up regulation 
of phage genes 
 Would be a useful biomarker for starvation in vivo 
 
Table 7.1 Summary of the key findings of the studies on each sRNA 
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There is only one sRNA in M. tb with an identified target to date. This sRNA 
is mcr7 which was identified in CHIP seq analysis using PhoP. By using 
target prediction and proteomic analysis of the secretome mcr7 was 
identified as regulating tatC, through translational repression. This search 
for a target of mcr7 was very much aided in its focus due to unpublished 
results from the group suggesting that secretion of Tat-dependent 
substrates was affected in the phoP mutant strain [156]. Importantly, RNA 
seq analysis of the PhoP mutant in the same study did not identify any 
differences in the expression levels of tatC.  If a mcr7 mutant was analysed 
using the methods employed in this study target identification would not 
have been possible. The knowledge of a well-defined system allowing very 
specific investigation of the secretome aided in the target identification for 
mcr7. This highlights the difficulties in studying sRNAs which is further 
hindered in M. tb where functional identification for a large number of 
proteins is yet to be ascertained. The characterisation of the functional mcr7 
in M. tb confirms that sRNA regulation in this important pathogen is 
comparable to other bacteria. It would therefore seem that the disappointing 
end points in this study were as a result of the limitations of the tools 
employed and not poor choice of candidates for investigation. 
The findings of the mcr7 study and the proteomic analysis of the 
ncRv11690 over expression occurred at the end of this project and 
therefore secretome analysis was not possible. Due to the implication of 
ncRv11690 in the regulation of the virulence factor EsxA this was 
unfortunate as such analysis could have proved highly informative. 
Obviously secretome analysis would not yield the answers to all sRNA 
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functions but the lessons learned from these studies shows alternate 
investigation to transcriptional analysis needs to be focused upon. 
An approach would be to test viability of mutants in a variety of stress 
conditions such as the Wayne model, where a phenotype was observed for 
the ncRv10243. Such survival experiments might be likely to reveal true 
induction conditions for the sRNA in question and allow target identification. 
In addition analysis of mutant strains by sucrose gradient ultracentrifugation 
can be employed to look at interacting protein partners through proteomic 
analysis of co-sedimented proteins. Full fractional analysis of mutant 
compared to wildtype could show differential sedimentation of proteins. 
If it were possible to identify essential sRNAs in M. tb these would be ideal 
candidates for study. However, lack of knowledge on essentiality of these 
RNAs prevents this selection process at present. Due to the size of sRNAs 
it is difficult to assess essentiality by transposon mapping, as is the case for 
protein coding genes. If a sRNA lacks a transposon it could simply be due 
to the lack of attaining one due to its size. It is known from studies in 
Salmonella however, that few sRNAs are known to be essential. 
Many sRNAs have been identified from studies of E. coli and Salmonella 
which possess the RNA chaperone Hfq. The importance of Hfq has been 
demonstrated in these bacteria by the pleiotropic effects of deletion. These 
phenotypes include decreased motility, attenuation in host cell invasion and 
decreased replication within macrophages [261, 262]. The strong 
phenotypes observed led to coIP studies with Hfq employing microarray or 
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RNA sequencing technologies to identify sRNAs [60, 263]. In addition to this 
many sRNAs originally identified in E. coli were found to be present in 
Salmonella by sequence conservation, and confirmed later in the coIP 
experiments. This represents another limitation in the study of sRNAs in M. 
tb which lacks the chaperone Hfq preventing this approach from being 
adopted. 
One method of identification employed has been the ‘reverse target search’ 
approach in which sRNAs were systematically deleted in Salmonella and 
resulting strains screened for the appropriate phenotype. All outer 
membrane proteins in Salmonella had known sRNA regulators except 
OmpX. Due to the lack of an identified sRNA regulator for OmpX 35 sRNA 
deletion strains were created and assessed for effects on OmpX synthesis. 
This screen identified the Hfq-dependent CyaR sRNA as an OmpX 
repressor [264]. This approach has major limitations for application to other 
targets and bacteria. The likelihood of RNA regulation of this outer 
membrane protein (OMP) was extremely high due to all other OMP having 
sRNA regulators identified. In addition this extremely laborious process of 
creating 35 deletion strains especially in a slow growing strain would not 
viable. The creation of deletion mutants in M. tb requires at least 6 months 
and is not a high throughput technique. 
Despite the increase in our knowledge of sRNAs, their contribution to 
virulence has been much less well established though examples have been 
demonstrated [58, 265, 266]. Phenotypic investigations for roles of sRNAs 
and mRNAs deletions in infection have traditionally relied on CFU readouts 
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to infer virulence. The role of sRNAs in infection is in its infancy but there 
have been few published studies that have employed RNA seq to monitor 
the response of the host cell to infection [267]. Exceptions include a study 
into the eukaryotic miRNA response to bacteria using either macrophage or 
HeLA cells and enriching for the miRNA fraction. Dual RNA seq would 
provide a much greater depth of understanding of the complex interplay 
between bacteria and host [268]. Cytokine readouts from host infections 
could also provide a route to functional characterisation [269]. 
sRNAs involved in Hfq-mediated interactions are generally degraded along 
with their mRNA target [13]. In contrast, we observed accumulation rather 
than degradation of M. tb sRNAs in both stationary phase and starvation 
induction model. Even higher levels of sRNA accumulation were observed 
in the lungs of infected mice as seen with other sRNAs [3], with ncRv13661 
achieving levels equal to 16S rRNA. This might suggest that the RNA 
degradation pathways in mycobacteria are distinct from other bacteria such 
as the model organism E. coli. 
The lack of phenotypes observed for the sRNA deletion strains along with 
small changes in mRNA target abundance leads to the conclusion that the 
sRNAs selected in this study (with the exception of ncRv13661) are either 
involved in the fine tuning the stress response under particular induction 
conditions or the specific induction conditions are yet to be identified.  
Assays where CFU measurements are used to measure survival of a 
particular stress are very limited. It is difficult to observe changes in specific 
stress experiments where more global protein-mediated responses can 
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mask that of the sRNA. This is especially evident in a whole animal infection 
model where the pathogenesis of M. tb does not rely on the expression of a 
single response but a coordinated array of responses and as such possess 
a plasticity that allows the maintenance of virulence. Few cases of deletion 
strains lead to attenuation and it is these candidate targets that drive drug 
development and discovery. 
However, it is important to understand the riboregulation occurring within M. 
tb for pathways involved in pathogenesis. This greater level of 
understanding of the biology of M. tb could lead to better targeted therapies 
and rational drug design. The increasing drug resistance in cases of 
tuberculosis make this all the more important. In fact RNAs could already 
represent valid targets as antimicrobials. Riboswitches in particular are 
being pursued as targets due to a high degree of sensitivity and specificity 
for their ligands [270]. Recently, one compound targeting the guanine 
riboswitch of S. aureus was shown to successfully reduce bacterial load in 
animals after infection [271]. 
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Appendix I – Media and buffer composition 
 
L-Broth/Agar  
10 g Tryptone  
5 g Yeast Extract  
10 g NaCl  
15 g Agar (if required; Difco, Becton Dickinson)  
dH2O to 1 litre  
Autoclave at 121 ºC for 15 minutes  
 
Mycobacteria 7H9 Broth 
2.35 g Mycobacteria 7H9 Broth Base (Sigma-Aldrich)  
4 ml Glycerol  
2.5 ml 20% Tween80 
dH2O to 900 ml  
Autoclave at 121 ºC for 15 minutes  
Add 100 ml ADC Supplement (Becton Dickinson)  
 
Mycobacteria 7H11 Agar  
21 g Mycobacteria 7H11 Agar Powder (Sigma-Aldrich)  
5 ml Glycerol  
dH2O to 900 ml  
Autoclave at 121 ºC for 15 minutes  
Add 100 ml OADC Supplement (Becton Dickinson)  
 
Sautons Medium  
0.5 g KH2PO4 
+/- 0.5 g MgSO4 where required 
4.0 g L-asparagine  
60 ml glycerol  
0.05 g Ferric ammonium sulphate  
2.0 g Citric acid  
0.1 ml 1 % ZnSO4.7H2O dH2O to 1 litre  
Adjust to pH 7.0  
Filter sterilized (0.22 µM)  
 
 
SSC Buffer (20x)  
175.2 g NaCl  
88.2 g Tris: Sodium Citrate  
dH2O to 1 litre  
Adjust to pH 7.0-7.2  
 
TBE Buffer (10X)  
121.1 g Tris Base  
61.83 g Boric acid  
18.6 g EDTA  
dH2O to 1 litre  
Adjust to pH 8.0  
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TE Buffer  
1.211 g Tris Base  
0.372 g EDTA  
dH2O to 1 litre  
Adjust to pH 8.3  
 
PBS  
8 g NaCl  
0.2 g KCl  
1.44 g Na2HPO4  
0.25 g KH2PO4 
dH2O to 1 litre  
Adjust to pH 7.5 
 
TBS (5X) 
12.1 g Tris  
146.2 g NaCl  
750 ml dH2O  
Adjust to pH 7.5 and make up to 1 litre. 
 
TTBS (5X) 
200 ml 5X TBS 
800 ml dH2O  
1 ml Tween20 
Adjust to pH 7.5 and make up to 1 litre. 
 
Semi-dry transfer buffer 
2.9g Glycine 
5.8 g Tris Base 
1.85 ml 20% SDS 
750 ml dH2O  
Check pH is 8.3 
200 ml Methanol and make up to 1 litre. 
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Appendix II – Oligonucleotides used in this study 
Primers used for cloning deletion constructs 
Primer Name Sequence (5’-3’) Description 
2823_3’F CGGAATTCAGTGACCGTTTGGCC ncRv13661 
targeting plasmid 
2823_3’R CGACTAGTCCCGCCAGTTGCTTC ncRv13661 
targeting plasmid 
2823_5’F GTAGATATCGCAATGGAAAGCAC ncRv13661 
targeting plasmid 
2823_5’R GCCGAATTCTGCGAAAGTTACGA ncRv13661 
targeting plasmid 
G2KOnewFHind 
 
CGCGGCCGCCGACTCACCAATGGG 
 
ncRv11690 
targeting plasmid 
G2KOnewRNot 
 
CAAGCTTGTCAACGCCTGCTCCAGTTGC 
 
ncRv11690 
targeting plasmid 
G2SDMF GGATGATGACCCGTTGTCTCTAGACCCTACC
GCCCAGCG 
ncRv11690 
targeting plasmid 
G2SDMR CGCTGGGCGGTAGGGTCTAGAGACAACGGG
TCATCATCC 
ncRv11690 
targeting plasmid 
F6RevXbaI 
 
GGTCTAGACGAGTGATCGGG 
 
ncRv10243 
targeting plasmid 
F6ForXbaI 
 
GGTCTAGATGGGCTTGCCC 
 
ncRv10243 
targeting plasmid 
F6RevSDM GGGGCAAGCCCAAAAAGATCTAGACCGAGT
GATCGGGTACCC 
ncRv10243 
targeting plasmid 
F6ForSDM GGGTACCCGATCACTCGGTCTAGATCTTTTT
GGGCTTGCCCC 
ncRv10243 
targeting plasmid 
 
Primers used for cloning complementing constructs 
Primer Name Sequence (5’-3’) Description 
2823compF GGGGATCCGCGCCCTAGCCGCC 
 
ncRv13661 
complementing plasmid 
2823compR GGGAAGCTTTGTCGATTGCCGAGTCGTTG ncRv13661 
complementing plasmid 
F6compF GAAAAGCTTGCCGCTGTTGACCAG 
 
ncRv10243 
complementing plasmid 
F6compR CGGATCCCTGCGCGGGCTGA 
 
ncRv10243 
complementing plasmid 
G2compF CGGAAGCTTAACCCGCCAAAGATAAGTCA ncRv11690 
complementing plasmid 
G2compR 
 
CGA TCT AGA ACG TCC TCG ACG TCC TCG 
GGT 
ncRv11690 
complementing plasmid 
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Primers used for PCR screening of SCO and DCO colonies 
Primer Name Description Sequence (5’-3’) 
F6pair2F ncRv10243 deletion 
screening 
CCGGCGGCCAAGGTGTG 
F6pair2R ncRv10243 deletion 
screening 
ACGGCGTCAAGCGGTTCATTAC 
F6pair3F ncRv10243 deletion 
screening 
GTGGGCGGTGCGGTGCTCAAACA 
F6pair3R ncRv10243 deletion 
screening 
GGGCCTGCGTGCGCTCTACCTCTA 
G2pair2F ncRv11690 deletion 
screening 
GCAGCTCGCGGCACCACCAAACAC 
G2pair2R ncRv11690 deletion 
screening 
GCGCGGCCCGGGAAACCTCTG 
G2pair3F ncRv11690 deletion 
screening 
AGCGCAGGTCGTGGCCAATGTAGG 
G2pair3R ncRv11690 deletion 
screening 
ACGGCACCAAGTTCGGCAAATCAA 
2823pair2F ncRv13661 deletion 
screening 
CGCCGCGCCGTGCTGAAGTC 
2823pair2R ncRv13661 deletion 
screening 
GCTGCGCCCGGAGGTATTGGTGT 
2823pair3F ncRv13661 deletion 
screening 
CCACCGCGACCCCCGATGACC 
2823pair3R ncRv13661 deletion 
screening 
CGACCCGCTGGCTCCGCTAATGG 
 
Oligonucleotides used for probe creation for northern blotting 
Riboprobe Name Sequence (5’-3’) 
2823nrt gcacccacgcggagtcatagccacgataacggcagaaCCTGTCTC 
G2nrt atcgatgcatccccaccccatccctcgagataagCCTGTCTC 
F6nrt cggatagccccgtgttgttgtctgaCCTGTCTC 
2048nrtLONG gacctgcggtttcatccacaaaatctgggctgcgtgaactaaatgtCCTGTCTC 
2660nrtLONG aacctttcggtggttgcaccgagtcagttcacatttagttcacgcagcCCTGTCTC 
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Primers used for qRT-PCR in ncRv10243 investigation 
Primer Name Sequence (5-3’) 
16sTqmF TCCCGGGCCTTGTACACA 
16sTqmR CCACTGGCTTCGGGTGTTA 
F6TqmF GGATAGCCCCGTGTTGTTG 
F6TqmR GGGATTGCCCCGCATT 
Rv0693TqmF CGATCCCGGCGAGTTG 
Rv0693TqmR TGCGTTCCAGTTCGTCGAT 
Rv0694TqmF GGAGGCTGCCGAAATCG 
Rv0694TqmF CGACCGTGATTCCCTTTTCA 
Rv1130TqmF TGAAGTGATCGTGGACGAACTG 
Rv1130TqmR CTGTTCAACGGGTTCCACTACA 
Rv0169TqmF CGGGCTGGGCGATAAGTT 
Rv0169TqmR GCGAATTGAGGTCATCCAGAA 
Rv0440TqmF CGTCGTCCTGGAAAAGAAGTG 
Rv0440TqmR GGTCTTCTTGGCTACCTCTTTGAC 
Rv3418cTqmF CGTTGCGGAGGGTGACA 
Rv3418cTqmR TCCTCGCCGTTGTACTTGATC 
Rv0990cTqmF GGCCGCGCACGATCT 
Rv0990cTqmR CGTTTTTCCAGCCTGACATCA 
Rv0991cTqmF TTCAAAGGCACCGGCTTCTA 
Rv0991cTqmR TGGTCTGGCTCTTGGACTTCTT 
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Primers used for qRT-PCR in ncRv11690 investigation 
Primer Name Sequence (5’- 3’) 
G2TqmF CTTCAGCGGGGGGCTTAT 
G2TqmR ATCTTATCTCGAGGGATGGGG 
DesA3TqmF GGCGCTGCGGTTCATG 
DesA3TqmR CAGGTCCGGATAGAGGTGATG 
Rv1535TqmF GACGCGCAGCCTTTCG 
Rv1535TqmR CCACAACGCGGCGTAGAG 
Rv3841TqmF TGCAATGATGCTCGTGCAA 
Rv3841TqmR TCTACGCCGGGAATTTCG 
Rv0791cTqmF ACATCCAGGGCACCATCTTC 
Rv0761cTqmR CCGGCCTTATACATCGACAAC 
Rv0846cTqmF CGACTGAGCCAGGCCACTA 
Rv0846cTqmR GCCGTCCGTCCAATCG 
Rv0634BTqmF CACCGTAACTACATCACCAAAAAGA 
Rv0634BTqmR CGCAATTCGGGCAGAACT 
Rv2582TqmF CCGATTAGCCTGTGCTTTCG 
Rv2582TqmR CGTTCGAGTTTGCGTTTGG 
Rv3116TqmF GCCCGCCGAGTTCGA 
Rv3116TqmR TCGCCTTTGGGTATCAAGATG 
Rv2338cTqmF TGTCGCAACCTTGGATTGATT 
Rv2338cTqmR GCGATTGCAACGCGACTAT 
Rv0891cTqmF GATGTTGGCCGATGTGAGTTC 
Rv0891cTqmR CGTCTAATCCCTGGTTGGCTAT 
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Primers used for qRT-PCR in ncRv13661 exponential phase investigation 
Primer Name Sequence (5’-3’) 
2823TqmF GGCGCCCAGCATGGT 
2823TqmR CATCTGCTGTTCGCAATTACG 
Rv1130TqmF TGAAGTGATCGTGGACGAACTG 
Rv1130TqmR CTGTTCAACGGGTTCCACTACA 
Rv1131TqmF CGGGATCTTGCCCAACCT 
Rv1131TqmR GAAGCTGGCGATGTCGAATC 
Rv2931TqmF CTGCGAGTGCCTGAGAAAGAG 
Rv2931TqmR GAATCGCCATTGCCATAAGG 
Rv1813cTqmF CGCCAACGGTTCGATGTC 
Rv1813cTqmR CAATCGCCCCGTAATGGATA 
Rv2948cTqmF GCATAGGTTTGCCGTTGTTGA 
Rv2948cTqmR CGCCACGCACCAATTTC 
Rv1935cTqmF CGGCACTGCTGATCAAGGA 
Rv1935cTqmR AGCTGGTGGATCTTGAAGCAA 
Rv2598TqmF CTACCACCTCCAATCCCATACC 
Rv2598TqmR CGCGTGCAGCGTTCAC 
Rv0676cTqmF CGCCCATGCGTTTTACG 
Rv0676cTqmR CCCCCAAAAGTCCTGCAA 
Rv0678TqmF TGATCCAATTTGGGTTCATTGA 
Rv0678TqmR GCCCGGATGCGTTCAC 
Rv2428TqmF TGCTAACCATTGGCGATCAA 
Rv2428TqmR ACAGGTCACCGCCGATGA 
Rv2934TqmF AAGGCGCGTCCTTGCAT 
Rv2934TqmR CGAATAGTGTCAGCGTTGTTGAG 
Rv1592TqmF TGACCCAAATGGAGCTGTTG 
Rv1592TqmR GGTACTGATACCGCCCATCCT 
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Primers used for qRT-PCR in ncRv13661 stationary phase investigation 
Primer Name Sequence (5’-3’) 
Rv0270TqmF TCGACCAGCTGGAGAAAACC 
Rv0270TqmR CCGGATACGAACACGATCTTC 
Rv0721TqmF GTCGCTGGGCAGTGACAAC 
Rv0721TqmR GACGTCCTCTATCGGCAAACC 
Rv0867cTqmF CCTTGCCACCGATTTGGA 
Rv0867cTqmR TTCTTCGTATAGGCGATGTTCGA 
Rv1252cTqmF GCCCGATACCTATGGGTTCA 
Rv1252cTqmR CGTCAATGCCACCGTGTCT 
Rv2140cTqmF GCGGTGAAGGTCGAAAAGC 
Rv2140cTqmR CGTGCTGGAACAGGTTGAATC 
Rv2692TqmF CCGCAACGAGTGGCTGTT 
Rv2692TqmR TGACGGCCTCTTCGATCAG 
Rv2725cTqmF GGCTGTGCAGGTTAAGGTTATTG 
Rv2725cTqmR GCATGCTGGGCAAAGATGT 
Rv2884TqmF GCTCACCGAATTCAAACTCATG 
Rv2884TqmR GCCGAGTCCGGGTGAAC 
Rv2342TqmF CGTGGCCAGGTCGATGAT 
Rv2342TqmR CAGGGTCACAAACCCAGCAT 
 
Primers used for qRT-PCR in ncRv13661 propionate growth investigation  
Primer Name Sequence (5’-3’) 
Rv1217cTqmF TGGGTGCGGTCGGAATC 
Rv1217cTqmR GCCGAATCACCGTGAGGAT 
Rv1218cTqmF AAGCGCTGTGCGAAAAGG 
Rv1218cTqmR CGTCTAGTGAACCGCTTTCGA 
Rv1219cTqmF ATGGCCGAGATCGAATCCT 
Rv1219cTqmR CGCCGGATTGCATGCT 
 
Primers used for qRT-PCR in ncRv12659 investigation 
Primer Name Sequence (5-3’) 
16sTqmF TCCCGGGCCTTGTACACA 
16sTqmR CCACTGGCTTCGGGTGTTA 
5’q12659F CACCGGCCCACTAGTGAAAC 
5’q12659R GGATGAAACCGCAGGTCAA 
3’q12659F TGACCTGCGGTTTCATCCA 
3'q12659R TGCACCGAGTCAGTTCACATTTA 
2658cTqmF CGAAGCTTCACGAGCTGAGA 
2658cTqmR GCGCCTCTGCTATTGATGGA 
2659cTqmF GGCTGAAGCAGCGTGGAAT 
2659cTqmR TTGTCCAGCAGTTTGCGATAGT 
Rv3229cTqmF GGCGCTGCGGTTCATG 
Rv3229cTqmR CAGGTCCGGATAGAGGTGATG 
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Appendix III  
SNP analysis from High throughput sequencing of gDNA extracted from M. tb strains 
 
 
SNP type coding_type codon_change aminoacid_change gene gene_name H37Rv_allele * derived_allele * H37Rv ΔncRv11690B ΔncRv10243 ΔncRv13661
293606 intergenic - - - - - G T G G T G
293607 intergenic - - - - - A C A A C A
337959 coding nonsynonymous aTc/aGc I372S Rv0279c PE_PGRS4 A C C C C A
1212228 coding synonymous ggA/ggC G223 Rv1087 PE_PGRS21 A C A A A C
1313338 intergenic - - - - - A G A A A G
1313339 intergenic - - - - - A C A A A C
1780588 coding synonymous cgC/cgG R130 Rv1575 Rv1575 C G G G G C
1916491 coding synonymous gcG/gcA A181 Rv1691 Rv1691 G A G A G G
2864730 coding nonsynonymous Cgg/Tgg R102W Rv2541 Rv2541 C T C C T C
3054724 coding nonsynonymous Agc/Ggc S271G Rv2741 PE_PGRS47 A G G G G A
3278306 coding synonymous ttC/ttT F1470 Rv2940c mas G A G G G A
3278390 coding synonymous gtT/gtC V1442 Rv2940c mas A G A A A G
3278391 coding nonsynonymous gTt/gGt V1442G Rv2940c mas A C A A A C
3550149 intergenic - - - - - G A G G G A
4101048 intergenic - - - - - G A G G G A
4101049 intergenic - - - - - T G T T T G
4178146 intergenic - - - - - C T C C T C
17
JHD2 JHD3 JHD4 JHD5
SNPs number: 3 1 7 12
* bases are relative to the forward strand, but the codon_change column is strand correct
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Appendix IV – Microarray results for ΔncRv11690 
 
 
ID 
Corrected  
p-value p-value 
Fold 
change regulation 
MtH37Rv-0097 (1I1) 0.04241779 5.99E-04 2.97 down 
MtH37Rv-0098 (1J1) 0.04769973 9.11E-04 2.24 down 
MtH37Rv-0128 (8J2) 0.04241779 6.56E-04 2.27 down 
MtH37Rv-0310c (2I18) 0.04241779 2.90E-04 2.05 down 
MtH37Rv-0348 (2I22) 0.04241779 5.34E-04 2.21 down 
MtH37Rv-0465c (1B21) 0.04241779 5.51E-04 2.05 down 
MtH37Rv-0467 (9O14) 0.04567742 7.71E-04 2.36 down 
MtH37Rv-0565c (9M17) 0.049999036 0.001881779 2.12 down 
MtH37Rv-0634B (11F14) 0.04241779 2.64E-04 2.79 down 
MtH37Rv-0644c (9O22) 0.04769973 0.001017182 2.17 down 
MtH37Rv-0760c (3N19) 0.04241779 3.97E-04 2.07 down 
MtH37Rv-0761c (3O19) 0.04769973 0.00104955 2.66 down 
MtH37Rv-0846c (4K3) 0.04769973 0.001120128 2.73 down 
MtH37Rv-0854 (4I4) 0.04121322 8.95E-05 2.07 down 
MtH37Rv-0888 (4O6) 0.048158832 0.001643126 2.23 down 
MtH37Rv-0891c (4I7) 0.04075228 1.43E-05 2.48 down 
MtH37Rv-0925c (4I10) 0.04121322 8.96E-05 2.17 down 
MtH37Rv-1008 (5E5) 0.04241779 3.51E-04 2.07 down 
MtH37Rv-1078 (5F11) 0.04241779 6.45E-04 2.29 down 
MtH37Rv-1374c (5N1) 0.04769973 0.00120875 2.04 down 
MtH37Rv-1490 (5O11) 0.04769973 0.001425657 2.11 down 
MtH37Rv-1498c (5N12) 0.04241779 3.01E-04 2.41 down 
MtH37Rv-1515c (5C14) 0.04769973 0.001143594 2.54 down 
MtH37Rv-1535 (10A22) 0.04769973 0.001074942 3.95 down 
MtH37Rv-1724c (7J21) 0.04964896 0.001846333 2.34 down 
MtH37Rv-1749c (7K23) 0.04769973 0.001240551 2.03 down 
MtH37Rv-1754c (7O23) 0.04241779 3.32E-04 2.53 down 
MtH37Rv-1860 (7F8) 0.04241779 3.33E-04 2.50 down 
MtH37Rv-1885c (7C11) 0.04241779 4.51E-04 2.55 down 
MtH37Rv-1980c (6O6) 0.04241779 6.31E-04 2.30 down 
MtH37Rv-2000 (6L14) 0.04241779 5.45E-04 2.59 down 
MtH37Rv-2001 (6M14) 0.04241779 4.91E-04 2.43 down 
MtH37Rv-2140c (6I19) 0.04121322 1.57E-04 2.08 down 
MtH37Rv-2185c (6N23) 0.04241779 5.42E-04 2.16 down 
MtH37Rv-2281 (5K21) 0.048893973 0.001685406 2.16 down 
MtH37Rv-2288 (8O13) 0.04769973 9.55E-04 2.63 down 
MtH37Rv-2289 (5P21) 0.041673273 1.76E-04 2.63 down 
MtH37Rv-2299c (5P22) 0.045126397 7.14E-04 2.97 down 
MtH37Rv-2332 (6A2) 0.04241779 2.67E-04 2.1 down 
MtH37Rv-2338c (6G2) 0.04769973 8.80E-04 2.00 down 
MtH37Rv-2429 (6D10) 0.04964896 0.001792336 2.59 down 
MtH37Rv-2520c (8P21) 0.04567742 7.60E-04 2.73 down 
MtH37Rv-2529 (6E19) 0.04769973 0.001481529 2.10 down 
MtH37Rv-2560 (6C22) 0.04121322 1.46E-04 2.42 down 
MtH37Rv-2563 (8M23) 0.04121322 9.75E-05 2.18 down 
MtH37Rv-2582 (6E24) 0.04121322 4.36E-05 2.94 down 
MtH37Rv-2699c (10F4) 0.04769973 9.20E-04 3.53 down 
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ID 
Corrected  
p-value p-value 
Fold 
change regulation 
MtH37Rv-2876 (10B11) 0.04964896 0.001754237 2.23 down 
MtH37Rv-3033 (3C16) 0.04241779 2.30E-04 2.42 down 
MtH37Rv-3116 (3G23) 0.04241779 4.08E-04 2.11 down 
MtH37Rv-3168 (3I4) 0.04121322 1.59E-04 2.19 down 
MtH37Rv-3169 (3J4) 0.04769973 0.001102102 2.16 down 
MtH37Rv-3198A (11M5) 0.04121322 5.51E-05 2.31 down 
MtH37Rv-3229c (3P9) 0.04769973 0.001477411 6.70 up 
MtH37Rv-3390 (4A12) 0.04241779 6.25E-04 2.07 down 
MtH37Rv-3472 (4E19) 0.04612943 7.95E-04 2.06 down 
MtH37Rv-3528c (4A24) 0.04567742 7.48E-04 3.48 down 
MtH37Rv-3750c (11B6) 0.04769973 8.88E-04 2.24 down 
MtH37Rv-3789 (3A12) 0.04241779 3.59E-04 2.07 down 
MtH37Rv-3790 (3B12) 0.04121322 1.22E-04 2.53 down 
MtH37Rv-3822 (8A3) 0.04769973 0.001499619 2.08 down 
MtH37Rv-3831 (8E3) 0.04241779 2.42E-04 2.09 down 
MtH37Rv-3841 (8G4) 0.04769973 0.001290105 2.94 up 
MtH37Rv-3891c (11A11) 0.04769973 0.001150007 2.14 down 
MtH37Rv-3914 (11G11) 0.04769973 0.001338082 2.04 down 
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Appendix V – Microarray results for over expression of 
ncRv13661 during growth on propionate 
 
Gene Fold change Average p value 
Regulation in Over 
Expression 
MT0196 3.0587957 0.00980657 Down 
MT1182 3.0006094 0.023238488 Down 
MT2011 3.0349927 0.006924124 Down 
MT3762 35.238476 0.006237192 Up 
Rv0057 2.86091175 0.015669447 Down 
Rv0059 2.61027485 0.01868597 Down 
Rv0060 3.0894288 0.026269772 Down 
Rv0094c 2.957336 0.030012533 Down 
Rv0095c 2.8233376 0.014221886 Down 
Rv0118c 2.74658885 0.0136694 Up 
Rv0181c 3.1077776 0.025533231 Down 
Rv0182c 3.0271215 0.029473556 Down 
Rv0186 3.7745452 0.01055969 Down 
Rv0251c 2.5038342 0.009377076 Down 
Rv0336 2.9063153 0.020244885 Down 
Rv0412c 2.8750796 0.009912577 Down 
Rv0631c 5.8720517 0.048923384 Up  
Rv0677c 2.6815865 0.013024882 Up 
Rv0678 2.5164318 0.026071586 Up 
Rv0867c 3.7430665 0.015942314 Up 
Rv1128c 3.4049668 0.024536425 Down 
Rv1148c 3.805765 0.010034436 Down 
Rv1216c 2.617082 0.006774418 Up 
Rv1217c 3.3887401 0.030274616 Up 
Rv1218c 2.7499008 0.013520777 Up 
Rv1219c 2.705120033 0.019153395 Up 
Rv1221 5.0242654 0.00856264 Down 
Rv1223 3.7582123 0.024196637 Down 
Rv1277 3.3219272 0.024417192 Down 
Rv1278 2.8379604 0.015888278 Down 
Rv1406 2.554684 0.02209204 Down 
Rv1588c 2.84607185 0.017964559 Down 
Rv1638 2.7975264 0.013553251 Down 
Rv1724c 2.5253325 0.042626966 Down 
Rv1765c 2.858969 0.021133548 Down 
Rv1833c 3.83359035 0.006236968 Down 
Rv1945 3.4613276 0.039719146 Down 
Rv1948c 2.6439235 0.029949432 Down 
Rv1961 3.91197285 0.007089806 Down 
Rv1992c 3.2435637 0.028226381 Down 
Rv1993c 2.8233626 0.014726047 Down 
Rv1994c 2.76717055 0.019774498 Down 
Rv2011c 2.7260609 0.009694663 Down 
Rv2015c 2.6771557 0.009516206 Down 
Rv2023A 2.9150717 0.048923384 Down 
Rv2024c 2.563521 0.019562772 Down 
Rv2107 21.123097 0.015234817 Down 
Rv2108 6.4326725 0.016876131 Down 
Rv2693c 3.85578315 0.007963537 Down 
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Gene Fold change 
 
Average p value 
 
 
Regulation in Over 
Expression 
Rv2710 2.8844397 0.013936628 Down 
Rv2717c 3.7130489 0.023848809 Down 
Rv2719c 2.864418833 0.013706735 Down 
Rv2734 2.8250954 0.017285895 Down 
Rv2742c 3.17499335 0.017598349 Down 
Rv2934 2.5031354 0.048960336 Down 
Rv2974c 2.9324815 0.010789794 Down 
Rv3017c 4.145676 0.003636259 Down 
Rv3191c 4.200498 0.01055969 Down 
Rv3201c 2.8019693 0.016812492 Down 
Rv3223c 2.6593902 0.017057654 Down 
Rv3252c 2.6010687 0.027826516 Down 
Rv3269 2.8918612 0.00440765 Down 
Rv3270 2.7440443 0.017680854 Down 
Rv3370c 2.63619445 0.020636477 Down 
Rv3463 2.8282888 0.008852384 Down 
Rv3466 2.5057275 0.00440765 Down 
Rv3585 2.5827568 0.012668396 Down 
Rv3639c 3.3419392 0.03373858 Down 
Rv3640c 4.40455655 0.024131601 Down 
Rv3641c 5.045832667 0.029639102 Down 
Rv3644c 2.7123706 0.008372897 Down 
Rv3776 3.0363762 0.01542011 Down 
Rv3839 3.7717898 0.049165383 Down 
TBFG_11172 4.214123 0.02545547 Down 
TBMG_04080 3.3390186 0.042626966 Down 
TBMG_04100 3.1477306 0.00980657 Down 
TBMG_04100 2.8947976 0.009516206 Down 
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Appendix VI - In vivo testing of ΔncRv13661 (DCO 3.21) 
 
 
Figure S1 Survival of the ΔncRv13661 in a macrophage model of infection  
Survival of Wildtype M. tb H37Rv, ΔncRv13661, and complementing strain 
within naive a) and IFN-γ activated BMDM b) over a time course of infection. 
Significance was tested with One-way ANOVA p>0.05. Data is the mean and 
standard deviation of triplicate infections.  
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Figure S2 Survival of ΔncRv13661 from aerosol infected mice. 
Survival of wildtype M. tb H37Rv, ΔncRv13661, and complement within the 
lungs and spleens of Balb/C mice. The data represents the averages and standard 
deviations from 5 mice per time point. Significance was tested with Two-way 
ANOVA. 
 
 
